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SUMMARY
Matrix metalloproteinases (MMPs) have been implicated in the aetiopathogenesis of 
periodontitis. MMPs are degradative host proteinases that are not only involved in the 
destruction process but also in embryologic development, tissue remodeling and wound 
healing processes. Accumulating evidence has gathered over the years for their 
involvement in periodontal destruction. Higher level of MMPs has been found in 
periodontitis sites compared to healthy sites or individuals. The 'active state' of the MMP 
enzyme has been associated with active periodontal lesions and reductions of MMP 
levels have been reported following periodontal treatment.
Repair and wound healing are most likely to be influenced by the matrix-modifying 
enzymes, the MMPs. MMP levels have been investigated during wound healing and 
stromelysin (SL) were found to be overexpressed and overactivated during the wound 
repair process. SL-1 and -2 have also been found in a variety of chronic wound lesions 
and also in acute skin wounds, suggesting their roles in tissue repair. MMP-9 levels 
measured 48 hours after injury can predict the amount of collagen deposited later as 
higher levels have been linked to retarded healing.
Resident connective tissue cells produce MMP-3 and MMP-8 are produced by 
polymorphnuclear leukocytes (PMN) in addition to fibroblasts of gingivae, mucosae and 
periodontal ligament. Both PMN and fibroblasts are increased during the wound healing 
process. PMN predominates immediately after the injury and up to three days after,
XVIII
while an increased number of fibroblasts are found in the granulation tissue after the third 
day onwards.
GTR is now an acceptable technique for the treatment of inffabony defects. 
Compromised clinical results have been associated with microbial contamination during 
the membrane insertion. Microbial contamination has also been demonstrated in 
association with a non-resorbable barrier membrane owing to the lack of tissue 
integration leading to pocket formation. With resorbable membranes, this factor has 
been eliminated and the only concern is membrane contamination during insertion. 
Preliminary microbiological results have demonstrated that Guidor® barrier membranes 
do not seem to develop facultative anaerobic bacteria and black pigmented gram-negative 
anaerobic rods in high numbers during the first 6 weeks post-operatively. High dose 
amoxycillin, a broad-spectrum penicillin active against aerobe and facultative anaerobic 
microflora given 1 hour prior to the guided tissue regeneration (GTR) procedure may 
reduce the possible contamination of the material and the wound during membrane 
insertion.
The purpose of the study was to investigate the clinical outcome, the microbiological 
colonization and the levels of matrix metalloproteinases during the wound healing 
following insertion of a resorbable membrane (GUIDOR®) either alone or combined with 
one presurgical systemic application of amoxycillin. It was also investigated whether the 
fluctuation of GCF levels of MMP-3 and -8  during the wound healing could be linked to 
the clinical outcome and microbiological colonization. Gingival crevicular fluid (GCF)
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samples were collected by means of sterile paper strips and the volume was assessed 
using the Periotron 6000. Fibroblast derived MMP-3 levels in GCF were assayed using 
modification of the sandwich ELIS As described by Cooksley et al. (1990). Antibodies 
detected both the active and the latent MMP-3. MMP-8 levels were determined by a 
time-resolved fluorescence immunoassay (FLA) as described by Hanemaaijer et al., 
(1997) for the detection of active MMP-8. The results were expressed as absolute 
amounts, that is, ng/30s of sample collection.
GCF samples were collected from test, surgical control and healthy control sites from 
each patient. The test sites are the sites treated with membranes and the surgical control 
sites were the adjacent teeth involved in the surgical flap without the membrane 
insertion. The MMP-3 levels were only altered at week one for the test sites, while for 
the surgical control and healthy control sites the levels remained undetectable at all visit. 
Inspection of individual data revealed that 45% of the surgical sites had detectable 
increase in MMP-3 at week one.
The active MMP-8 levels for the test sites were significantly higher compared to the 
healthy control sites. For the test there was a significant increase in the MMP-8 levels at 
week one. There were also increased levels for the surgical sites, but the differences 
were not significant from the baseline values. Based on evidence presented in the 
literature about cellular aspects during healing, it can be presumed that most of the 
MMP-8 levels present after week 1 were derived mostly from fibroblasts.
To assess the microbiological effects of placing bioresorbable membranes in deep 
inffabony pockets, microbiological samples were obtained from test and healthy control 
sites. Both sites had deep pockets with BOP but the test sites were treated by the GTR 
procedure. The results demonstrated that the presence of the bioresorbable membranes 
did not influence the number of microorganisms detected in both sites. In other words, 
these membranes do not appear to act as a niche for the colonization of microorganism.
To assess the clinical outcome of the GTR procedures using Guidor®, clinical 
measurements of pocket depth, clinical attachment level, relative attachment level, and 
clinical indices of plaque index and bleeding on probing were recorded at baseline and at 
6 and 12 month post-surgery. At one year post-surgery, a mean of 3.2mm pocket 
reduction and 2.6 mm of attachment level gain were achieved. In this study there was a 
significant negative correlation between the CAL gain and the plaque index at 12 
.months, demonstrating the fact that maintenance of good oral hygiene over the long-term 
is of paramount importance.
The present study found no differences between the antibiotic and non-antibiotic groups, 
in all clinical and biochemical aspects except that there was a greater percentage of 
microorganism's resistance to amoxicillin encountered in the antibiotic group. In 
conclusion, the clinical, microbiological and MMP results following the GTR procedure 
were not influenced by the administration of a high dose of pre-operative amoxicillin.
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CHAPTER 1 
INTRODUCTION
1.1 PERIODONTAL DISEASE
The term ‘periodontal diseases’ is a non-specific term that refers to any disease or disease 
process that affects the periodontium. The periodontium is a functional system of 
different tissues supporting the teeth, comprising two soft tissues and two hard tissues 
namely the gingivae, the periodontal ligament, the cementum and the alveolar bone. The 
term ‘periodontal disease’, as commonly used, refers to the inflammatory periodontal 
diseases, which are broadly grouped into two distinct entities, depending upon the 
regional involvement of the inflammatory response: gingivitis and periodontitis. Both 
gingivitis and periodontitis are bacterial plaque associated diseases. Gingivitis refers to 
reversible inflammatory changes which are confined to the gingivae, and are clinically 
manifested by a change in colour (redness), texture and appearance (swelling) of the 
gingivae, together with an increased tendency to bleeding on gentle probing and gingival 
sensitivity (Loe, Theilade & Jensen, 1965). Periodontitis occurs when advanced 
destruction of both the hard and soft connective tissues becomes evident as a result of 
bacterial downgrowth leading to pocket formation and irreversible bone loss. 
Periodontitis being an inflammatory, bacterially induced disease has several features 
including visual signs of inflammation i.e. bleeding from the gingivae on probing, pocket 
formation, recession, tooth mobility and migration as well as recognizable radiographic 
evidence of bone loss.
1.2 THE PERIODONTIUM
1.2.1 Gingivae
The gingivae is the most peripheral component of the periodontium that begins at the 
mucogingival junction and terminates as the free marginal gingivae surrounding the 
cervix of each tooth.
Healthy gingivae is described as “salmon or coral pink,” firm in consistency and not 
movable upon the underlying structures. The interdental papillae are firm, do not bleed 
on gentle probing and occupy the entire space available below the contact area of 
neighbouring teeth. The surface of the gingivae is keratinised and may also exhibit 
stippling.
The gingivae comprises the free gingivae and the attached gingivae. The healthy free
gingivae has a scalloped outline and terminates in the free gingival margin. The free
gingival margin is often rounded in such a way that a small invagination or sulcus is 
formed between the tooth and the gingivae. When a probe is inserted into this
invagination and advanced apically towards the cemento-enamel junction (CEJ) a
gingival pocket is opened. The epithelium covering the free gingivae is divided into oral 
epithelium, oral sulcular epithelium and junctional epithelium (JE) as illustrated in 
Figure 1.1. The oral epithelium faces the oral cavity, the oral sulcular epithelium faces 
the tooth without being in contact with the tooth surface and the JE participates in the
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Figure 1.1 Schematic drawing o f the epithelium covering the free gingivae. The oral 
epithelium faces the oral cavity, the oral sulcular epithelium faces the tooth without in 
contact with the tooth surface and the junctional epithelium provides the contact 
between the gingivae and the tooth.
E: enamel; CT: connective tissue; B: alveolar bone
f
Oral sulcular 
epithelium
 ±_____
Junctional epithelium
S
Oral
epithelium
contact between the gingival soft tissues and the calcified structure of the tooth. JE 
manifests a uniform interface with the underlying connective tissue (CT) without rete 
ridges and is roughly 15 to 18 cells thick at the sulcus bottom and tapering to 4 to 5 cells 
at the most apical termination. The JE is physically attached to the tooth via 
hemidesmosomes. A characteristic morphological feature of the oral epithelium and the 
oral sulcular epithelium is the presence of invagination of epithelial ridges into the CT, 
so called rete pegs. These structures are lacking in normal JE but may be present in 
inflamed JE. The JE is permeable and serves as a pathway for diffusion of metabolic 
products and plaque bacteria. The size of the cells and the intercellular space in the JE 
are larger and wider than in the oral epithelium. The gingival epithelium forms the first 
line of defense against bacterial assault.
One of the earliest reported changes to occur in the periodontal tissues during 
development of plaque-induced periodontal inflammation is widening of the intercellular 
spaces between the epithelial cells of the sulcular and JE. While it is recognized that 
exudation occurs across the sulcular and JE both from the CT to the gingival sulcus and 
from the gingival sulcus to the CT, the mechanisms of intercellular widening are not 
understood (Brill & Krasse, 1959; Brill & Bjom, 1959; Cimasoni, 1983).
The attached gingivae which extends in apical direction towards the mucogingival 
junction, is firmly attached to the underlying alveolar bone and cementum by connective 
tissue fibres and is therefore immobile. In the apical direction the gingivae is continuous 
with the non-attached, darker red alveolar mucosa. There is no mucogingival junction in
the palate since the alveolar process and -the hard palate are both covered by attached 
keratinised gingivae.
1.2.2 Periodontal Ligament
The periodontal ligament is the soft, richly vascular fibrous connective tissue that 
surrounds the roots of the teeth and joins the root cementum with the alveolar bone. It is 
derived from the dental follicle. The periodontal ligament space has the shape of an 
hour-glass being narrowest at the mid-root level. The width of the periodontal ligament 
is approximately 0.25 mm + 50%. The width of the periodontal space also varies 
according to the functional state of the periodontal tissues. The space is reduced in non­
functional and unerupted teeth and is increased in teeth subjected to the heavy occlusal 
stress. With age the periodontal space narrows slightly. The presence of the periodontal 
ligament makes it possible to distribute and absorb forces elicited during function, into 
the alveolar process via the alveolar bone proper. The periodontal ligament is also 
related to tooth mobility, which to a large extend is determined by the width, height and 
quality of the ligament. Its cells form, maintain and repair alveolar bone and cementum. 
The periodontal ligament has a high rate of turnover compared to other soft connective 
tissue. The daily regeneration rate of periodontal ligament cell in normally functioning 
rodent is between 0.5-2% (McCulloch & Melcher, 1983).
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The connective tissue fibres are mainly collagenous. The portions of the principal fibres 
that are embedded in the root cementum and in the alveolar bone are called Sharpey’s 
fibres. The principal collagen species in Sharpeys’s and other collagen fibres of the 
periodontal ligament is type I. Type IE collagen appears to coat type I collagen of 
Sharpey’s fibres.
The principal collagen fibres show different orientations in different regions of the 
periodontal ligament. The periodontal ligament also contains small amounts of elastin, 
which are present in connective tissue in association with blood vessels and in zones 
along cementum and bone (Lukinmaa, Mackie & Thesleff, 1991). Elastin is a very 
flexible and distensible protein which provides tissues the ability to stretch, bend and 
twist and is present in most vertebrate tissues to varying degrees (Mecham & Heuser, 
1991). Oxytalan fibres are present in all connective tissue structures of the periodontium 
and they run mainly parallel to the long axis of the tooth in the periodontal ligament.
1.2.3 Cementum
The cementum is a specialized calcified tissue covering the root surfaces. It has many 
features in common with bone tissue; however the cementum contains no blood or lymph 
vessels, has no innervation, does not undergo physiological resorption and remodeling, 
but is characterized by continuing deposition throughout life. Cementum attaches the 
periodontal ligament Sharpey’s fibres to the root and contributes to the process of repair
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after damage to the root surface. Cementum is thicker apically than coronally and 
contains viable cells (cementocytes) in the apical 1/3 of the root. Two different types of 
cementum are recognized, primary or acellular cementum and secondary or cellular 
cementum. The primary cementum is formed in conjunction with root formation and 
tooth eruption and has no cells, thus denoted acellular cementum. Secondary or cellular 
cementum is laid down on top of the primary cementum throughout the functional period 
of the tooth. Both acellular and cellular cementum is produced by cementoblasts.
Changes that occur in cementum adjacent to tissue affected by periodontal inflammation 
includes obvious accrual of a variety of bacterial products either on the cementum 
surface or possibly within the cementum matrix (Hughes & Smales, 1986; Hughes, 
Auger & Smales, 1988), and changes in the inorganic composition (Selvig & Zander, 
1962; Stepnick, Nakata & Zipkin, 1975), all of which may contribute to the reported 
structural changes noted in exposed cementum. The collagens of periodontally affected 
cementum appear to be denatured and have relatively high affinity for mineral adsorption 
(Furseth, 1971).
1.2.4 Alveolar Bone
The alveolar bone is part of the alveolar processes of the maxilla and mandible. It is a 
mineralized connective tissue. Its main function is to distribute and resorb forces 
generated by mastication and other tooth contacts. The alveolar process consists of bone,
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which is developed both by cells from dental follicle (alveolar bone proper), and cells 
which are independent of tooth development. The process can be divided anatomically 
into two: 1) the alveolar bone proper (lamina dura, the cribiform plate)- a thin layer 
lining each socket, and exhibiting numerous perforations through which blood vessels, 
lymph channels and nerves pass; 2) the supporting alveolar bone which is made up of 
cortical bone and cancellous bone.
The alveolar process develops in conjunction with the development and eruption of teeth 
and is gradually resorbed if the teeth are lost. The alveolar bone is constantly renewed in 
response to functional demands. A number of cell types can be distinguished in bone. 
The bone-forming cells are termed osteoblasts and are found on the surface. They 
become trapped in their own secretion (osteoid) and subsequently become incorporated 
into the matrix as osteocytes. Large multinucleated cells are responsible for absorbing 
bone and are called osteoclasts.
1.3 EXTRACELLULAR MATRIX (ECM) OF THE CONNECTIVE
TISSUE OF THE PERIODONTIUM
Most connective tissues can be divided into fibrous and non-fibrous elements. The 
fibrous elements include proteins such as collagen and elastin while the non-fibrous 
components include a variety of glycoproteins (laminin, fibronectin, proteoglycans) as 
well as minerals, lipids, water and tissue-bound growth factors (Bartold, 1995).
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The extracellular matrix (ECM) of the periodontium or the intercellular substance is 
composed of a diverse number of macromolecules. Its function is to regulate cellular 
function by mediating the adhesion of cells and the binding of soluble growth factors, 
and it can also regulate the gene expression of cells. The composition of ECM can be 
altered by inherited disorder (Ehlers-Danlos syndrome), metabolic disorder (diabetes 
mellitus), inflammatory disorder (periodontitis) and drug-induced changes (phenytoin) 
(Mariotti, 1993).
The ECM consists of glycoproteins and proteoglycans that are secreted by cells and 
assembled locally into an organized network. The components of the ECM vary between 
tissues but generally include several types of collagen and proteoglycans (versican, 
decorin, biglycan, syndecan). The other components include noncollagen proteins 
(elastin, flbronectin, laminin, osteocalcin, osteopontin, bone sialoprotein, osteonectin, 
and tenascin). The proteoglycan consists of one or more sulfated polysaccharide, called a 
glycosaminoglycan, covalently linked to a protein core. The glycosaminoglycans are 
represented by several species, including chondroitin-4-sulphate, chondroitin-6-sulphate, 
heparan sulfate, heparin, hyaluronic acid and keratin sulfate. There are six different 
collagen types detected in the ECM of the periodontium. Collagen contains one or more 
triple-helical domains of polypeptide chains.
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In the gingivae, collagen accounts for approximately 3/5 of the total protein (Page, 1972), 
and the majority of the collagen is type I. Gingival type I collagen is biochemically 
different from type I collagen found in other parts of the body e.g. skin. Other collagen 
types found are type IE, IV, V, and VI. Type HI is localized to the subepithelial CT, type 
V is distributed throughout the CT in a fibrillar pattern while type IV and VI are localized 
to basement membrane.
Changes in the gingival protein composition develop when a transition from dentate to 
edentulous occur and also as a result of inflammatory processes. During inflammation 
there is a small reduction in type I collagen (4%), 50% reduction in type III collagen and 
over 700% increase in type V collagen (Mariotti, 1993). Collagen type I and type III 
were almost entirely lost in areas of inflammation of the pocket walls in rapidly 
progressive periodontitis (RPP) and adult periodontitis (AP) patients (Hillmann, Dogan 
& Geurtsen, 1998). Furthermore, a collagen not detected in healthy gingivae appears, 
trimer type I collagen (Narayanan, Page & Meyers, 1980). Both the noncollagenous 
protein and proteoglycan content also change during inflammation.
Collagen is the principal protein found in periodontal ligament (Becker et a l, 1991; 
Eastoe & Melcher, 1971; Fullmer, 1967). The biochemical nature of collagen identified 
consists of type I and accounts for approximately 80% of periodontal ligament collagen 
(Becker et a l,  1991; Butler et a l, 1975), III (Becker et al., 1991; Rahemtulla, 1992), IV 
(Andujar et al., 1985; Romanos et al., 1991), V (Becker et al., 1991; Romanos et a l,
1991), VI (Becker et al., 1991; Romanos et al., 1991), XII (Dublet et al., 1988). Type m
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collagen is the second most common collagen found (Butler et a l, 1975) and, similar to 
type I collagen, is distributed throughout the periodontal ligament (Wang et al., 1980) 
which form banded fibrils. Noncollagenous protein make up 10% of total protein found 
in periodontal ligament (Eastoe & Melcher, 1971; Guis, Slootweg & Tonino, 1973).
The periodontal ligament is one of the most metabolically active tissues in the body 
(Sodek & Ferrier, 1988; Sodek, 1977; Sodek et a l, 1977). Collagen metabolism 
represents most of the protein activity in the periodontal ligament (Sodek et a l, 1977). 
Sodek (1977) has demonstrated that the biological half-life of mature collagen was 20% 
and 17% less than found in gingivae and alveolar bone, respectively. The biological 
significance of the rapid turnover in the periodontal ligament is not understood, but it 
may have something to do with the adaptive function of this tissue due to forces of 
occlusion and support. An important feature of connective tissues in general and the 
periodontal ligament in particular, is the process of constant renewal of the extracellular 
matrix components (Everts & Beertsen, 1988; Sodek & Overall, 1988). Of all connective 
tissues studied so far it appears that periodontal ligament has the fastest turnover of 
collagenous proteins.
In cementum, 90% of the organic matrix is made up of type I collagen and 5% is type III 
collagen. Noncollagenous proteins account for the remaining components of the organic 
matrix.
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In bone, collagen is almost solely produced by osteoblasts, is comprised predominantly 
of type I collagen, with small amounts of type in and type V collagen (Hauschka & 
Wians, 1986). Noncollagenous protein represents approximately 8% of the organic 
matrix.
Distribution of collagens types within the periodontal tissue
Tissue Collagen
Healthy gingivae I, III, IV, V, VI
Periodontal ligament I, III, IV, V, VI, XII
Cementum I, III
Alveolar bone I, HI, V
Inflamed gingivae i, in, iv, v, vi
1.3.1 Collagen Turnover/Breakdown
Degradation of the ECM involves six distinct pathways (Stenman, 1990; Koivunen, 
Huhtala & Stenman, 1989; Birkedal-Hansen et al., 1993; Sorsa et al., 1997a). Matrix 
components may be dissolved by extracellular matrix metalloproteinase (MMP)- 
dependent (see 1.5), polymorphnuclear leukocytes (PMN) serine proteinase pathway, 
trypsin-mediated pathway, plasmin-dependent cleavage reactions, and that larger 
fragments may be disposed of by a phagocytic pathway by way of cleavage by lysosomal 
proteinases. Mineralized matrices appear to be degraded by an osteoclastic pathway
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which relies on degradation by lysosomal proteinases in a narrow pericellular 
compartment.
The breakdown of collagenous proteins occurs via two different pathways: an 
intracellular and an extracellular route (Everts et a l, 1989; Everts & Beertsen, 1992; 
Murphy & Reynolds, 1993; Birkedal-Hansen, 1993a; Birkedal-Hansen et al, 1993). This 
is shown in Figure 1.2
1.3.1.1 Intracellular Route
Under non-pathological conditions phagocytosis and intracellular digestion of collagen 
fibrils is a process observed at a high level in dynamic soft connective tissues such as 
gingivae and periodontal ligament (Ten Cate & Freeman, 1974; Beersten & Everts, 1977; 
Beertsen, Brekelmans & Everts, 1978; Melcher & Chan, 1981; Everts et a l,  1996). 
Fibroblasts appear to be the predominant cell involved in this process (Beertsen & 
Everts, 1977; Shore & Berkovitz, 1979; Yamasaki, Rose & Mahan, 1981; Everts & 
Beertsen, 1988). It was concluded that this pathway may be responsible for all collagen 
breakdown during normal turnover and therefore could be considered as the primary 
route of collagen degradation in soft connective tissues under steady state conditions 
(Shore & Berkovitz, 1979; Everts & Beertsen, 1988; Sodek & Overall, 1988; Everts et 
a l, 1989). In order for phagocytosis to occur the collagen must first be partially digested 
extracellularly. The mechanism by which this occur is not entirely clear. Once inside the
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Figure 1.2 Routes of collagen breakdown
The major routes of collagen breakdown in soft tissue: [A] the intracellular pathway and 
[B] the extracellular pathways. The intracellular pathway primarily occur during normal 
turnover and remodeling. [Al] Cytoplasmic protrusion surround a collagen fibril, thus 
forming a phagosome. [A2] The lysosomal enzymes degrade the fibril intracellularly. 
[B] Following production, procollagenase is released in the extracellular environment 
where it may be activated. [B2] Activated collagenase degrades collagenous proteins or it 
may be inhibited by tissue inhibitor of metalloproteinases (TIMP).
cell the phagocytosed collagen collects in small vacuoles which appear to coalesce with 
lysosomes.
1.3.1.2 Extracellular Route
In pathological conditions, such as during periodontal disease, the balance between 
synthesis and degradation is disturbed. During early gingivitis many of the collagen 
fibrils in the gingivae are broken down, and replaced by inflammatory cells, changing a 
firm, pink gingivae into a swollen, loose and reddish tissue which has lost its integrity. 
When this condition becomes chronic, progression of the lesion into periodontitis may 
eventually occur. During the latter process collagen fibrils of the periodontal ligament 
that are attached to the cementum are broken down, usually together with the supporting 
alveolar bone.
Under such pathological conditions a different pathway of collagen degradation is likely 
to occur: a metalloproteinase-mediated extracellular digestion (Sodek & Overall, 1992; 
Birkedal-Hansen, 1993a). Interstitial collagenase (MMP-1) is the best known 
representative of this enzyme. It cleaves Type I and IE collagen thus producing 
characteristic N-terminal 3A and C-terminal V* fragments. MMP-2 (gelatinase), MMP-9 
(type IV collagenase), MMP-3, MMP-10 and MMP-11 (stromelysin) have also been 
suggested to have a significant role in the initial destruction of periodontal extracellular 
matrix macromolecules (Birkedal-Hansen, 1993a). Neutrophil collagenase (MMP-8) is 
also involved in the periodontal destruction process and is the main collagenase in
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gingival crevicular fluid (GCF), saliva and inflamed gingivae in adult periodontitis 
patients (Sorsa et al., 1988; Ingman et al., 1993). MMP-8 when produced by PMN is 
stored as mature enzymes in the subcellular granules. Among collagenases, MMP-8 
most effectively hydrolyses the native type I, and II collagens, whereas MMP-1 prefers 
type III collagen. MMP-8 is a considerably more efficient enzymes than MMP-1 with 
respect to almost all substrates except type ffi collagens (Hasty et al., 1987). The dental 
plaque has been shown to have the potential to serve as a reservoir and site of activation 
of PMN derived MMP in the periodontal inflammation (Sorsa et al., 1995). Subsequent 
to the initial depolymerization caused by these enzymes more complete degradation of 
the proteins involves the action of other less specific host and bacterial enzymes
Other mechanisms of extracellular matrix disruption are associated with microbial 
colonization which include:
(i) release of degradative enzymes by bacterial cells
(ii) release of reactive oxygen species, or
(iii) alteration in matrix synthesis by fibroblasts, keratinocytes, endothelial cells and 
osteoblasts induced by a variety of cytokines and inflammatory mediators.
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1.4 GINGIVAL CREVTCULAR FLUID (GCF)
1.4.1 Introduction
The GCF is a pre-inflammatory serum transudate or an inflammatory exudate which 
exudes through the sulcular and junctional epithelium. The constituents of GCF are 
derived from serum, the periodontal tissues through which the fluid passes, bacteria 
present in the tissue and crevice, and host cells in the crevice. These constituents have 
been broadly classified by Cimasoni (1983) into cellular elements, electrolytes, organic 
compounds (including carbohydrates, proteins and lipids), bacterial products, metabolic 
products (including prostaglandins), and enzymes and enzymes inhibitors.
During inflammation the flow of crevicular fluid increases into the pocket. The 
production of GCF is primarily related to an increase in permeability of the vessels 
underlying the junctional and sulcular epithelia (Brill, 1959). In the case of healthy 
gingivae, these vessels will show signs of increased permeability, characteristics of an 
acute inflammatory reaction, only when stimulated, either by mechanical or chemical 
means. In a chronically inflamed but resting gingivae the permeability of the endothelial 
cells of these vessels is not normally increased, unless provoked by a stimulus in the 
sulcus. Even in the absence of inflammation, interstitial fluid could pass into the sulcus.
The GCF contains most of the components of serum which are present within the 
circulation, but in periodontitis it is selectively enriched in certain components as it
passes through the resident inflammatory cell infiltrate, such as immunoglobulin which is 
secreted locally by the plasma cell population. Furthermore, the GCF has high levels of 
metabolic products of neutrophils.
1.4.2 Passage of GCF
The epithelial covering of the gingival sulcus represents a relatively weak barrier to the 
penetration of foreign materials from the sulcus into the connective tissue. It is 
conceivable that plaque components, even of relatively high molecular weight, could 
pass within the gingival CT, when allowed to accumulate in the sulcus (Cimasoni, 
Ishikawa & Jaccard, 1977).
The state of health or inflammation of the marginal region could play a major role in the 
permeability of junctional and sulcular epithelia. Among the earliest ultrastructural 
changes during inflammation of the gingivae is the enlargement of intercellular spaces of 
the JE (Thilander, 1964; Freedman, Listgarten & Taichman, 1968) and the thinning and 
partial destruction of the basal membrane (Takarada et a l , 1974; Cergneux et a l, 1982). 
The basal membrane is to some extent a limiting barrier to products diffusing either from 
the sulcus into the connective tissue or from the connective tissue into the sulcus. The 
morphological alterations are even more dramatic during pocket formation, when JE 
gradually disappears and is replaced by pocket epithelium (Page & Schroeder, 1976).
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1.43 Mechanism of Fluid Production
Alfano (1974) hypothesized that a very early or preinflammatory flow of gingival fluid 
may be osmotically mediated. In the absence of inflammation, macromolecules 
originated from plaque will diffuse intercellularly and reach the basement membrane 
where they create an osmotic gradient and attract interstitial fluid toward the sulcus. This 
is not an inflammatory exudate. When more macromolecules reach the basal membrane, 
an inflammatory reaction will start.
Gingival fluid production is modulated by the passage of fluid from capillaries into the 
tissues and by the removal of this interstitial fluid by the lymphatics of the gingivae. 
When the production of fluid from the capillaries is greater than the lymphatic uptake, 
fluid will accumulated as oedema or leave the area as gingival fluid.
The net flow of crevicular fluid depends on;
1) capillary filtration
2) lymphatic uptake
3) filtration coefficient of junctional and sulcular epithelium.
Due to the presence of bacterial by-products, increased production of gingival fluid 
occurs when the oncotic pressure of the sulcular compartment exceeds that of interstitial 
fluid. When inflammation is present, the oncotic pressure will be identical in both the 
sulcular and tissue compartments, due to the identical protein concentration in gingival 
fluid and serum (Bang & Cimasoni, 1971). The equality of both oncotic pressures would
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thus cancel out their importance in fluid production. In inflamed gingivae, therefore the 
capillary pressure is more important than osmotic gradients.
GCF is derived from plasma (Pashley, 1976) and its rate of production depends on the 
regulation of the gingival microcirculation. It is agreed that gingival fluid flow increases 
several days prior to detectable clinical inflammation and persists some time after clinical 
inflammation has resolved (Loe & Holm-Pedersen, 1965). The GCF collected from 
inflamed gingivae contains the same concentration of total protein as serum (Bang & 
Cimasoni, 1971), but in clinical healthy gingivae the proteins are lower and similar to 
that of extracellular fluid.
1.4.4 Methods of Collection of Gingival Crevicular Fluid
Sampling of GCF exhibits several features, and, the diagnostic potential of GCF has been 
widely recognized (Page, 1992; Johnson, 1991; Lamster, 1992). For practical purposes, 
GCF is an inflammatory exudate from the gingival microcirculation that crosses inflamed 
periodontal tissues and en route collects molecules of potential interest from the local 
inflammatory reaction (Cimasoni, 1983). In terms of application to diagnostic tests, 
sampling of crevicular fluid provides advantages that are analogous to the drawing of 
blood by the physician (McCulloch, 1994).
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Several techniques have been utilized for the collection of GCF. The choice of the 
technique depends on the aim of the investigation and the amount of the fluid required. 
The various methods include the use of paper strips/paper points, capillary tubes or 
micropipettes and gingival washings. Absorbing paper strips have been widely used 
when measuring the flow of GCF and also for quantitative analysis of fluid components. 
A second method based on the use of capillary tubes (Larivee, Sodek & Ferrier, 1986) or 
micropipettes (Eisenhauer et a l, 1983) allows the collection of large volume of GCF (10- 
40 pi) along the upper anterior teeth.
The accurate and reproducible sampling of fluid is important. A number of studies 
demonstrated that the choice of collection device (Brill, 1962; Sueda, Bang & Cimasoni, 
1969; Takamori, 1963; Oppenheim, 1970; Egelberg & Attstrom; 1973), the various 
materials for sampling (Nakashima, Demeurisse & Cimasoni, 1994), the length of 
collection time, the number of sample repetition (Binder, Goodson & Socransky, 1987; 
Persson & Page, 1990), the presence of supragingival plaque (Stoller, Karras & Johnson, 
1990) and the calculation of data as absolute measures or as flow rates (Lamster, Hartley 
& Vogel, 1985), contribute in a large measure to overall variability. The potential 
depletion of the sample by a prolonged collection time (Persson & Page, 1990), the 
potential contamination by serum components (Lamster, Hartley & Vogel, 1985), the loss 
of the sample from the collection device (Rossomando, Kennedy & Hadjimichael, 1990), 
and the differences between sites (Smith & Gaegan, 1991) are also factors which affect 
variability.
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Crevicular Fluid Sampling 
Advantages 
Ease of access 
Atraumatic
Rapid equilibration with whole pool 
Can vary with time and site 
Repeated sampling possible
Uncertainties
Type of collection device
Length of collection time
Number of repetitions
Absolute or relatives value
Contamination by serum components
Loss of sample over time
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1.5 MATRIX METALLOPROTEINASES
1.5.1 Introduction
Matrix metalloproteinases (MMP) are members of a large subfamily of zinc- and 
calcium-dependent protelytic enzymes, proteinases which are responsible for remodeling 
and degradation of ECM components (Woessner 1991). The components degrade 
interstitial and basement membrane collagens, fibronectin, elastin, laminin, and 
proteoglycan core protein. These potent enzymes are made in a proenzyme form, and 
activation occurs after leaving the cell synthesizing them, the connective tissue cells. 
These proteinases are involved in a number of physiologic events, such as embryologic 
development, tissue remodeling, wound healing, salivary gland morphogenesis and tooth 
eruption, in addition to various pathologic process such as periodontal disease, arthritis, 
cancer, atherosclerosis, pulmonary emphysema and osteoporosis (Ryan, Ramamurthy & 
Golub, 1996).
It is now recognized that an imbalance between activated MMP and their endogenous 
inhibitors (excess of MMP over the inhibitors) can have profound effects on the 
composition and organization of the extracellular matrix during periodontitis. At the 
tissue level, this affects tissue morphology and function, while at the cellular level, 
changes in the composition of the extracellular matrix influence cell adhesion, migration, 
differentiation and activity (Overall, 1991).
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MMP comprises at least twenty members, each of which is the product of different gene. 
Members of this family generally possess quite broad specificity.
There is a high degree of similarity between the amino acid sequences of 
metalloproteinases in each group and between groups, and 6 domain have been defined 
as shown in Figure 1.3 (Reynolds & Meikle, 1997). The MMP structural features 
include:
• a propeptide domain that contain the ‘cysteine’ switch (Van Wart et aL, 1990; 
Springman et al., 1990),
• the catalytic zinc-binding domain,
• a C-terminal (hemopexin-like) domain (Birkedal et al., 1993; Docherty et al., 1990).
(absent from the smallest MMP, pump-1)
• a hinge region
• a gelatin-binding domain (for gelatinases only)
• a trans-membrane (for membrane bound group)
The chief characteristics of the matrix metalloproteinases are:
• The catalytic mechanism depends on zinc at the active center
• The proteinases are secreted in zymogen form.
• The zymogens can be activated by proteinases or by organomercurials.
• Activation is accompanied or followed by a loss of Mr of about 10,000.
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• The cDNA sequences all show homology to that of collagenase.
• The enzymes cleave one or more components of the extracellular matrix.
• Activity is inhibited by tissue inhibitor of metalloproteinases (TTMP).
(Woessner, 1991).
MMP family member can be simply divided into five subgroups, based on substrate
characteristics:
Collagenases (MMP-1 and MMP-8)
Gelatinases (MMP-2 and MMP-9) 
stromelysin (MMP-3, MMP-10 and MMP-11) 
membrane-type MMPs (MT-MMPs) 
and others.
Table 1.1 shows the family members of the MMPs.
1.5.2 MMP Classification
1.5.2.1 Collagenases (CL)
This is the first member of the metalloproteinase family discovered. It was discovered by 
Gross and Lapiere in 1962. Only the ‘fibroblast’ collagenase (FIB-CL/MMP-1) and the 
‘neutrophil’ collagenase (MMP-8) can cleave native undenatured interstitial collagen 
(type I, II, III, VII, VIII,X) at neutral pH. MMP-1 is a neutral MMP capable of cleaving
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Table 1.1 Matrix M etalloproteinase Family
Enzyme MMP Mr Extracellular matrix Substrates
Collagenases
Fibroblast-
coilagenase
MMP-1 57,000/52,000 Collagen I, II, III, VII, VIII, X, Gelatin
PMN-Collagenase MMP-8 75,000 Same as FIB-CL
Collagenase-3 M M P-13 65,000 Proteoglycan core protein
G elatinases
Mr 72K (Gelatinase 
A)
MMP-2 72,000 Gelatin, Collagen IV,V, VII, X, Elastin, 
Fibronectin
Mr 92K (Gelatinase 
B)
MMP-9 92,000 Gelatin, Collagen IV, V, XI, Elastin
Stromelysins
Stromelysin-1 MMP-3 60,000/55,000 PG Core Protein, Fibronectin, Laminin, 
Collagen IV,V, IX, X, Elastin
Stromelysin-2 MMP-10 60,000/55,000 Same as SL-1
Stromelysin-3
M em brane-type
M M Ps
M M P-11 51,000 Elastin, fibronectin, gelatins, 
procollagen 1, II, III
MT MMP-1 MMP-14 63,000
Gelatin, elastin, fibronectin, laminin, 
vitronectin, PG core protein, proMMP- 
2, MM P-13, collagen, I, II, III.
MT MMP-2 MMP-15 72,000 not determined
MT MMP-3 M M P-16 64,000 proMMP-2
MT MMP-4 MMP-17 70,000 not determined
Others
Matrilysin 
(PUMP-1)
MMP-7 28,000 Fibronectin, Laminin, Collagen IV, 
Gelatin, proCL, PG Core Protein, 
urokinase
Macrophage 
metal loelastase
MMP-12 54,000 elastin, fibronectin, gelatin, laminin, 
vitronectin, PG core protein, collagen 
IV.
MMP-18 57,000 not determined
M M P-19 57,000 not determined
enamelysin MMP-20 52,000 amelogenin
(modified from Nagase et al., 1992)
the collagen triple helix at a single locus to yield characteristic one-quarter - three-quarter 
products (Gross & Nagai, 1965). The initial cleavage of native collagen by tissue 
collagenase (MMP-1) is essential to the degradation of collagen extracellularly. 
However, the activity of several related MMP, including MMP-2 and MMP-3, are also 
required to complete the collagenolytic process (Sodek & Overall, 1988).
MMP-1 is expressed after appropriate stimulation by a variety of cell types: 
fibroblasts (Goldberg et al., 1986; Stricklin et al, 1977), 
keratinocytes (Lin et al., 1987; Petersen et al., 1987), 
endothelial cells (Herron et al., 1986; Moscatelli, Jaffe & Rifkin, 1980), 
macrophages (Campbell et al., 1987; Welgus et al, 1985), 
osteoblasts (Otsuka et al., 1984; Quinn et al, 1990) 
and chondrocytes (Lefebre, Peeters-Joris & Vaes, 1990).
MMP-1 is synthesized on demand in response to growth factor/cytokine activation of 
gene transcription. The fully functional protein emerges from the cell after 6- to 12-h lag 
period required for activation of the transcriptional translational machinery. MMP-1 
degrade preferentially type I and III collagen over type II collagen. MMP-1 levels were 
more prominent in GCF of localized juvenile periodontitis (LJP) than in adult 
periodontitis patients (Suomalainen et al., 1991; Ingman et al., 1996).
MMP-8 is expressed mostly by PMN. It is synthesized and packaged in the specific 
(secondary) granules of PMN before the cells emigrate from the bloodstream and is
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rapidly released when the cells are triggered. MMP-8 transcripts and protein can also be 
found in gingival and periodontal ligament fibroblasts (Salo et al, 1995, Sorsa et al, 
1996) and also in chondrocytes (Chubinskaya et a l , 1996; Cole et al., 1996), suggesting 
their possible ability to also produce MMP-8. MMP-8 are also expressed by other non- 
PMN cells which includes mucosal fibroblast, rheumatoid synovial fibroblast, cultured 
squamous cell carcinoma of the tongue, and human umbilical vein endothelial cells (Cole 
& Kuettner, 1995). Among collagenases, MMP-8 most effectively hydrolyses the native 
type I, and II collagens, whereas MMP-1 prefers type III collagen. MMP-8 is a 
considerably more efficient enzymes than MMP-1 with respect to almost all substrates 
except type Eli collagens (Hasty et a l , 1987). PMN-derived MMP (MMP-8 & MMP-9) 
predominantly in autoactive form was detected in both supra- and subgingival dental 
plaque extracts of adult periodontitis patients. The activity of PMN derived MMP-8 is 
influence by PMN degranulation and pro-MMP-8 activation (Hasty et a l , 1987; Weiss, 
1989; Mainardi, Pourmotabbed & Hasty, 1991) while non-PMN MMP-8, like other 
MMPs is also most likely regulated by inflammatory mediators such as interleukin-lp 
(IL-ip) and tumour necrosis factor-a (TNF-a) (Hanemaaijer et a l , 1993; Chubinskaya et 
a l , 1996; Cole et a l, 1996; Schopov et a l, 1997; Hanemaaijer et a l, 1997).
1.5.2.2. Gelatinases (GL)/ Type IV Collagenases
These two gelatinases cleave types IV, V, VII, X, XI collagens, elastin, fibronectin, and 
perhaps other matrix substrates as well.
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Mr 72K gelatinase (GL-A or MMP-2)/type IV collagenases is expressed by most cell 
types:
fibroblast (Seltzer et al., 1981), 
keratinocytes (Salo et al., 1991), 
endothelial cell (Kalebic et al., 1983) 
macrophages (Garbisa et al., 1986), 
osteoblast (Overall, Wiebkin & Thonard, 1987) 
and chondrocytes (Lefebvre et al., 1991) 
but characteristically not by PMN.
The gelatinase, MMP-2 is perhaps the most widely distributed of all MMP and is present 
in a circulating form in plasma (Birkedal-Hansen, 1993).
Mr 92K GL (GL-B or MMP-9) is produced by PMN but also by a number of other cell 
types including:
keratinocytes (Salo et al, 1991; Wilhelm et al, 1989) 
macrophages (Mainardi et al, 1984) 
and occasionally fibroblasts.
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1.5.2.3 Stromelysin (SL) Group
Stromelysin have virtually identical substrate specificities and cleave a wide range of 
ECM proteins. SL-1 (MMP-3) and SL-2 (MMP-10) cleave ECM proteins: proteoglycan 
core protein, type IV, V, IX, X collagen, fibronectin, elastin and laminin (reviewed in 
Murphy, Nagase & Brinckerhoff, 1988; Nicolson, Murphy& Breathnach, 1989). Induced 
stromal cells, macrophages, and endothelial cells express the SL-1 gene, where as 
keratinocyte express the homologous SL-2 gene. SL-3 transcripts are expressed by 
stromal cells of human mammary carcinomas and by embryonic fibroblasts. 
Stromelysin-1 (MMP-3) not only degrades connective tissue component but is also 
involved in the proteolytic activation of MMP-1, MMP-8 and MMP-9 (Ogata, Enghild & 
Nagase, 1992). In a study by Tonetti, Pini-Prato & Cortellini (1993) MMP-3 transcripts 
were not detectable in healthy sites while they could be specifically detected in 38 % of 
the periodontitis sites. The presence of MMP transcripts in some but not all periodontitis 
sites was not unexpected in light of the current models of disease progression. Kubota et 
al. (1996) also shown that mRNA levels of MMP-3 were significantly higher in 
periodontitis tissue samples when compared to healthy samples.
1.5.3 Regulation of MMP Activity
The activity of MMP against ECM substrate is regulated at four “gates”:
1) by transcriptional regulation of MMP genes;
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2) by precursor activation;
3) by differences in substrate specificity; and
4) by MMP inhibitors.
1.5.3.1 Transcriptional Regulation
Endogenous growth factors and cytokines regulate the transcription of most MMP genes. 
Inflammatory and mesenchymal cells secrete them and generally they stimulate enzyme 
production. Stimulation or repression of growth factors and cytokine-responsive MMP 
genes results in up to a 50-fold change in mRNA and proteins levels.
Transcription of the CL and MMP-3 genes is induced by: 
interleukin-1P (IL-1P)
Tumour necrosis factor-a (TNF-a) 
platelet-derived growth factor (PDGF)
Transforming growth factor-a (TGF-a) 
epidermal growth factor (EGF) 
basic fibroblast growth factor (b FGF) 
nerve growth factor (NGF) 
and with few exceptions abrogated by TGF-p and interferons-y (IFN-y).
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Other endogenous pathway may also regulate transcription of MMP genes. MMP-1 is 
induced/stimulated in osteoblasts by parathyroid hormone (PTH) and 1, 25 di (OH) D3 
and MMP-1 and MMP-3 are down-regulated by glucocorticoids and by retinoids.
Regulation of MMP expression
Type of regulation
Induction IL-la, IL-lp, TNF-a, TGF-a, EGF, PDGF, bFGF, NGF, TGF-
P, PGE2, l,25-di(OH)D3
Repression IFN-y, IL-4, TGF-P, glucocorticoids, retinoic acid
1.5.3.2 Activation of Precursors
MMPs are not stored in cells but are secreted as inactive or latent proenzymes or 
zymogens. In vivo, it is likely that the procollagenases are activated by proteolytic 
cleavage catalyzed by other proteinases such as plasmin. Also, the activity of 
stromelysin is probably required for complete activation of collagenases (Harris & Vater, 
1982; Goldberg et a l , 1990).
All the MMPs have an N-terminal propeptide that determines the latency of the 
proenzyme form. Here, the cysteine interacts with the Zn (II) of the adjoining catalytic 
domain, displacing the water molecules required for catalytic activity.
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In the activation process, the secreted zymogen first loses its signal peptide. Activation 
of most MMPs involves sequential exogenous/endogenous cleavages of the propeptide 
which destabilize the cysteine - Zn (II) interaction, modify the enzyme conformation, and 
permit further exogenous or autocatalytic processing to the final active form.
Latency is overcome by physical (chaotropic agents and detergents), chemical (oxidants 
and organomercurials), or enzymatic (trypsin, plasmin, and other proteinases) processes 
that allow the separation of the cysteine residue from the zinc in the active domain of the 
enzyme.
Only procollagenase and prostromelysin are activated by plasmin. Plasmin is a serine 
proteinase derived from plasminogen. Plasmin itself is not a proteinase in matrix 
degradation.
MMP-2 has no apparent plasmin- susceptible propeptide cleavage site. A number of 
independent studies have described a cell membrane mediated activation process for 
progelatinase A, the membrane bound metalloproteinase (MT-MMP, MMP-14) gives a 
second mechanism of activation. MT-1 metalloproteinases can also process 
procollagenase-3 (MMP-13) to active enzyme. The membrane “activator”, which is 
specific for gelatinase A can be induced in a number of cell types, such as : 
fibroblasts,
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osteoblasts, 
chondrocytes, 
endothelial cells and 
tumour cells
by effectors such as concanavalin A, cytochalasin D, phorbol esters, 
transforming growth factor pi or by exposure to collagen.
There is also evidence that exogenous proteases, such as those from periodontally 
pathogenic bacteria, can act as activators of procollagenase (Sorsa, Uitto & Suomalainen,
1992).
1.5.3.3 Substrate Specificity
The different types of substrate have been shown to be one of the factors involved in 
regulation of MMP activity. Accordingly, regulation of cell function is affected by 
changes in the extracellular matrix composition. At the tissue level, this affects tissue 
morphology and function, while at the cellular level, changes in the composition of the 
extracellular matrix, influence cell adhesion, migration, differentiation, and activity. The 
enzymes have some overlapping effects on the substrate, however there are some 
differences with respect to their function. Virtually all of the enzymes cleavage gelatin 
and fibronectin at some rate, and most cleave type IV and V collagens at sufficiently high
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temperature. The characteristics ability of MMP-1 and MMP-8 to dissolve interstitial 
collagen fibrils is not shared by other members of the family.
1.5.3.4 Inhibition
Endogenous or natural inhibitor such as tissue inhibitors of MMPs (TIMPs) and a- 
macroglobulins bind in a high affinity, noncovalent fashion to inhibit members of the 
MMP family. TIMPs bind to the active sites of MMPs. TIMP is widely distributed in 
tissues, fluids (in serum, amniotic fluid (Welgus, 1983; Murphy, Cawston, Reynolds, 
1981) and saliva (Drouin, Overall & Sodek, 1988). TIMPs are expressed by many cell 
types including fibroblasts, keratinocytes, monocytes/macrophages, endothelial cells, and 
osteoblast (Settler-Stevenson, Krutzch & Liotta, 1989; Welgus, 1983). TIMPs probably 
control MMP activity pericellularly, whereas a 2 -macroglobulin functions as a regulators 
of MMPs in body fluids (Ryan, Ramamurthy & Golub, 1996). During inflammation, 
however a-macroglobulins, may escape the vasculature and function in the ECM.
ct2 -macroglobulin is a major physiologic plasma proteinase inhibitor that is restricted in 
its site of activity owing to its large size, a-macroglobulin inactivates susceptible 
proteinase by entrapment following cleavage of a peptide bond in the bait region, by a 
unique venus-fly- trap mechanism (Sottrup-Jensen 1989; Sottrup-Jensen et al., 1989). 
a 2 -macroglobulin levels in the GCF of inflamed sites range from 0.2 to 2.4 mg/ml, level 
far above those for TIMPs (Birkedal-Hansen, 1993).
32
The inhibitory activity of TIMP resides in the first three loops of structures defined by six 
disulfide bridges (Docherty et al., 1992; O’Shea et al., 1992; Williamson et a l, 1990). It 
is believed that the three-dimensional structure of tissue inhibitors of TIMP uniquely 
determines their high affinity for MMP since disruption of disulfide bonds result in loss 
of activity.
TIMPs form classical irreversible non-covalent bimolecular complexes with the active 
forms of MMPs and, in some instances, with latent MMP precursors MMP-9 (Goldberg 
et a l, 1989; Howard, Bullen & Banda, 1991a; 1991b) in a 1:1 stoichiometry. The 
complex can be dissociated under acid conditions and the inhibitor is readily destroyed 
by reduction and alkylation (Nagase, Barrett & Woessner, 1992). TIMPs appear to 
regulate matrix degradation both by proteinase elimination and by blockage or autolytic 
MMP activation. Four members of the TIMP family, TIMP-1, -2, -3 and -4, have been 
identified (Aiba et a l, 1996).
TIMP-1 is a Mr 28K glycoprotein and is highly associated with the zymogen form of the 
MMP-9 and active MMP-1. TIMP-2 is unglycosylated protein, associated with MMP-2 
expressed by fibroblasts and endothelial cells and perhaps by other cells as well. TIMP-2 
forms a complex with the zymogen form of MMP-2. Also, in-vitro studies had shown 
that TIMP-2 has a higher inhibitory effect on gelatinases (MMP-2 and -9) and neutrophil 
collagenase (MMP-8) than TIMP-1 (Howard, Bullen & Banda, 1991a; Klein et al.,
1993). TIMP-2 is 2- to 10-fold more effective than TIMP-1 against the two gelatinases
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whereas TIMP-1 appear more effectively inhibit CL. (Howard, Bullen & Banda, 1991b). 
The two TIMP genes are differently regulated. TIMP-1 expression is stimulated by 
growth factors (EGF, TNF-a, IL-1, TGF-P), phorbol esters, retinoids, and 
glucocorticoids - whereas TIMP-2 expression is down regulated by TGF-P and fails to 
respond to phorbol esters. In contrast to the solubility of TIMP-1 and -2, TIMP-3 is a 
2 IK protein tightly bound to ECM (Leco et al., 1994). TIMP-4, with a molecular mass 
of 22K, has been cloned from human (Greene et al, 1996) and mouse (Leco et al., 1997) 
cDNA libraries.
1.5.4 Role of MMP in Human Periodontal Diseases
Loss of attachment, as occurs in periodontal disease, is associated with extensive 
breakdown of collagen fibres in the periodontal tissues. Since the major structural 
protein of the periodontium is collagen, the assessment of MMP levels during 
inflammation will reflect the association of MMP in collagen destruction in periodontitis. 
The involvement of matrix metalloproteinases in pathological tissue destruction is well 
documented. The evidence for the role of MMPs in periodontal destruction has 
accumulated over the years. In earlier studies, collagenases has been identified in 
explanted gingival tissues and their culture fluids (Fullmer & Gibson, 1966; Bennick & 
Hunt, 1967; Fullmer, Taylor & Guthrie, 1972; Robertson & Fullmer, 1973; Birkendal- 
Hansen et al., 1974; Wooley et a l, 1978) and in homogenates of gingival biopsies (Uitto, 
Turto & Saxen, 1978). Collagenases activity has also been demonstrated in GCF, and
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this activity increased with the severity of inflammation (Golub, Stakiw & Singer, 1974; 
Smith, Rule & Rosen, 1974; Golub et a l , 1976; Kowashi, Jaccard & Cimasoni, 1979). 
Further evidence that MMP are involved in tissue destruction in human periodontal 
disease were summarized by Birkedal-Hansen (1993), which includes 1) cells isolated 
from normal and inflamed gingivae are capable of expressing a wide complement of 
MMP in culture, 2) several MMPs can be detected in cells of human gingivae in vivo, 3) 
MMP-8 and MMP-9 are readily detected in gingival crevicular fluid from gingivitis and 
periodontitis patients.
Each of the major cell types of human periodontal tissues is capable of expressing a 
unique complement of MMP when properly stimulated as been shown in Table 1. 2. The 
cells include PMN-leukocyte, fibroblast, keratinocyte, macrophage and endothelial cells.
Collagenases in tissues may exist in different forms, i.e. in active form, in inactive form 
that is an enzyme inhibitor complex, or in latent form (proenzyme). Total collagenase 
activity has been shown to be high in GCF of inflamed dogs gingivae (Kryshtalskyj, 
Sodek & Ferrier, 1986), in GCF of LJP and chronic AP patients when compared to 
gingivitis and control patients (Villela et al., 1987a; b), in GCF of untreated LJP patients 
and also that the activity decreased after treatment (Larivee, 1986). Collagenase activity 
increased with disease severity in GCF, i.e. CAP & LJP > gingivitis > normal (Villela, 
1987a; b). Ingman et al (1993) demonstrated that saliva samples did not reflect 
periodontal tissue destruction clearly as they found only low amount of total collagenase 
activity in saliva of untreated LJP patient and the level was comparable to normal
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Table 1.2 Expression of Matrix Metalloproteinases by Five Major Cell Types of Human 
Periodontal Tissues.
Cell Type PMN-
Leukocyte
Fibroblast Keratinocyte Macrophage Endothelial
cell
Enzymes
expressed
MMP-8,
MMP-9
MMP-1, 
MMP-3, 
MMP-2, 
MMP-7, 
M M P-11
MMP-1,
MMP-2,
MMP-9,
MMP-10
MMP-1,
MMP-3,
MMP-2,
MMP-9
MMP-1,
MMP-3,
MMP-2,
MMP-9
Transcriptional
activation
9 1L-I, TNF- 
a , EGF, 
TGF-a, 
PDGF, TPA
TNF-a, EGF, 
TGF-a, TGF- 
(3, TPA
TPA TPA
mobilization o f  
enzymes
Granule
release
transcriptional activation
Response time Seconds 6 to 12 hours
Response
duration
Minutes Days
patients. Ingman et a l (1996) also demonstrated that in saliva no difference in 
collagenolytic activity could be seen in AP, LJP and control patients.
Latent collagenase levels were found to be higher in GCF of gingivitis sites in humans 
and dogs compared to periodontitis and progressive sites (Lee et al., 1995; Kryshtalskyj, 
Sodek & Ferrier, 1986; Kryshtalskyj & Sodek, 1987), and also in normal sites 
(Kryshtalsky et al, 1986). It was also detected in the explant of clinically normal tissue 
(Heath et a l, 1982). Higher latent collagenase levels seem to reflect either normal 
healthy state or gingivitis state.
Little or no active collagenase activity was demonstrated in GCF of healthy and gingivitis 
sites in dogs (Kryshtalsky et al, 1987), but higher levels were found in GCF of LJP 
compared to healthy patients (Larivee, 1986). Higher levels were also detected in GCF 
of progressive periodontitis sites compared to stable and gingivitis sites (Lee et a l, 
1995). In whole saliva, high active collagenases activity were demonstrated in untreated 
AP (Ingman et a l, 1993; Gangbar et a l, 1990) and LJP but as treatment progressed more 
collagenase is present in the latent form (Gangbar et a l , 1990). Higher levels of active 
collagenase levels seem to reflect diseased and active state of periodontal disease.
Collagenase inhibitors were detected in GCF of normal healthy sites (Larivee et a l, 
1986) and low activities were found in inflamed and degenerating sites in GCF of dogs 
(Kryshtalsky et a l, 1986). Kryshtalsky et a l (1987) also found the highest amount of 
inhibitor in GCF of control normal sites in dogs. The amount of inhibitor increased in
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GCF of LJP patients after treatment was carried out, though it was absent at baseline 
(Larivee et a l, 1986). From these studies it was shown that higher levels of inhibitor 
indicates healthy periodontal state. In contradiction to the above findings, free TIMP was 
found to be at significantly higher levels in GCF of gingivitis and periodontitis sites 
compared to the control sites (Haerian et a l, 1995), and also the levels were reduced by 
treatment in advanced periodontitis patients (Haerian et a l, 1996).
In the earlier studies, since the cellular source MMP was not determined, the MMP 
studied were just simply designated the term collagenase. Collagenase that is found in 
the case of periodontitis is derived from the host and not from the periopathogenic 
bacteria (Kryshtalsky & Sodek, 1987). Gangbar et a l (1990) has established that the 
source of procollagenase in patients with periodontal disease and inflammation are PMN 
cells, which is abundant in acute inflammation. Their results are in agreement with those 
ofSorsa et a l (1988).
Collagenase immunolocalization in human gingival biopsies from untreated periodontitis 
patients suggested the enzyme was frequently associated with inflammatory cells 
(Wooley & Davies, 1981). Pinchback, Gibbins & Hunter (1996) demonstrated by 
immunohistochemistry, that MMP-1 and TIMP-1 in advanced destructive tissue were 
associated with the vasculature of the connective tissue.
Once the MMP cellular source and characteristics were determined, more work was done 
on specific MMPs. It is established that MMP-1 and MMP-8 share the unique ability to
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cleave types I, II and El collagen and serve as initiators of extracellular matrix 
destruction in periodontal disease. These fibrillar collagens form about 60% of the 
content of gingival connective tissue in healthy periodontium. Thus, synthesis and 
activation of MMP-1 and MMP-8 are important steps in the pathologic ECM destruction 
associated with inflammatory periodontal disease (Birkedal-Hansen, 1993; Lindhe, 
1985). The outcome of the later studies revealed that in GCF, MMP-1 levels were much 
higher in LJP compared to AP and healthy subjects, while MMP-8 is the main 
collagenase in gingival crevicular fluid, saliva, and inflamed gingivae in adult 
periodontitis. (Sorsa et a l , 1988; Ingman et a l , 1993). MMP-3 (proenzyme and active 
form) levels in GCF of gingivitis and periodontitis sites were significantly higher than in 
control sites (Haerian et a l , 1995). Evidence also shows that MMP-1 and MMP-3 can 
be synthesized (and presumably activated) during adult periodontitis. It is likely that 
MMP-1 and MMP-3 may play a role in more chronic inflammatory processes, whereas 
MMP-8 contributes more to acute injury (Ingman et a l , 1994), conflicting with earlier 
findings. There is no consensus in the literatures on the role of MMP-1 and MMP-8 in 
periodontitis.
When the levels of the transcripts of the MMP were investigated, Nomura, Takahashi & 
Hara (1993) found out that MMP-1 and TIMP-1 mRNA were higher in periodontitis- 
affected gingivae compared to healthy gingivae. Aiba et al (1996) also demonstrated the 
significantly elevated levels of MMP-1 mRNA in inflamed gingivae compared to normal 
gingivae in periodontitis patients, while there was no difference in the two groups for 
MMP-8 and TIMP transcript. These results suggest that MMP-1 rather MMP-8 may play
38
an important role in the initiation of collagen degradation in periodontal disease. 
However, the possibility remains that MMP-8 plays an important role in periodontal 
destruction. Kubota, Nomura & Takaahashi, (1996) had shown that the level of MMP-1, 
-3, -8 and TIMP-1 mRNA were significantly higher in the periodontitis group than in the 
healthy controls, and mRNA of MMP-3 > MMP-1 > MMP-8. But Tonetti, Pini-Prato & 
Cortellini (1993) could only demonstrate the presence of MMP-3 mRNA in 38% of the 
periodontitis patients, while MMP-8 mRNA was found in 46% of the periodontitis 
patients. TIMP-1 and -2 mRNA were both found to be elevated in the periodontitis 
patients compared to the minimal gingivitis group (Kubota et al, 1997).
Below is a summarized tabulation of work done on MMP to support the association of 
MMP and destructive periodontal disease.
Enzymes
collagenases
coilagenase-
A uthor and year
Fullmer et al., 1969.
Robertson et al., 1973
Experim ents & Findings
From human gingival tissues, pure epithelial cells, and 
variably inflamed gingival connective tissue were 
capable o f  producing collagenases on culture.
Collagenases was also detected in culture fluids o f  both 
pure epithelial and fibroblast-like cells derived from 
primary explants o f  gingivae.
Culture fluids o f  gingival biopsies o f  healthy and mildly
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inhibitor
collagenases
collagenases
Collagenases,
inflamed tissue were mixed with partially purified 
collagenases to show the effect o f  serum inhibitor on 
determination o f  the collagenolytic activity. There was a 
decrease in collagenolytic activity in inflamed tissue in 
untreated culture fluids. This showed that in-vitro 
determination o f  collagenolytic activity may be 
influenced by specific inhibitors.
W oolley & Davies (1981)
Uitto, Applegren & 
Robinson, 1981
Heath et a l,  1982
Immunolocalization techniques on diseased gingival 
biopsies on patients who had treatments and in untreated 
patients. Tissues had 4-6 mm pocketing at time o f  
biopsy. In the treated group, no significant 
immunoreactive enzyme was detected compared to half 
o f  the untreated group. The enzyme in the untreated 
group was distributed throughout the connective tissue 
and especially concentrated at the interface between 
epithelium and connective tissue and often associated 
with the presence o f inflammatory cells.
Gingival specimens from treated periodontal patients 
were used. The proteinases were found to exist in the 
extracts mostly in latent form and the enzyme activities 
were significantly higher in inflamed samples than in 
non-inflamed samples.
Early studies showing production o f  MMPs and TIMP
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gelatinases and 
TIMP
collagenases
Collagenase
collagenases
by gingival tissue. Gingival normal and inflamed tissues 
were obtained from patients during periodontal surgery. 
The explants in culture produced collagenases and 
gelatinases in both active and latent forms. The enzymes 
in clinically normal tissue were detected in the latent 
form. Human gingival, fibroblasts in monolayer culture 
produced no metalloproteinases, but did produce TIMP.
Yanagimura, Hara & 
Nohara, 1983
Golub et al., 1984
Golub et al., 1985
Normal and inflamed tissues o f  dogs were excised. The 
collagenases activities in the neutral salt extract were 
significantly higher in inflamed gingivae after 1 week o f  
plaque formation than in healthy gingivae. Gelatinase 
activity did not vary significantly with the induction o f  
inflammation.
PMN rat collagenases when treated with minocycline, 
doxycycline and tetracycline (16|ig/ml) inhibited the 
activity o f  collagenase in-vitro by 90%.
GCF and subgingival plaque from periodontitis patients 
were used to evaluate the effect o f  2-week regime o f  low  
dose (40-80m g per day) minocycline. Low-dose 
minocycline therapy reduced GCF flow (40 to 72 % 
reduction) as well as collagenolytic activity (26-93%  
reduction) even just after one week. The effects on the 
clinical parameters were less consistent and the 
crevicular microflora showed minimal changes except in
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Collagenase and
collagenase
inhibitor
Collagenase and
collagenase
inhibitor
spirochetes reduction. Therefore, minocycline therapy 
reduced collagenolytic activity by interacting with and 
inhibiting the host-derived collagenase rather than by 
antimicrobial action.
Larivee et al., 1986
Kryshtalsky, Sodek & 
Ferrier, 1986
GCF samples o f  LJP and healthy control patients were 
used to analyze the latent, active and collagenase
inhibitor levels at baseline and after treatment. At 
baseline collagenase activity (total) was significantly 
higher in diseased patients and this activity decrease 
substantially after clinical treatment. Latent collagenases 
remain high in diseased sites and in inflamed sites. LJP 
has higher active collagenase activity. Collagenase 
inhibitor was only detected in sites free o f  active
collagenases and believed to be free o f  acute
inflammation. It was absent at baseline in LJP, but
increased after treatment was carried out.
GCF from healthy, gingivitis, and periodontitis sites 
were obtained from beagle dogs. Higher collagenolytic 
and low inhibitory activities were found in inflamed an 
degenerating sites. Periodontitis sites had higher active 
enzyme, compared to latent activities, whereas latent 
collagenase was predominant in control and gingivitis 
sites. Higher activity o f  collagenolytic enzyme, 
combined with absence o f  latent enzyme and collagenase 
inhibitor, was only found in periodontitis sites.
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Collagenase
Collagenase and
collagenase
inhibitor
Villela et al., 1987a; 
Villela et al., 1987b.
Kryshtalskyj & Sodek, 
1987
GCF collagenase activity in healthy, gingivitis, CAP and 
LJP patients. Higher collagenase activity in GCF o f  
CAP and LJP when compared to gingivitis, and in 
gingivitis higher than in control. Thus, collagenase 
activity increases with disease severity. Little or no 
collagenase activity is related to clinically healthy sites. 
Collagenase activity correlated well with pocket depth in 
the CAP and LJP group. GCF volume increased with 
disease severity in the order healthy < gingivitis < 
periodontitis, and stated that GCF volume was dependent 
on pocket depth. There is no correlation o f  collagenase 
activity and fluid volume in gingivitis and CAP. Both 
collagenase activity and GCF volume were correlated to 
PD. The collegenolytic enzyme was shown to be 
genuine vertebrate collagenase derived from unidentified 
host cells.
GCF from healthy, gingivitis and periodontitis sites from 
beagle dogs. In the baseline, control and gingivitis 
samples has little or no active collagenolytic activity. 
The gingivitis samples contained the greatest amount o f  
latent collagenase. The highest amount o f  inhibitor was 
found in control samples.
Analysis o f  plaque, crevicular cell debri, saliva and 
serum indicated that the collagenolytic activity was 
derived from connective tissue and/or inflammatory
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collagenase
PMN collagenases 
and gelatinase
Collagenase
(MMP-8)
cells, whereas collagenase inhibitor could also be 
derived from saliva and serum.
Hakkarainen, Uitto & 
Ainamo, 1988
Gangbar et al., 1990.
Sorsa, Suomalainen & 
Uitto, 1990.
Collagenase activity were found to be high in 
periodontitis affected teeth either mobile or immobile. 
The collagenase activity decreased after scaling and root 
planing and further decreased after occlusal therapy in 
the mobile teeth.
Whole pooled saliva from AP, LJP and control patients 
were used. Active collagenase level were found to be 
significantly higher in AP and LJP compared to controls, 
and MMP activity not found in edentulous patients. 
Collagenase inhibitor were generally low in all groups. 
Following clinical treatment (tetracycline treatment and 
scaling) active collagenase and gelatinase were reduced.
The characteristics o f  interstitial collagenases found in 
inflamed gingivae, GCF and saliva are consistent with 
those o f  human neutrophils interstitial collagenases 
rather than the fibroblast-type interstitial collagenase. 
These collagenase degraded preferentially type I and II 
collagen as compared with type III (3) collagen and their 
molecular weight was about 70 K. The neutrophil 
collagenase was rather ineffectively activated by plasma 
kallikrein and plasmin, compared to trypsin,
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collagenase
(MMP-1)
mRNA TIMP-1, 
TIMP-2 and 
collagenase
mRNA MMP-3
chymotrypsin and neutrophil cathepsin G.
Suomalainen et al., 1991
Nomura, Takahashi & 
Hara, 1993
Tonetti, Pini-Prato & 
Cortellini, 1993
GCF o f  untreated juvenile periodontitis patients was 
found to contain only vertebrae collagenase and 
degraded type I and III (3) collagen faster than type II 
collagen into % and % length fragments. This is 
indicative o f  collagenases produced by fibroblasts, 
epithelial cells and macrophages
Gingival samples o f healthy and periodontitis patients 
were used in reverse transcription-polymerase chain 
reaction to look for levels o f  mRNA o f fibroblasts 
collagenases (MMP-1), TIMP-1 and TIMP-2. TIMP-1 
mRNA level in periodontitis- affected gingivae was 
higher than in healthy gingivae, so was the level o f  
mRNA o f  fibroblasts collagenases (MMP-1). There was 
no significant different between the level o f  mRNA  
TIMP-2 in the two groups.
MMP-3 (stromelysin) transcripts were not detectable in 
the soft tissues biopsies in healthy sites and only detected 
in 38% o f  the periodontitis sites. MMP-8 mRNA was 
detected in 17% in healthy patients and 46% in 
periodontitis patient.
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Salivary
collagenases
MMP-8
MMP-3, MMP-1, 
TIMP-l
Ingman et a i,  1993
Lee et a i,  1995.
Haerian et al., 1995
Whole stimulated saliva were obtained from untreated 
LJP and AP patients as well as healthy controls. Low  
amount o f  interstitial collagenase activity was found in 
the saliva o f  LJP, which was comparable to healthy 
controls. Tissue destruction in LJP cases was not clearly 
reflected in salivary samples. In AP high active 
collagenase levels was detected. There was no evidence 
o f  bacterial proteases.
GCF samples from progressive, stable periodontitis and 
gingivitis sites were obtained. Progressive periodontitis 
GCF had higher (5X) active collagenase activity 
compared to stable and gingivitis patients. Latent 
collagenase (2X) was higher in gingivitis group 
compared to progressive group. Only in sites with 
progressive destruction was there significant increase o f  
active collagenase with time. At the time o f  detection o f  
destruction there was 40% increase o f  pooled active 
collagenase activity. This study demonstrated that there 
is a direct evidence for the role o f  active collagenase in 
the destruction o f  periodontal connective tissue.
(fibroblasts derived MMP and TIMP)
The mean amounts o f  SL (proenzymes and active form) 
and TIMP (free) in diseased sites (gingivitis and 
periodontitis) were significantly higher than the mean
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MMP-1, TIM P-1, 
TIMP-2
mRNA MMP-1, 
MMP-8, TIMP-1
Pinchback, Gibbins & 
Hunter, 1996.
Aiba et a i,  1996
amount o f  these GCF components in healthy sites in the 
same individual (permitting within subjects comparison).
Tissues biopsies from advanced destructive periodontitis 
(PD 8-13 mm) and minimally inflamed sites (PD 3 mm) 
were used in immunohistochemistry to locate the 
distribution o f  M M P-1. In advanced destructive tissue, 
MMP-1 was found pronouncedly in the vasculature o f  
intact connective tissue, particularly in the proximity to 
oral epithelium. There were also scattered in the small 
vessels immediately adjacent to pocket epithelium. In 
minimally inflamed specimen only weak staining 
associated with a few blood vessels. TIMP-1 in 
advanced lesion were found particularly centered on the 
vasculature corresponding to MMP-1 region but more 
diffuse. TIMP-2 were confined to the remaining islands 
o f  connective tissues in advanced lesion. Both TIMP-1 
and TIMP-2 were not found in inflamed tissues.
Biopsies o f  normal and inflamed gingivae were obtained 
from periodontal patients during surgery. Using RT- 
PCR, it was shown there was an increase in MMP-1 
mRNA in the inflamed gingivae compared to the control. 
MMP-8 and TIMP-1 gene expression did not change. 
When comparing the 3 mRNA in inflamed gingivae,
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MMP-1, MMP-3, 
TIMP.
MMP-1, MMP-3, 
MMP-8, MMP-9, 
TIMP-1
TIMP-1 was the highest and MMP-8 was the lowest 
mRNA. MMP-1 mRNA in inflamed gingivae is 5-fold  
higher than that found in control gingivae. This finding 
o f  higher mRNA MMP-1 level in adult periodontitis in 
agreement with Nomura et al. (1993), while MMP-1 was 
found to be higher in JP (Sorsa et al., 1988; 
Suomalainen et al., 1991).
Haerian et al., 1996.
This longitudinal study was looking at the level o f  FIB- 
CL, SL and TIMP in sites with advanced periodontal 
breakdown before and after treatment. It was shown that 
SL and TIMP levels are reduced by treatment.
SL level reduction was significant 3 months after therapy 
(RP), but not 6 weeks after therapy. Pre-treatment levels 
o f  FIB-CL, SL and TIMP failed to predict the response 
to treatment or the outcome o f  treatment.
Ingm aneta/., 1996. GCF and whole stimulated saliva were obtained from
AP, LJP, and control subject before any periodontal 
treatment. MMP-1 levels were found to be higher in 
GCF o f LJP patients in comparison to AP and healthy 
controls. Significantly elevated levels o f TIMP-1 were 
also detected in LJP GCF compared to AP and control. 
Higher levels o f  MMP-8 were detected in saliva o f  AP 
patients compared to LJP and the control salivary 
samples. Both MMP-1 and TIMP-1 were detected in all 
studied saliva samples, but no significant differences
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MRNA MMP-1, - 
3, - 8 TIMP-1 and 
- 2 .
MMP-3 & TIMP
Kubota et al., 1996
Pourtaghi et al., 1996,
were detected between the groups! MMP-9 levels were 
also significantly higher in AP compared to LJP and 
control GCF. MMP-8 is the main collagenase in saliva, 
GCF and gingival tissue in AP patients, whereas in LJP 
GCF it seems to be MMP-1.
The levels o f  MMP-1, -3, -8, and TIMP-1 mRNA  
relative to |3-actin were significantly higher in the 
diseased group than in the healthy controls. However, 
the difference in TIMP-2 was not significant between the 
two groups.
It was shown that MMP-3 mRNA > MMP-1 mRNA > 
MMP-8 mRNA in periodontally affected tissues, while it 
was shown that in GCF MMP-8 > MMP-1 in adult 
periodontitis (Ingman et al., 1993; Sorsa et al., 1988; 
1990; Suomalainen et al., 1991), which contradict each 
other.
52 adult periodontitis patients previously been treated 
were divided into 4 groups o f  treatment, scaling and RP 
(S+RP) alone and S+RP plus 3 different locally 
delivered antibiotic. Stromelysin level significantly 
decreased in tetracycline fiber and monocycline treated 
group, whereas it remained unchanged in the other two 
groups. TIMP levels increased significantly in all three 
adjunctive antimicrobial treatment.
49
mRNA TIMP-1 & 
- 2 .
Kubota et al., 1997. Using in situ hybridization and immunohistochemistry, it 
was shown that the numbers o f  both TIMP-1 and -2 
mRNA expressing cells are higher in the periodontitis 
than in the minimal gingivitis group. Both TIMP-1 and 
TIMP-2 mRNA-expressing cells were frequently 
observed in connective tissue where inflammatory cell 
infiltration was prominent was broadly observed in the 
gingival connective tissue while TIMP-2 mRNA was 
predominantly expressed in the connective tissue 
adjacent to the pocket epithelium.
Although there is no direct evidence for a causal relationship between MMP and 
periodontal tissue destruction, the involvement of collagenase in collagen breakdown 
during chronic inflammatory periodontal disease is highly suggestive and based on a vast 
amount of studies. MMP-8 is detected at high levels in GCF and saliva during gingivitis 
or periodontitis whereas it is undetectable in healthy individuals (Sorsa, Uitto & 
Suomalainen, 1992). In extracts or homogenates of diseased periodontal tissues MMP-1 
is abundantly present in contrast to healthy specimens and, as with MMP-8, a positive 
correlation was found between its presence and the severity of inflammation (Overall, 
Wiebkin & Thonard, 1987; Sorsa et al., 1988; Robinson et al., 1992). In addition, MMP- 
1 has been immunolocalized in inflamed but not in healthy periodontal tissue (Wooley & 
Davies 1981). These data may suggest that, following production during inflammation,
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most MMP-1 remains in the gingival tissue, whereas the majority of released MMP-8 
finds its way to the pocket.
1.5.5 MMP and TIMP during Repair
Wound repair involves many processes including cell migration, provisional matrix 
deposition, and remodeling. All of these processes are likely to be affected by matrix- 
modifying enzymes. Members of the MMP family are physiological mediators of the 
ECM. It is important to monitor the early stages of postoperative wound repair in order 
to identify those problems associated with impaired healing. Many of the crucial cellular 
responses of early wound healing, such as inflammatory infiltration, angiogenesis and re- 
epithelization, are made possible through the action of MMP.
Stromelysins had been shown to be produced during wound healing by human surface 
respiratory cells (HSRE), thus involved in cell migration and extracellular matrix 
remodeling. Stromelysins were overexpressed and overactivated during the wound repair 
process, with the maximal production observed at wound closure (Buisson et al., 1996).
Partially activated stromelysin were observed in the repair tissue of injured cornea, 
synthesized by stromal fibroblasts which decreased in a gradient radiating from the repair 
tissue (Girard et al., 1993). Synthesis of collagenase was detected in repair tissue as long 
as nine months after injury. Stromelysin are also synthesized by resident comeal cells in
thermally injured corneas of rabbit, but correlated more closely to deposition of repair 
tissue, while MMP-9 synthesis was correlated to basement membrane dissolution which 
led to failure to re-epithelialize (Fini et a l, 1996). The expression of MMP-2 has been 
detected both in undamaged and damaged cornea, but this expression increased in the 
damaged cornea and much of it appears in the active form. These changes persisted for 
at least 7 months, suggesting its involvement in the prolonged process of collagen 
remodeling in the stromal repair tissue (Fini et a l, 1992).
Stromelysin-1 and -2 are found to be produced by basal keratinocytes in a variety of 
chronic wounds (Saarialho-Kere et a l, 1994), and also in acute and chronic skin wound 
(Vaalaamo et a l, 1996) and thus suggest these two MMP serve distinct roles in tissue 
repair. Bullard et a l (1997) data suggested that increased MMP-2 & -3 found in fetal 
skin contribute to scarless healing, as when TGF-beta were added to fetal skin, it induced 
scarring by decreasing the interstitial MMP production.
MMP-9 level in the early inflammatory phase can predict the amount of collagen 
deposited later in the wound healing process (Agren et al, 1998; Tarlton et al, 1997). 
The levels of MMP-2 and MMP-9 in wound fluid were increased post-surgery compared 
to control serum, although MMP-9 decreased in the wounds 24-48 hr after injury (Agren 
et al, 1998). Tarlton et a l (1997) also found an increase in both MMP-2 and -9 in acute 
wounds, but still greater levels are found in chronic wounds. Yager et a l (1996) 
demonstrated the elevation to be more than 10-fold and 25-fold respectively. This 
finding indicates that uncontrolled proteolysis is a characteristic of retarded healing.
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Wounds which were healing were found to expressed maximal levels of MMP-9 at 24 hr, 
followed by a significant decline by 48 h. Persistent elevation of MMP-9 expression was 
associated with infected and chronic wounds. Therefore, measurement of MMP-9 in 
postoperative wound fluids within 48 hour of injury provides an early indicator of 
impaired healing. The expression of MMP-13 has been demonstrated in fibroblasts deep 
in the chronic ulcer bed, but it was not detected in epidermis and acute wounds (Vaalamo 
et al., 1997). MMP-13 most likely plays a role in the remodeling of collagenous matrix 
in chronic wounds.
When the levels of MMP-1 and TIMP mRNA were analyzed in normal and fibrotic 
fibroblasts, the MMP-1 mRNA were greatly reduced to undetectable levels whereas 
TIMP mRNA levels increased fourfold in fibrotic fibroblasts compared to normal 
(Lafuma et al., 1994). TIMP-1 mRNA in granulation fibroblasts was only down- 
regulated by 20% between day 3 and 14 after wounding (Petri et al., 1997). TIMP-1 
mRNA in epithelium was not detected in chronic cutaneous wound but were expressed in 
acute cutaneous wound in both human and pig (Vaalamo et al., 1996). TIMP-1 level 
were found by Bullen et al. (1995) to be lower in chronic than in healing wounds.
The levels of MMP-8 during wound healing or repair has not been studied before.
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1.6 DETECTION OF PERIODONTAL DISEASE
Periodontal disease can be detected clinically and rad;ographically. Clinical detection 
includes visual examination - changes in colour and texture of the gingivae, probing to 
measure the pocket depth (PD) and the clinical attachment level (CAL), bleeding on 
probing (BOP) and checking the tooth mobility. Radiographs can reveal horizontal or 
vertical bone loss.
A diagnostic procedure is used to supply information about the type of periodontal 
disease, where it is located and how severe it is. The findings can then be used to 
formulate a treatment plan. Diagnostic procedures are also useful in monitoring patients 
during and after treatment and detecting recurrence of disease.
The general uses of periodontal diagnostic procedures are in:
i) screening
ii) diagnosis of specific periodontal diseases
iii) treatment planing
iv) monitoring of therapy
v) identification of sites or subjects at a higher risk of progression of periodontal 
destruction.
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1.6.1 Probing
Use of the periodontal probe has been proved to be a simple and efficient method to 
measure periodontal support, gauge tissue health, and gain tactile appreciation of areas 
that are not visually apparent. The rationale behind probing is to detect and measure 
attachment loss or gain (CAL), in order to determine the extent of previous or ongoing 
periodontal disease activity, to assess the apical extension of the inflammatory lesion 
(PD) and to assess therapy and treatment efficacy. Additional findings obtained during 
probing include descriptions of bleeding, suppuration, and tissue consistency.
The results of probing depth measurements are conditional upon the probe tip diameter 
and shape (Cianco et al, 1992; Gabathuler & Hassel, 1971; Van Der Zee, Davies & 
Newmann, 1991; Atassi et al, 1992), the probe angulation (Kaarim et al, 1990), the 
force applied (Mombelli, Mukle & Frigg, 1992; Osborn et al, 1990), and the location, 
presence or absence of inflammation in the subepithelial connective tissue (Armitage et 
al, 1977; Keagle et al, 1989; Zappa et al, 1990; Anderson et al, 1991; Caton, 
Greenstein & Poison, 1981).
Conventional, manual probes that do not control for probing force or pressure are called 
first generation probes. The introduction of constant-force or pressure-sensitive probes 
allowed for improved standardization are called second-generation probes. Third- 
generation probes have computer-assisted direct data capture thus reducing examiner 
bias.
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In the present study the first-generation probe (University of North Carolina and PCP 12 
manual probe) and the third-generation probes (Florida probe) were used. University of 
North Carolina probes have 1 mm graduation marks with black bands of 1 mm every 5 
intervals while PCP 12 probes are graduated with consecutive 3 mm black bands and 3 
mm unmarked bands. The maximum depth that can be measured with these probes is 15 
and 12 mm respectively.
1.6.1.1 The Florida Probe
Gibbs et al. (1988) developed the Florida Probe system, a third generation probe, which 
features constant probing force, precise electronic measurement to 0.1 mm, computerized 
data capturing, and sterilization of all system parts entering or close to the mouth. The 
system consists of a probe handpiece, a digital read-out, foot switch, computer interface 
and computer. The probe tip reciprocates through a sleeve and is connected to a movable 
arm, which transfers the movement to a transducer with a digital read-out. The edge of 
the sleeve which is 0.6 mm in radius is the reference from which measurements are 
recorded. The probe tip is 0.4 mm in diameter and the probing force is usually set at 0.25
'y
N (1.99 N/mm ). The actual measurement of pocket depth (or relative attachment level) 
is made electronically and transferred to the computer when the foot switch is pressed.
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Besides the pocket depth probe, the stent probe and the disk probe are also available. 
The former uses an acrylic stent as a reference and for the reproducible placement of the 
probe tip. The latter has a small metal disc attached to the sleeve and uses the occlusal 
surface or incisal edge of a tooth as a reference for relative attachment level 
measurement. In the present study the pocket depths measurements are taken with the 
manual probe as well as with the Florida probe. Manual probing is also used to take 
measurements of the attachment level from the CEJ (CAL), while the relative attachment 
level (RAL) taken with the Florida disc probe. Pressure-controlled probing is more time 
consuming than conventional probing. However, the use of a pressure-sensitive probe at 
least standardizes the probing pressure employed during a study. Repeated 
measurements have been shown to increase the measurements sensitivity and specificity 
with pressure-controlled probes (Mullally & Linden, 1994). Magnusson, Batich & 
Collins (1988) and Osborn et a l (1990) found that pocket depth measurements recorded 
when using the manual probe with visual readings were consistently deeper than those 
obtained using the constant pressure probes.
Based on reports in the literature, a small diameter tip (0.4 mm) and moderate probing 
force (25g), would likely place the probe tip about 0.25 mm coronal to the base of the 
junctional epithelium in healthy sites and as much as 1.25 mm beyond the coronal level 
of the connective tissue in diseased sites (Poison et al., 1980; Robinson & Vitek, 1979; 
Spray et al, 1978; Caton, Greenstein & Poison, 1981; Listgarten, Mao & Robinson, 
1976).
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Ahmed, Watts & Wilson (1996) measured the CAL of 34 teeth scheduled for extraction 
clinically and in the laboratory using an automated probe (Florida probe) and Vernier 
calipers. Vertical grooves were made on six sites of the teeth and used for guidance in 
measuring the AL before extraction. After the extraction, using dissecting stereo 
microscopy, the distance from the most coronal attachment fibres and the center of the 
end of each groove were measured and compared to the measurement done clinically. In 
all cases there was a statistically significant correlation between clinical and laboratory 
measurements. However, the molar sites as a group displayed a distinct difference to the 
non-molar sites in that the mean clinical probing AL was 0.45 mm greater than the 
laboratory measurement.
Another study into the accuracy of a controlled force electronic probe and a manual 
probe was performed in 15 patients scheduled for tooth extraction. It was found that the 
electronic probe significantly underestimated the clinical probing depths (-0.48 mm) 
whereas no significant difference was found between the manual CAL and the actual AL 
(Hull, Clerehugh & Ghassemi-Aval, 1995). This study demonstrated that the constant 
force electronic probe under-measured the probing depths as determined in the 
laboratory.
In another study by Reddy, Palcanis & Geurs (1997) 3 examiners recorded AL with four 
different probing techniques, Florida disc probe relative to the occlusal surface, modified 
Florida probe relative to a stent, North Carolina probe read to 1 mm relative to CEJ or
restoration base and North Carolina probe read to 0.5 mm relative to the CEJ or 
restoration base. 8 subjects were involved and each quadrants were randomly measured 
using different methods. At a subsequent visit during the week the subjects were 
reexamined by repeating the experimental design in the same sequence. The highest 
repeatability was observed with the manual probe read to 1 mm, where as the modified 
constant force probe and stent represented the group with the greatest variability between 
measurement. The site measured on the tooth also had a significant result on the 
repeatability outcome. The distal surfaces, either buccal or lingual, showed significantly 
more variability in the repeated measurements of attachment levels. In this study a 
reproducibility of 0.6 mm was accomplished with both manual and electronic probes. 
The use of modified Florida probe with a stent had no true advantage with regard to 
repeatability in this study. Rams and Slots (1993) reported that periodontal pockets > 5 
mm have better repeatability when measured using an electronic probe than a 
conventional probe. Walsh and Saxby (1989) also demonstrated better agreement 
between two examiners when a controlled force probe was utilized. Comparable 
repeatability between constant force and manual probes have been reported (Quirynen et 
a l , 1993; Mullaly & Linden, 1994; Tupta-Veslicky et al, 1994; Wang et al, 1995). A 
lack of agreement between measurements taken at the same site has also been reported 
(Galgut & Waite, 1990; Rams & Slots, 1993; Perry et al, 1994; Hull, Clerehugh & 
Ghassemi-Aval, 1995) with electronic probes having a tendency toward shallower 
probing depth measurements.
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Oringer et a l (1997) compared the manual probe and the automated probe (Florida 
probe) to measure PD and CAL in 411 interproximal sites in untreated patients in a 6 
months study. Variability between the 2 passes at a single site at the same visit was 
significantly larger in automated probe, but when inter-visit analysis was done over the 6- 
month period, automated probe appeared to demonstrate better repeatability than the 
manual probe. This study demonstrated that automated probing may have less variability 
of AL over a 6-month period and it may be advantageous using automated probe for 
monitoring periodontitis patients in a longitudinal clinical trial.
Marks et al (1991) evaluated the reproducibility of 2 models of the Florida probe, the 
original stent model and the modified disc model, in measuring attachment levels. The 
disc probe uses the occlusal surface of the tooth as a static reference point in calculating 
changes in attachment level. In this study, examiners using both types of probes took 
duplicate measurements. The results demonstrate that the disc probe yields reproducible 
measurements similar to the stent probe and is therefore suitable for use in longitudinal 
clinical studies. Osborn et al (1990) has demonstrated that double passes with the 
Florida disc probe offers significant advantages for measuring relative attachment level 
in longitudinal studies as the mean intra-examiner standard deviation of differences in 
repeated relative attachment level measurement using the disc probe was one-half smaller 
(0.44 to 0.57 mm) using double passes than using the conventional probe in single pass 
(0.78 to 0.95 mm). Using double passes with the Florida disc probe reduced intra- 
examiner error by approximately 40% when compared to measurement level using one 
pass with a conventional periodontal probe.
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1.6.1.2 Assessment of Probing Depth
When the probe is inserted into the sulcus of a healthy tissue, it easily penetrates the 
junctional epithelium at the bottom of the sulcus, which does not offer any significant 
resistance to probing. Further penetration of the probe is halted by the pressure of the 
dense network of collagen fibres of the connective tissue (Armitage et al, 1977). The 
probe tip penetration is coronal to the apical end of the junctional epithelium.
In mild inflammatory conditions, the probe will likely penetrate through the junctional 
epithelium, but will be stopped quickly by the resistance of the impenetrable arrangement 
of intact connective tissue fibre bundles in the gingival connective tissue. The clinical 
measurement will be similar to that measured in the healthy tissue. Some minor bleeding 
may be observed as a result of injury to blood vessels.
When a periodontal pocket develops and the tissue is inflamed the probe will easily 
transverse the pocket epithelium and penetrate more or less deeply into the connective 
tissue, as shown by Magnusson & Listgarten (1980) and Fowler et al (1982). Presence 
or absence of inflammation of the gingival connective tissue is an important determinant 
in the probe tip penetration. Fowler et al (1982) stated that reduced inflammatory 
infiltrate level would allow for greater resistance to probe penetration. The precise 
location of the probe tip during the probing event remains an enigma.
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1.6.2 Radiographs
In general dentistry, panoramic, bitewing and periapical radiography are widely used for 
diagnostic purposes. In periodontics, periapical radiographs provide the most useful 
views for periodontal diagnosis, but for screening purposes, panoramic radiograph can 
also be used. The clinical implications of radiography in the diagnosis of periodontal 
disease are twofold; to visualize the initial status of the bone tissue and to illustrate 
changes in the bone tissue over time. Assessments of bone loss in intraoral radiographs 
are usually performed by evaluating a multitude of qualitative and quantitative features of 
the visualized interproximal bone, e.g. i) presence of an intact lamina dura, ii) the width 
of the periodontal ligament space, iii) the morphology of the bone crest (even or angular 
appearance), and iv) the distance between the CEJ and the most coronal level of the 
normal width of the periodontal ligament space. The threshold of bone loss, i.e. the CEJ- 
bone crest distance considered to indicate that bone loss has occurred, varies between >1 
(Schei et a., 1959; Lennon & Davies 1974; Hugoson & Rylander, 1982; Mann et al, 
1985; Bishop et al, 1995) and > 3 mm in different studies (Blankenstein et al, 1978; 
Latchman et al, 1983; Sjodin et al, 1989; Albandar, Buischi & Barbosa, 1991; Albandar 
et al, 1995; Shapira et al, 1995). Most studies have used > 2 mm as the criterion for 
damage (Belting, Massler & Schour,1953; Hoover, Ellegaard & Attstrom, 1981; Gjermo 
et al, 1984; Kronauer, Borsa & Lang, 1986; Aass et al, 1988; Aass, Preus & Gjermo, 
1992; Aass, Tollefsen & Gjermo, 1994; Kallestal & Matsson, 1989; 1991; Sandholm et 
al, 1989; Sjodin & Matsson 1992; 1994; Sjodin et al, 1993; Bimstein et al, 1994), and 
two studies have indicated that this is the appropriate threshold for radiographic
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assessment of bone loss (Kallestal & Matsson 1989; Hausmann, Allen & Clerehugh, 
1991).
1.6.2.1 Infrabony Defects
Pockets are classified into suprabony or infrabony depending on the location of the 
bottom of the pocket to its relationship to the alveolar crest. These horizontal or vertical 
bone loss can be revealed by radiographs. A suprabony pocket is defined as a 
pathological sulcus where the base of the pocket is coronal or occlusal to the alveolar 
crest, while infrabony is defined as a pathological sulcus where the bottom of the pocket 
is apical to the alveolar crest. Infrabony defects are sometimes called angular bony 
defects. Goldman et al. (1958) proposed a classification of the infrabony pocket on a 
morphologic basis which is dependent on the number of osseous walls present in the 
defect. These are: 1) three osseous walls defect, 2) two osseous walls defect, 3) one 
osseous wall defect and 4) combination defect (Figure 1.4). Prichard (1967) classified 
infrabony defects as intrabony defects, hemisepta or craters. According to his 
classification, a crater is a wide mouthed cup or bowl shaped defect, with bone 
destruction about equal on the roots of contiguous teeth; and the side walls are formed by 
marginal bone of the vestibular and lingual surfaces. When a tooth is affected and the 
septal bone adjacent to it is destroyed without affecting the contiguous tooth, a
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Figure 1.4 Schematic drawings 
illustrating the classification of 
infrabony defects based on the 
number o f surrounding osseous 
walls,
a) 1-wall
b) 2-wall
c) 3-wall defects
hemiseptum would exist. The intrabony defect is surrounded by bony walls on three 
sides with the tooth root forming the fourth wall.
Subgingival plaque has been demonstrated to play a major role in the pathogenesis of the 
infrabony defect as observed in 48 periodontally involved extracted teeth with 
radiographic evidence of infrabony pocket. Subgingival plaque was found covering the 
root surface to a distance of 1 to 2 mm from its apical limitation (Waerhaug, 1979a). 
Based on autopsy results, Waehaug (1979b) also observed that the configuration of 
interdental septum of the infrabony defects was dependent on the level of plaque of the 
two neighbouring teeth. If plaque had proliferated down to different levels on the two 
neighbouring teeth, the crest of the interdental septum was oblique and angular defect 
hereby established. There was no evidence to indicate that trauma from occlusion had 
been involved in the pathogenesis of the infrabony defects in both studies.
Anatomic factors have also been assumed to influence the alveolar bone loss pattern, e.g. 
distance between neighboring teeth - open contact points with resultant food impaction, 
morphology and quality of the alveolar bone, concavities/fissures on the root surface, 
position of the tooth, the relationship of adjacent marginal ridges and cementoenamel 
junctions.
Radiographically detectable angular bony defects are a common finding in adults with a 
reported prevalence ranging from 18 to 32% (Nielsen, Glavind & Karring, 1980; 
Wouters et al., 1989). An increasing frequency of periodontal infrabony defects with age
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has been observed in both human skull material (Larato, 1970b) and in clinical and 
radiographic study (Nielson et al., 1980). As regards the teeth and tooth surfaces most 
frequently involved, varying findings have been reported. When Lorato (1970b) 
examined 337 dry human skull for three wall defects he found that in the maxilla, the 
second molar was the tooth most affected, while the site most affected was the mesial. In 
the mandible, it was the wisdom tooth and the mesial site was the most common area 
affected. Based on examination during periodontal surgeries in all 4 quadrants in 30 
patients, Manson & Nicholson (1974) observed more infrabony defects in the maxilla 
than in mandible. Interdental crater was more common in the posterior segment of the 
mandible, while 3-, 2-, 1-walled defects and hemiseptum were found almost exclusively 
in the maxilla, and mostly in the anterior segment. A clinical and radiographic study by 
Nielsen, Glavind & Karring (1980) on 209 dental patients, revealed that there was no 
significant difference between the prevalence of defects in male and females, but the 
defects occurred most frequently in the older age group. Only 47 individuals out of the 
209 were affected with osseous defects which had a higher incidence in the distal than 
the mesial surfaces and most frequently in the mandible. The prevalence is lower than 
that reported by Larato (1970b), 36% in 17-29 age group and 72% in 60 and above, 
compared to 34% and 14%. Periodontal infrabony defects have also been observed in 
skulls of children (Larato 1970a).
It is well known that infrabony defects can present special therapeutic problems 
(Steffensen & Weber, 1989; Heins et al., 1990) but it has not been clearly established if 
their elimination is mandatory for long-term periodontal stability. Based on the results of
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a 10-year retrospective study of a population without any special periodontal therapy, a 
higher percentage of teeth were lost which had angular bony defects (32.2%) than teeth 
without such defects (12.7%) (Papapanou & Wennstrom, 1991). However, results from 
two retrospective studies of treated and maintained patients suggest that sites with 
residual angular bony defects are not at a higher risk of breaking down than sites without 
these defects (Pontoriero, Nyman & Lindhe, 1988; Heins et al, 1989).
1.7 TREATMENT OF PERIODONTAL DISEASE AND HEALING
PROCESS
The main aim of periodontal treatment is to eliminate disease. Ideally, treatment should 
resolve inflammation, arrest disease progression, maintain aesthetics, maximize patient 
comfort, regenerate lost periodontium, and create an environment that deters recurrent 
disease. This can be carried out by several measures, which include initial (cause- 
related) measures, corrective measures, and maintenance measures.
1.7.1 Initial Therapy
The main aim of initial therapy is to eliminate or control the recurrence of supra- and 
subgingivally located bacterial deposits from the tooth surfaces. Instructions in oral 
hygiene measures, scaling and root planing and in combination with removal of retention 
factors for plaque, and extraction of teeth with poor prognosis are included in this
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category. Subsequent check-ups and reinstruction are carried out to maintain good oral 
hygiene. The patients are motivated and educated on proper oral hygiene techniques. To 
facilitate proper oral hygiene the use of toothbrushes, interdental cleaning aids such as 
dental floss or tape, toothpicks and interproximal brushes, are introduced to the patients.
Scaling is a procedure aimed at the removal of plaque and calculus from the tooth 
surface. Root planing denotes a technique of instrumentation by which the altered 
cementum is removed and the tooth surface is made hard and smooth. Subgingival 
instrumentation aims at resolving the inflammation in the gingivae and arresting the 
progressive destruction of the attachment apparatus by removing the microbiota of the 
gingival pocket.
Once this therapy is finished the patient is re-examined in order to reevaluate the 
outcome of the treatment and whether further treatments or guidance is needed. If the 
results from the reexamination, made at the termination of the initial treatment phase 
show that periodontal disease has been brought under proper control, the corrective 
treatment may be carried out.
1.7.2 Corrective Therapy
The corrective treatment includes periodontal surgery, extraction, hemisection, and also 
prosthodontic treatment. Periodontal surgery can be carried out in those areas of the
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dentition where the inflammatory lesions had not been resolved by scaling and root 
planing. The planning of the type and the extent of surgical treatment should be based on 
the pocket depth and “bleeding on probing” measurements made at the end of the initial 
phase of treatment.
Surgical treatment of the periodontal lesions offers obvious advantages over a 
nonsurgical approach: the root surfaces can be inspected and cleaned by direct vision. By 
doing surgery the diseased pocket epithelium can be excised and removed and the flap 
can be replaced either coronally or apically. If an apically repositioned flap procedure is 
carried out the pockets are virtually eliminated as the soft tissue flaps are repositioned to 
the level of the alveolar bone. The modified Widman flap, which is also recognized as 
the open flap curettage technique, is usually used for the anterior segment of the dentition 
as it exposes less of the root surfaces while giving access for removal of pocket 
epithelium and granulation tissue. Other periodontal surgical procedures include, distal 
wedge procedure which excise a triangular wedge of tissue to remove the distal pocket of 
a distal molar, and gingivectomy procedures removing excess gingival tissue.
1.7.3 Maintenance Therapy
Following completion of cause-related and corrective therapy the patient must be 
enrolled in a recall system which aims at preventing the recurrence of disease. The
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ability of the patient to maintain a proper oral hygiene standard determines the time 
interval between the recalls appointments.
At the recall appointments the oral hygiene standard should be assessed and scaling and 
polishing should be carried out if indicated. At least once a year a comprehensive 
examination should be performed to assess the overall dental health and particularly the 
periodontal health by checking the depth of pathologically deepened pockets, furcation 
involvement, tooth mobility and alterations of the alveolar bone level.
1.7.4 Wound Healing
Definitions
• Repair is defined as ‘healing of a wound by tissue that does not fully restore the 
architecture or the function of the part.’
• Reattachment is defined as ‘the reunion of surrounding soft tissue and a root surface 
with preserved periodontal ligament tissue.’
• New attachment is defined as ‘the formation of new cementum with inserting 
collagen fibres on a root surface deprived of its periodontal ligament tissue.’
• Regeneration is defined as ‘reproduction or reconstitution of a lost or injured part in 
such a way that the architecture and function of the lost or injured tissue are 
completely restored.’
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Wound healing is a response to various kinds of injury toward the restoration of normal 
structure and function. Healing is divided into regeneration and repair. Regeneration is 
the complete restoration of damaged tissues by proliferation and differentiation of the 
original parenchymal elements. In comparison, repair (incomplete regeneration) is 
healing by the replacement of lost tissues by non-specialized connective tissue 
(granulation tissue) maturing to fibrosis and eventuating in scar tissue formation.
The cells of the body are divided into three groups according to their mitotic activity, i.e., 
labile cells, stable cells, and permanent cells. Labile cells (epithelial cells, fibroblasts 
cells, hematopoietic cells, lymphoid cells) undergo continuous replication even under 
normal physiological condition. Stable cells, including glandular parenchymal cells of 
the liver, pancreas, endocrine glands, and so forth, have a decrease or loss of mitosis in 
adults but reenter the cell cycle as the situation demands. Permanent cells, e.g. neurons 
and cardiac myocytes, lose their ability to regenerate. Tissue composed of labile and 
stable cells can be expected to regenerate, but permanent cells cannot be renewed if lost.
Periodontal tissues are composed of cells belonging to the labile or stable groups. These 
cells are expected to exhibit their high ability to proliferate when the periodontal tissues 
are damaged.
In periodontitis, cells from gingival epithelium, gingival connective tissue, bone cells, 
and cells from the periodontal ligament participate in the healing of the damaged
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periodontal tissues. Melcher (1976) proposed a theory on the repair potential of 
periodontal tissue and postulated that the cells that repopulate the exposed root surface 
determine the nature of the attachment that will form. If the epithelium cells proliferate 
along the root surface, precisely on the surface of the granulation tissue of the gingivae, 
long junctional epithelium (LJE) will result. If cells from the gingival connective tissue 
populate the root surface, the attachment occurs in the form of connective tissue 
adhesion, and root resorption may occur. If bone cells migrate into contact with the tooth 
surface, root resorption and ankylosis occur. The ideal new connective tissue attachment 
develops if cells from the periodontal ligament proliferate to cover the denuded surface. 
The formation of the new connective tissue together with bone restoration by the cells 
from periodontal ligament is described as regeneration.
1.7.4.1 Healing After Root Planing
Coronal attachment of the periodontal tissues as a result of root planing and soft tissue 
curettage have been described (Beube, 1947; Ramfjord, 1951; Waerhaug, 1952; Schaffer 
& Zander, 1953; Ramfjord et ah, 1968). The increased resistance to probing following 
root planing and soft tissue curettage may be due to a more coronal connective tissue 
attachment, and/or to the formation of a long junctional epithelium, or increased 
resistance of the less inflamed tissue. A LJE was demonstrated following subgingival 
plaque control in humans (Waerhaug, 1978) and following periodontal flap surgery in 
primates (Caton & Kowalski, 1976; Yukna, 1976). Caton & Zander (1979) concluded
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that the coronal attachment of gingival tissues to the root surface commonly reported 
following root planing and soft tissue curettage appears to result from formation of a long 
junctional epithelium rather than a new connective tissue attachment. This work was 
based on a non-human primate model.
It was stated that teeth with a LJE were not more prone than other areas to develop new 
pocket formation (Magnusson et al, 1983; Beaumont et a l, 1984; Aukhill et al, 1988). 
Aukhil and coworkers concluded that the type of attachment (connective tissue vs. LJE) 
present was irrelevant and that plaque control was the critical element that promoted 
health (Aukhill et a l, 1988).
1.7.4.2 Healing After Conventional Surgical Procedure
Healing of surgical wounds in skin or oral soft tissues begin with the chemoattraction of 
cells to the wound area and end with the formation and maturation of a new extracellular 
matrix. This matrix bridges the margins of the wound, supports cells and a regenerating 
vasculature, and restores the resistance of the tissues to functional stress. Superficially, 
epithelial cells migrating from the wound margins rapidly cover the maturing fibrin clot 
in the wound space.
In a periodontal defect, the gingival flap is seated against a vascularized wound margin, 
namely the gingival connective tissue and the alveolar process, and also it opposes the
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avascular, calcified, and rigid root surface. Healing of such lesions has generally been 
characterized by maturation of the gingival connective tissue, some regeneration of 
alveolar bone and cementum, and most significantly, epithelialization of root surface 
(Caton & Zander, 1976; Listgarten & Rosenberg, 1979; Steiner, Crigger & Egelberg, 
1981). The dentogingival epithelium seems to be the ‘sprinter’ in the race, thus 
traditional flap surgery routinely results in healing with a long junctional epithelium 
lining the debrided root surface (Caton, Nyman & Zander, 1980; Magnusson et al, 1983; 
Beaumont et al, 1984; Listgarten & Rosenberg, 1979; Yukna, 1978), with no new 
connective tissue reattachment. The cells which repopulate the root surface determine 
the nature of the attachment that will form. The epithelial downgrowth prevents the 
formation of a new connective tissue attachment by preventing repopulation of the root 
surface by cells derived from the periodontal ligament. However, the coverage of the 
root surface by an epithelial layer has a beneficial barrier effect; i.e., the prevention of 
root resorption and ankylosis, which otherwise could be induced by gingival connective 
tissue and bone.
The sequence of healing based on experimental incision and excision wounds, primarily 
in the skin, is commonly divided into three overlapping phases; 1) inflammation; 2) 
granulation tissue formation; and 3) matrix formation and remodeling.
Early healing events at the dento-gingival interface have been examined using dentine 
blocks implanted in edentulous ridges in dogs by Wikesjo et a l (1991). Immediately 
following wound closure, a granular precipitate of plasma proteins with aggregates of red
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blood cells seems to adhere to the dentine surface. A few hours later, the intercellular 
matrix appears more organized with fibrin formation around erythrocyte aggregates and 
at the dentine surface. Neutrophils are present throughout the wound space at this time. 
As the inflammatory phase progresses, the numbers of neutrophils migrating towards the 
dentine are increasing. Strands of fibrin gradually become more distinct throughout the 
clot, binding to the connective tissue as well as to the dentine surface. Degradation of the 
erythrocytes begins.
Granulation tissue formation may be visualized within three days of healing. 
Macrophages can be seen at the dentine surface at this time and fibroblasts now occur in 
the wound space, which, however, is still dominated by inflammatory cells. Further 
degradation of fibrin clot is evidenced by loss of structure and presence of fragmented 
erythrocytes.
Seven days following wound closure, the wound site is dominated by a cell-rich 
granulation tissue with fibroblasts and young collagen fibres. At this stage, collagenous 
elements appear parallel to the dentine surface. Within 14 days, the newly formed 
collagen fibres may show arrangement indicative of physical attachment to the dentine. 
Cementum formation is not seen until at least three weeks after wound closure (Bjorvatn, 
1986; Selvig, Bogle & Claffey, 1988). However, a functional fibre arrangement followed 
by cementum formation does not always occur.
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Reported changes produced by conventional periodontal therapy in humans included 
pocket depth reduction mediated by recession of the gingival margin and gain of clinical 
attachment (Caton, Proye & Poison, 1982; Proye, Caton & Poison, 1982). Until the mid- 
1970s, the favorable changes produced by conventional periodontal therapy were often 
interpreted to represent a true periodontal regeneration. Indeed, longitudinal human 
clinical studies from several different research centers demonstrated that conventional 
periodontal therapy followed by good periodontal supportive therapy was effective in 
stabilizing periodontal status and maintaining periodontal health (Becker, Berg & 
Becker, 1984; Knowles et al, 1979; Lindhe & Nyman, 1984; Lindhe et al, 1987; 
Pihlstrom et al, 1983; Ramfjord et al, 1987).
Caton et a l  (1980) showed histological evidence of re-formation of an epithelial lining 
(long junctional epithelium) facing the instrumented root surfaces with no new 
connective tissue attachment after surgical and nonsurgical treatments in animals. The 
development of a long junctional epithelium occurred in sites with suprabony pockets as 
well as sites with infrabony pockets. New bone formation (bone fill) in infrabony defects 
was a frequent findings, but a long junctional epithelium was always interposed between 
the newly formed bone and the root. The formation of a long junctional epithelium was 
reported by Bowers (1989) to occur also in humans following flap curettage of infrabony 
defects. Therefore, conventional periodontal therapy results primarily in repair rather 
than regeneration of the periodontium (Caton et al, 1980; Listgarten & Rosenberg, 
1979). These studies were a turning point in the standards of evaluation of therapy and 
approach to modifying therapy to favor regeneration.
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1.7.4.3 Time for Healing and Maturation of the Periodontium to Occur
Following scaling and root planing, Proye and coworkers (1982) have reported a gain of 
clinical attachment after 3 weeks. Morrison, Ramfjord & Hill (1980) demonstrated that 
healing took at least 4 weeks. Kaldahl and colleagues (1988) demonstrated that the 
repair process extended for a year. It was concluded in the Proceedings of the World 
Workshop in Clinical Periodontics in 1989 that it appears that the greatest changes with 
respect to probing depth reduction and gain of clinical attachment can be recorded after 4 
to 6 weeks, but gradual repair and maturation of the periodontium may occur over 9 to 12 
months.
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1.8 REGENERATION
1.8.1 Definition
Periodontal regeneration is defined as the restoration of the various components of the 
periodontium, i.e. alveolar bone, periodontal ligament, root cementum, and gingivae lost 
due to disease, in their appropriate locations, amounts, and relationships to each other, 
thereby locating the epithelial attachment at a more coronal position before treatment. 
For the regenerative process to take place, it is vital to prevent the epithelium from 
contacting the root surface. It is believed that by placing a physical barrier between the 
gingival connective tissue and the root surface the following may be achieved: (a) 
epithelial cells are impeded from apically migrating and interfering with connective 
tissue-root surface interactions; (b) gingival connective tissue from the flap is excluded 
from healing sites; and (c) progenitor cells from the periodontal ligament are favoured to 
repopulate the coronal root surface, thereby facilitating formation of new periodontium
1.8.2 The Regenerative Capacity of the Periodontal Tissue
In the wound healing process following surgical treatment, the denuded root surface can 
be repopulated by cells derived from the dentogingival epithelium, the gingival 
connective tissue, the alveolar bone and the periodontal ligament. As stated before, the 
dentogingival epithelium seems to be the “sprinter” in the race. During the early healing
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phase, dentogingival epithelium migrates apically along the wound surface that faces the 
root, effectively preventing the formation of a new connective tissue attachment. This 
epithelial proliferation extends to or close to the bottom of the defect, resulting in the 
formation of so-called long junctional epithelium.
A critical step in periodontal regenerative therapy is to alter the periodontitis-affected 
root surface to make it a hospitable substrate to support and encourage migration, 
attachment, proliferation and proper phenotypic expression of periodontal connective 
tissue progenitor cells.
In order for regeneration to occur, cells having the capacity to form cementum, bone and 
periodontal ligament must occupy the periodontal defect and produce these specialized 
tissues. Current thought is that these periodontal progenitor cells reside in the 
periodontal ligament remaining around the tooth (Melcher, 1976; Melcher et al., 1987; 
Nyman et al., 1982). It has been shown by Karring, Nyman & Lindhe (1980) that 
ankylosis and root resorption occurred where bone tissue had grown into direct contact 
with the ligament deprived root surface. Gingival connective tissue has also been shown 
to lack the potential to induce the formation of new CT attachment to a root surface that 
has been deprived of its original periodontal ligament, and actually cause root resorption 
(Nyman et al., 1980). Karring et al. (1985) has demonstrated that extensive formation of 
new CT in the coronal portion of the roots occurred when the periodontal ligament in the 
apical half was maintained undamaged. This was taken as evidence that granulation 
tissue originating from the periodontal ligament possess the ability to form new
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attachment. Another study that supported this idea was the formation of cementum and 
periodontal ligament on implants placed in close contact with retained roots. Only 
osseointegration with no cementum or periodontal ligament formation occurred on 
implants with no direct contact to retained roots, thus suggesting that the progenitor cells 
for cementum formation reside in the periodontal ligament and not in the alveolar bone 
(Buser et. al., 1990).
1.8.3 Root Surface Conditioning and/or Bone Grafts or Bone Substitutes to
Enhance Regeneration
Removal of the cementum layer by citric acid has been shown to promote new 
attachment in animals (Register, 1973; Crigger et al, 1978; Nilveus, Johansson & 
Egelberg, 1978; Ririe, Crigger & Selvig, 1980). The citric acid exposes the collagen 
fibrils of the dentine matrix and a subsequent interdigitation of these fibrils occurs with 
collagen fibrils of the adjacent soft tissue flap (Ririe, Crigger & Selvig, 1980; Selvig et 
al, 1981; Poison & Proye, 1982). Formation of a new connective tissue attachment, 
without any sign of new cementum on the root surface following treatment of root 
surfaces with citric acid, have been observed in experimental studies (Bogle, Claffey & 
Egelberg 1985; Caffessee et al, 1985; Isidor et al, 1985). Formation of a long 
junctional epithelium (Nyman et al, 1981) and increased frequency of root resorption 
(Gottlow, Nyman & Karring, 1984b; Magnusson et al, 1985b; Dreyer & van Heerden, 
1986) have been reported in animals studies. Comparative studies in humans failed to
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detect clinically significant differences between acid treated and non-acid treated teeth 
(Renvert et al, 1981; 1985; Smith et al, 1986; Moore, Ashley & Waterman, 1987).
Most investigators have focused upon bone regeneration as being the prerequisite for 
new attachment formation. If bone regeneration could be induced it is hypothesized that 
this will also lead to induction of cementum formation (Hiatt et a l , 1978). To 
accomplish this goal several bone grafting materials or bone substitutes have been used 
mostly in the treatment of infrabony defects and furcation defects.
In a number of clinical trials and animal studies, surgical procedures have been combined 
with the placement of bone grafts or implant materials to promote regeneration in 
furcation and infrabony defects. The grafting materials can be divided into 1) autogenous 
grafts, 2) allografts, 3) hetero- or xenografts, and 4) alloplastic materials.
The rationale behind the use of bone grafts or alloplastic materials is the assumption that 
they may either be osteoproliferative, osteoconductive or osteoinductive and that they 
may favour cementogenesis (Melcher et al, 1987). Inconsistent results have been 
obtained following grafting procedures. Successful results with bone regeneration and 
gain in probing AL, in angular bony defects, has been demonstrated by Schallhom 
(1977), Dragoo (1981) Nabers (1984), Hiatt et al (1986), and Schrad & Tussing (1986). 
Other studies, however have failed to demonstrate any beneficial effect of using bone 
grafts compared to curettage alone (Ellegaard & Loe, 1971; Carraro, Sznayader & 
Alonso, 1976; Renvert et al, 1985b). In a study by Ellegaard et a l (1974) healing of
80
angular bony defects in monkeys was evaluated. It was observed that the use of grafts in 
defects favoured regeneration, but the placement of fresh autogenous marrow resulted in 
ankylosis and root resorption. Moskow, Karsh & Stein (1979) reported new bone 
formation associated with placement of cancellous bone, but noted the presence of long 
junctional epithelium between the grafts and the root surface. It has been indicated that 
by using bone graft the effect is more physical rather than biological, acting like a filler 
supporting the mucogingival flaps.
In summary, root surface conditioning and bone grafting in addition to conservative 
treatment only resulted in limited formation of a new attachment when evaluated 
histologically. Most frequently healing occurs with the formation of a long junctional 
epithelium extending to the base of the previous defect.
1.8.4 Earlier Studies on Guided Tissue Regeneration
The principal of guided tissue regeneration was bom as an extension of the window 
technique and first introduced by Nyman et al. (1982b). The window technique is a 
procedure where a U-shaped incision was made on the buccal mucosa to expose the root 
surface underneath the alveolar bone. By doing this dentogingival epithelium was 
prevented from interfering with the wound, and by placing a membrane in between the 
flap and the root surface the connective tissue was prevented from contacting the root 
surface. The guided tissue regeneration technique is based on the argument that cells
81
proliferating from the periodontal ligament bordering the periodontal defect should 
preferentially and selectively be guided to repopulate the denuded root surface. To 
achieve that purpose, a piece of physical barrier, i.e., a non-resorbable membrane or 
biodegradable membrane material is placed over the denuded root surface and covered by 
mucosal tissue. The membrane extends apically from the outer bone surface, laterally to 
the root defect and underneath the gingival margin, and allows cells of the adjacent 
periodontal ligament and of alveolar bone to repopulate the blood clot that fills the space 
between root and barrier, and later the denuded root surface. At the same time, the 
barrier prevents gingival epithelium and connective tissue from contacting that surface.
In a study by Minabe (1991), a new cementum matrix was formed along up to 70% of the 
denuded root surface extending from the apical or lateral border of the still intact 
periodontium coronally for distances varying between 1 and 5 mm. The regenerated 
cementum was thin, tapered coronally, overlapping the old cementum apically but did not 
adhere to the established root surface, neither the old cementum nor dentine (Gottlow, 
Karring & Nyman, 1984a; 1990; Ettetl et al., 1989). In humans, the outer surface of this 
new cementum is covered by connective tissue, rarely showing dense aggregates of 
collagen fibres oriented perpendicularly to and inserting into the new cementum, in 
contrast to dogs and non-human primates in which dense fibres were seen. Cells of the 
periodontal ligament along the intact periodontium bordering the denuded root surface 
proliferated in a very limited zone of 200 to 300 pm during the first 7 days after surgery. 
There is some evidence that periodontal ligament cells actually migrate towards the 
denuded root surface (Aukhil & Iglhaut, 1988; Iglhaut et al., 1988).
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Nyman et al. (1982) and Gottlow, Karring & Nyman (1984a) presented the first studies 
that demonstrated the formation of a new attachment and bone as a result of the GTR 
treatment. The results of these studies have been confirmed in a number of studies 
(Aukhil, Petterson & Suggs, 1986; Aukhil, Simpson & Schaberg, 1983; Caffesse et al, 
1990; 1988; Caton et al, 1992; Claffey et al, 1989; Gottlow, Karring & Nyman, 1990; 
Magnusson et al, 1985a). The first report of a human tooth treated according to the 
principle of GTR was by Nyman et a l (1982). The GTR procedure was performed on a 
single mandibular incisor scheduled for extraction, with a cemento-enamel junction to 
bottom of infrabony defect (CEJ-BD) distance of 11 mm and a cemento-enamel junction 
to bony crest (CEJ-Crest) distance of 9 mm giving 2 mm of infrabony defects, using a 
Millipore membrane. After 3 months of healing, a block biopsy revealed new cementum 
and inserting fibres had formed corresponding to 7 mm of new attachment on the 
exposed root surface. Case reports on 12 teeth in 10 patients were presented by Gottlow 
et a l (1986). Histological and clinical results were obtained from 5 and 7 teeth 
respectively, some with furcation lesion. Histological results were obtained 3 months 
after membrane placement and clinical results were measured 3 months after barrier 
removal. Histological result demonstrated new attachment. New attachment following 
the GTR treatment has also been shown histologically by Becker et al (1987), Stahl, 
Fronum. & Tamow, (1990), and Stahl & Froum (1991).
In the study by Gottlow et a l (1986), the clinical results following the GTR treatment of 
7 teeth with furcation class II or angular bony defects revealed a mean gain of clinical
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attachment of 5.6 mm, and the corresponding bone regrowth of 5.1 mm. Regeneration of 
bone was restricted to sites where angular bony defects were present before. Gains in 
probing attachment level and probing bone level following the GTR treatment have been 
reported in several short-term clinical studies, e.g., those by Becker et al (1988), 
Schallhom & McClain (1988), and Cortellini et a l (1990), and in long-term clinical 
study by Gottlow, Nyman & Karring (1992).
Controlled clinical studies with intra-individual comparison of the GTR therapy and 
conventional flap surgery in the treatment of class II furcation defects have been 
presented by Pontoriero et a l (1988), Lekovic et al (1989), and Caffesse et al (1990). 
All studies showed statistically significantly more gain in probing attachment level at 
GTR-treated sites. The study by Pontoriero et al (1988) comprised 21 patients and 
evaluated treatment of Class II furcation involvement in mandibular molars. GTR 
therapy resulted in clinical closure of 19 of the 21 test defects compared to 6 out of the 
21 defects in the control group (conventional surgery). In another study, Pontoriero et a l 
(1989) treated 21 patients with through and through mandibular molars furcation 
involvement in both sides of the jaw. Only 8 out of the 21 defects treated by GTR were 
completely closed, 10 were partially closed and three teeth showed remaining through- 
and-through furcation involvement after therapy. On the control side (non GTR treated), 
none of the 21 defects were completely closed, 10 showed partial closure, while 11 
showed remaining through-and through furcation involvement. It was found that the 
healing result at the test teeth was related to the size of the entrance opening to the 
original Class II defects.
84
It can thus be concluded that regeneration of the periodontium, i.e. the formation of new 
cementum with inserting connective tissue fibres as well as new bone formation, can be 
accomplished if the treatment procedure is based on the biological principle of guided 
tissue regeneration.
1.8.5 Nonresorbable Barrier Material
The first commercially available barrier for GTR was Gore-Tex® manufactured from 
expanded polytetrafluoroethylene (ePTFE). They were initially chosen because of the 
microporosity, which allowed for passage of liquid and nutritional products but not for 
cells, and they could be sterilized. It consists of an open microstructure collar and an 
occlusive apron. The microstructure facilitates early clot formation and collagen fibre 
penetration during healing and the occlusive apron excludes the gingival epithelium and 
connective tissue from the root surface. The barrier is preformed into various sizes and 
shapes to fit periodontal defects of different morphology and location. The safety and 
efficacy of this barrier has been confirmed in numerous animal and clinical investigation 
as illustrated in Table 1.3.
The first generation of GTR devices are non-resorbable, which calls for a second surgical 
procedure. This is a negative factor both from a cost-benefit point of view and with 
respect to the additional trauma to the patient and to their newly formed, immature
Table 1.3 Clinical outcomes of GTR using ePTFE membrane barrier
Study Animal m odel/num ber/ 
defect
observation period Treatm ent effects
Gottlow et al. (1984) Monkey/3/dehiscence/ex 
perimental periodontitis
3 months N ew  attachment:
Expt: 77% Control 33%
Gottlow et al. (1986) 
case reports
human/ 10/Class II & III 
furcation +  angular bony 
defects
3/6 months N ew  attachment 40%. Probing 
attachment gain 5.6 mm
Pontoriero et al. 
(1987)
Human/3 7/Class II and 
III furcations
6 months completely closed sites 
class II 67%/expt 10%/con 
class III 25%/expt 0%con
Becker et al. (1987) Human/3/1, II wall, class 
III furcations
3/6 months Probing attachment gain (PAG)
1 wall: 2-4mm
2 w a ll: 4 mm 
Class III: 4mm
Pontoriero et al. 
(1988)
Human/21/class II 6 months PAG
Vert: 4.1 mm/expt 1.5mm/con 
Horz: 4.1 mm/expt 1.9mm/con
Becker (1988) Human/27/class II & III 
furcations; 3 wall defects
6 months PAG
Class II: 2.3mm  
Class III: 1.3mm 
3 wall: 4.5mm
caffesse (1990) case 
reports
Human/9/class II 
furcations
6 months CAL gain 
expt:1.8 mm 
con: 0.6mm
lekovic (1990) Human/15/Class II 
furcations
6 months CAL gain
GTM only: 2.40 ± 0.48mm  
GTM + PHA grafts: 2.93 ± 
0.64 mm.
periodontal tissues which may jeopardize new attachment formation. Such problems 
could be overcome if the GTR devices were bioresorbable.
Other drawbacks observed when using GTR-barriers are the frequent incidents of apical 
downgrowth of the dentogingival epithelium along the surface of the connective tissue 
flap facing the barrier, even though they had a cervical collar with large pores aimed at 
preventing epithelial downgrowth along the barrier by ingrowth of connective tissues into 
the pores. However, this collar is often exposed to the oral cavity and therefore does not 
fulfill its intended function, but instead harbours large amounts of oral microorganisms 
rather than being filled with ingrowing connective tissue. This may seriously disturb the 
healing process, markedly reducing or even preventing regeneration. To increase the 
clinical benefit of GTR treatment, it was therefore necessary to find out if a barrier could 
be designed so that there would be minimal gingival flap recessions and epithelial 
downgrowth from the gingival margin when it was placed between the root surface and 
the soft tissue flap.
In conclusion, among the problems associated with the use of non-resorbable barrier 
membranes are:
1) the need for a second surgical procedure for membrane removal. This is associated 
with increased morbidity for the patients, is time consuming for the surgeon, and can 
interfere with the maturation of the regenerated tissues during an early and delicate 
stage of healing (Tonetti et al., 1993; Cortellini, Pini Prato & Tonetti, 1995b).
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2) the possibility of membrane contamination and/or infection whenever the membrane 
is exposed to the oral environment.
3) the optimal timing of membrane removal has not been determined in a human 
population (Caton et al, 1992).
In 1988 a research team was established with the purpose of developing and 
researching/testing a bioresorbable barrier. The objectives for the team were to develop 
the best possible barrier design and the best possible barrier material to enable a safe and 
effective single step GTR therapy (Lundgren, Mathisen & Gottlow, 1994).
Based on the knowledge gained from previous GTR research and the studies of the 
implant-soft tissue integration, a list of design criteria was set up to characterize a well- 
functioning bioresorbable barrier for periodontal regeneration:
- rapid integration with the adjacent connective tissue
- maintenance of space for selective tissue ingrowth
- maintenance of barrier function during a sufficient healing period
- effective anchorage to the tooth.
The main requirements of a material for use as a single-step GTR-barrier are:
1) bioresorbability
2) biocompatibility
3) a purpose-made resorption pattern
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4) initial dimensional stability
5) suitable malleability
1.8.6 Resorbable Barriers
A variety of resorbable membrane materials have been used for GTR including collagen, 
polyglycolic acid, polylactic acid, or copolymers of these materials (Bluementhal, 1988; 
Card et al, 1989; Caton, Greenstein & Zappa, 1994; Fleisher, Waal & Bloom, 1988; Kon 
et al., 1991; Magnusson, Batich & Collins, 1988; 1990; Pitaru et al., 1987; 1988; 
1989;Quinones et al, 1990a; 1990b; Tanner, Solt & Vuddhakanok 1988; Warren et al, 
1992). As the barriers resorb they do not require a second surgical procedure for their 
removal, thus eliminating any trauma that may occur to the immature, newly regenerated 
periodontal tissues during barrier removal.
Studies on type I collagen barrier were done by Pitaru et al. (1987; 1988) the second study 
of which showed healing by repair with a long junctional epithelium. Another study by 
Pitaru et al. (1989) confirmed this result. Tanner, Solt & Vuddhakanok (1988) showed 
that application of the microfibrillar collagen in the GTR procedures did not prevent the 
apical migration of epithelium and failed to facilitate periodontal regeneration.
Magnusson, Batich & Collins (1988b) evaluated the use of a polylactic acid polymer 
barriers in the treatment of surgically created dehiscence-like defects in 2 dogs.
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Histometric analysis after two months revealed more new attachment and bone 
regeneration in the test group compared to the control. A second study (Magnusson et 
al, 1990) using this barrier for 1-wall vertical and horizontal defects however failed to 
demonstrate a difference between experimental and control groups.
When our study was initiated, only two of these bioresorable barriers, Guidor® (John O. 
Butler Co., Chicago, IL) and Resolut® (W.L. Gore & Associates) have been approved by 
the U.S. Food and Drug Administration and commercially available for periodontal 
applications.
1.8.6.1 Resolut®
Resolut ® is a bioresorbable barrier composed of a synthetic copolymer of polyglycolic 
and polylactic acids. Histological evaluation of this bioresorbable barrier in beagle dogs 
found comparable results to those achieved with the non-resorbable ePTFE barrier. 
Evaluations performed at 1, 3, and 6 months demonstrated a minimal inflammatory 
reaction and the reformation of a connective tissue attachment with these barriers. New 
cementum with inserting collagen fibres occurred on the previously denuded root 
surfaces isolated by either the non-resorbable or the resorbable barriers (Caffesse et al., 
1994; Warren, Sanchez & Karring, 1994). Furthermore, studies in monkeys by Quinones 
et al (1994) and Huerzeler et al (1994) proved the benefits of this barrier when
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compared to open flap procedure in interproximal infrabony defects and class II 
furcations, respectively.
The clinical efficacy of this bioresorbable material in the treatment of deep infrabony 
defects in human has been evaluated and compared to the non-resorbable barrier 
membranes (ePTFE) or access flap procedure by Cortellini, Pini Prato & Tonetti, 
(1996c). Both the groups treated with bioresorbable and non-resorbable barrier materials 
gained significantly more CAL at 1 year than the access flap procedure group and there 
was no statistically significant difference in the CAL gain in both the membrane groups.
Another study was done by Caffesse et al. (1997) in human, evaluating the efficacy of 
this material and compared it to the proven non-resorbable ePTFE barrier material in the 
treatment of Class II furcations and infrabony lesions. Both treatments produced 
significant improvement from baseline in probing reduction, and gain in clinical 
attachment. No statistical differences were found when results were compared between 
the two different barrier membranes as shown earlier by Cortellini, Pini Prato & Tonetti, 
(1996c).
1.8.6.2 Guidor®
A resorbable barrier called Guidor® was commercially available when this study was 
initiated. It has been approved by the responsible authorities as a safe and effective
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method of promoting periodontal tissue regeneration. The composition of Guidor® is 
based on bioresorbable polylactic acid, softened with a citric acid ester to accomplished 
malleability and facilitate clinical handling. Apart from being bioresorbable, this product 
has a matrix design, which also allows for integration, prevention of gingival recession 
and formation of pseudo-pockets around the device and subsequent infection and 
gingival inflammation, problems frequently observed with available non-resorbable GTR 
products. This material is designed to maintain a barrier function for a minimum of 6 
weeks. During this period, both the design of the matrix and the stability of the polymer 
are maintained.
Afterwards, the matrix slowly resorbs and is gradually replaced by periodontal tissue. 
The process of degradation is by hydrolysis resulting in lactic acid which is absorbed by 
the surrounding tissues. The polymer fragments are eliminated by macrophages and the 
end degradation products are ultimately metabolized to water and carbon dioxide. 
Bioresorption is completed 6 to 12 months after placement.
Gottlow et al. (1992a) first evaluated the safety and efficacy of this barrier in recession- 
type and interproximals defects in monkeys in a 12-month study period. This study 
showed clinical healing with minimal or no inflammation and histological healing 
revealing cementum with inserting periodontal ligament fibres extending to the coronal 
border of the barrier after 1 month. Extensive new bone formation had occurred after 3 
months, and after 6 months complete resorption of the barrier had taken place. Gottlow 
et al (1993) also compared Gore-Tex and Guidor® membranes. It was found that more
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membrane exposure occurred by using the nonresorable membrane, and it was speculated 
whether the difference in the result in new connective tissue regeneration (72% in 
resorable, 63% in nonresorable) and bone regeneration (89% and 87%) was due to this 
fact.
The clinical use of the bioresorbable matrix barrier (Guidor®) for the GTR therapy, was 
also evaluated in humans (Laurell et al, 1992; Gottlow et a l , 1992b), where furcation 
class II defects and infrabony defects were followed for six months or more after the 
GTR treatment. The result of the therapy was evaluated by assessing PD and CAL prior 
to surgery and after 6 months. At furcation defects mean PD was reduced from 5.6 to 3.0 
mm. The mean gain of CAL-vertical was 3.2 mm and CAL-horizontal 3.1 mm resulting 
in complete closure of 7 of the 12 defects. At infrabony defects mean PD was reduced 
from 8.9 to 3.1 mm (5.8 reduction). It was concluded that the use of bioresorbable 
matrix barrier in GTR resulted in pronounced gain of CAL and a very low incidence of 
gingival pathology, gingival recession, and device exposure.
In a case report by Laurell et a l (1994) Guidor® was used in 19 class II furcation and 47 
infrabony (2 or 3 walls, or combination) defects in 59 patients scheduled for GTR 
therapy. Inflammation was found adjacent only to 3 defects and limited to the first 
month after membrane placement. Only 10 devices were exposed during the l st/2nd week 
of healing and never more than 2 mm. The PD reduction in the furcation defects was 3.7 
mm. Mean gain in vertical CAL was 3.4 and 1.4 mm for horizontal CAL gain. At the 
infrabony defects mean PD reduction was 5.4 mm and mean gain of CAL 4.9 mm. These
results were quite similar to the one described above, and this study also showed low 
incidence of gingival pathology, gingival recession and device exposure.
A study by Falk et a l (1997) involving 203 defects in 143 patients treated in three 
periodontal specialist practice evaluating the effect of GTR using Guidor® after 1 year 
showed comparable results in clinical attachment gain and bone fill to previous case 
studies and controlled clinical trials. Mean PD was reduced from 9.0 + 1.0 mm to 3.3 + 
1.0 mm. Mean CAL gain amounted to 4.8 + 1.5 mm corresponding to 79 + 13% of the 
initial infrabony defects. Bone fill averaged 3.2 + 1.8 mm. In this study it was also 
shown that the depth of infrabony defects were positively correlated to CAL gain and 
bone fill and also early barrier exposure and plaque in the defect area at the time of 
surgery negatively influenced the treatment outcome.
In a study by Weltman et al. (1997) periodontal regeneration of infrabony defects 
utilizing either Guidor® or ePTFE were assessed in 30 patients randomly divided into 
two groups; each patient having one infrabony defects of probing depth > 6mm. In this 
study, significantly more attachment gain and shallower probing depths were found with 
ePTFE, if the data were analyzed using the deepest site of the defect. However, less 
inflammation was noticed in Guidor® sites at 2 and 4 weeks compared to the ePTFE 
sites. Comparisons of PD reductions, CAL and bone fill after 12 months of healing 
between treatments reveals no statistically significant differences when the averaged-site 
data were analyzed between groups.
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When an in vitro study was done to examine the colonization of different bioresorbable 
and non-resorbable membranes by P. gingivalis it was established by Ricci et a l (1996) 
that Guidor® membrane do not harbour P. gingivalis even though they easily let the 
bacteria through, even after 6 hours.
Thus, Guidor® barrier membrane has been proved clinically to be effective in treatment 
of infrabony defects in GTR procedures and have shown low incidence of gingival 
pathology, gingival recession and device exposure.
1.8.7 Factors Affecting the Outcome of the GTR procedure
The factors affecting the outcome of the GTR relates to:
1) patient selection
2) morphology of defect
3) the GTR procedure and the healing period.
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1.8.7.1 The patient
Plaque control
The ability to maintain high levels of plaque control has been associated with better 
outcomes following the GTR procedures (Tonetti et al, 1995; Tonetti, Pini-Prato & 
Cortellini, 1996; Cortellini et al, 1994). It should be emphasized that the clinical 
attachment gain detected in patients with less than 10% of surfaces covered with plaque 
were 1.85 mm greater than the ones observed in patients with at least 20% full mouth 
plaque score (Tonetti, Pini-Prato & Cortellini, 1996). Presence of plaque in the defect 
area at the time of surgery has been shown to negatively influence the GTR treatment 
outcome (Falk et al, 1997).
Residual infection
Another important variable associated with GTR outcome is the level of residual 
periodontal infection in the dentition, evaluated clinically as a percentage of sites with 
bleeding on probing or microbiologically as persistence of periodontal pathogens after 
completion of initial therapy (Tonetti, Pini-Prato & Cortellini, 1993; Machtei et al,
1994). Control of patient’s oral hygiene and residual periodontal infection in the oral 
cavity has also been shown to be strongly associated with clinical outcomes of both 
regenerative and conventional surgical procedures (Tonetti, Pini-Prato & Cortellini, 
1996). GTR procedures should be deferred until an adequate level of control of 
periodontitis has been achieved in the dentition.
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Smoking
Smoking is a strong risk marker and probably a true risk factor for the development of 
periodontitis (Feldman, Bravacos & Rose, 1983; Bergstrom, 1989; Bergstrom, Eliasson 
& Preber, 1991). Smokers present a less favourable result following both non-surgical 
and surgical periodontal therapy (Preber & Bergstrom, 1985; 1990). Cigarette smoking 
has also been associated with reduced GTR outcomes: attachment level gains of 2.1 + 1.2 
mm were observed in subjects smoking more than 10 cigarettes per day, whereas 
nonsmokers gained 5.2 + 1.9 mm of clinical attachment (Tonetti, Pini-Prato & Cortellini,
1995). The negative correlation of smoking to CAL gain following GTR therapy has 
also been demonstrated by Trombelli et. al. (1997), and they also showed higher 
incidence of membrane exposure in the smokers.
The negative impact of smoking in GTR treated sites and sites treated with subgingival 
debridement (root planing) were demonstrated in a long-term study by Cortellini, Pini 
Prato & Tonetti, (1996a). The patients were divided into a loser group and a stable group 
comparing GTR sites which were matched to RP sites. The loser group included patients 
who lost CAL > 3 mm in at least 3 sites from different teeth. When CAL loss between 1 
and 5 years were compared in the two groups, the loser group lost 2.4 + 1.2 mm CAL in 
GTR sites and 2.2 ±1.5 mm in RP sites, while the stable group only lost 0.3 ± 0.7 mm in 
GTR sites and 0.7 ± 0.9 mm in RP sites. Most of the patients in the loser group were 
smokers and had not complied to the recall system.
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1.8.7.2 Defect Morphology
Considerable evidence indicates that defect morphology plays a major role in the healing 
response following GTR therapy of infrabony defects. It has been demonstrated that the 
deeper the baseline defect, the greater the amount of probing attachment and bone gained 
at 1 year (Tonetti, Pini-Prato & Cortellini, 1993; 1996; Garrett et al, 1988). This 
relationship is in agreement with several studies on the effect of conventional surgical 
therapy of infrabony periodontal defects without the application of barrier membranes 
(Knowles et al, 1979; Hill et al, 1981; Pihlstrom, Oritz-Campos & McHugh, 1981; 
Lindhe et a l , 1982) and also with barrier membranes application in class II furcation 
defects (Machtei, et al, 1994).
Early observations suggested that defect morphology in terms of number of residual bony 
walls could be associated with the outcomes of regenerative surgery without membrane 
application (Goldman & Cohen, 1958; Schallhom, Hiatt & Boyce, 1970). An 
investigation by Renvert et a l (1985a) has failed to demonstrate a significant association 
between the number of residual bony walls and the clinical outcome. Other 
investigations has also observed good clinical results irrespective of defect configuration 
in terms of one-, two-, and three-wall defects (Tonetti, Pini-Prato & Cortellini, 1993).
Based on these studies and the treatment objectives, the most positive outcome from 
guided tissue regeneration can be achieved in deep and narrow infrabony defects.
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1.8.7.3 The Guided Tissue Regeneration Procedure and the Healing Period
Different membranes, i.e. resorbable versus non-resorbable membranes, possess different 
abilities to create and maintain the necessary space for regeneration. The amount of 
available space has been associated with the extent of observed clinical improvements 
(Tonetti, Pini-Prato & Cortellini, 1996), as evidenced by significantly higher gains for 
titanium reinforced membranes with the modified papilla preservation technique versus 
the conventional GTR with ePTFE membranes.
A study by Sander & Karring (1995) in monkeys has demonstrated that significantly 
more new connective tissue attachment and bone formation could be achieved if bacterial 
contamination was limited by submerging the roots and the barrier material (Gore-tex® 
or Vicryl Mesh®) compared to non-submerged roots. A recent investigation by Falk et 
a l (1997) has also supported this fact by demonstrating a significantly greater gains in 
attachment level observed in sites where resorbable membrane were completely covered 
as compared with sites with partial exposure (5.0 + 1.8 mm versus 4.2 + 2.1 mm, 
respectively). Membrane exposure has been repeatedly reported to be a major 
complication with prevalence in the 70% to 80% range (Becker et al, 1988; Cortellini et 
a l , 1990; Cortellini, Pini Prato & Tonetti, 1993; Selvig, Kersten & Wikesjo, 1993; 
Murphy 1995; DeSanctis et al, 1996a; DeSanctis et al, 1996b). Early barrier exposure 
was found to be a negative predictor of CAL gain (Falk et al, 1997). Probing bone level 
(PBL) gain was significantly greater in patient without membrane exposure (Selvig et al,
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1992; Schallhom & McClain 1994; Trombelli et al., 1997) than in patient with 
membrane exposure, while there was no significant difference in reduction in PD or gain 
in CAL. The membrane exposure can be highly reduced with the use of an access flap 
specifically modified to preserve the interdental tissues (Cortellini, Pini Prato & Tonetti, 
1995a; 1996b). It was found that higher incidence of membrane exposure occur in 
smokers and also, the amount of gingival recession was significantly greater (increased 
by a factor of 2) in smokers than in non-smokers (Trombelli et al., 1997).
Once the membrane is exposed to the oral environment a bacterial biofilm is formed on 
the surface of the implanted barrier, thus affecting the outcome of GTR surgery. The 
presence of an organized bacterial biofilm, comprising a variety of bacteria including 
periodontal pathogens, was detected on both the outer and the inner aspects of the 
membrane (DeSanctis et al., 1996a; DeSanctis et al, 1996b; Selvig et al., 1992; Grevstad 
& Leknes, 1993; Nowzari, Matian & Slots, 1995b; Novaes et al., 1995).
The amount of newly formed tissue present at membrane removal positively predicts the 
expected outcome of 1-year CAL gain (Tonetti, Pini-Prato & Cortellini, 1996).
1.8.8 Long Term Results of GTR
In a long-term study, Gottlow, Nyman & Karring (1992) assessed the long term stability 
of clinical attachment gained by GTR procedures. Eighty sites in 39 patients which 6
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months after surgery exhibited a gain of clinical attachment of > 2mm were monitored 
during the additional periods of 1-5 years. Of the 80, 65 were monitored for 2 years, 40 
for 3 years, 17 for 4 years and 9 for 5 years. Six sites lost CAL > 2 mm in the first year, 
three in the second and third year, while in the fourth and fifth year, follow up sites 
retained the new gained CAL. The results of this study indicate that attachment gain 
initially obtained can be maintained on a long term basis.
Results by Becker & Becker (1993) of followed-up patients with infrabony defects 
treated by GTR procedures demonstrated clinically significant reductions in PD (6.2 
mm), gains in CAL (5.5 mm), and gains in bone fill (4.4 mm) after 3 years and 5 months. 
The patients who were re-entered and examined 3 times had sustained PD reduction and 
CAL gains for an average of 4 years and 3 months. The results from this study indicate 
that deep, multi-walled infrabony defects can be predictably treated by GTR procedures 
and the results can be sustained for a long term.
In another long-term followed-up study by Wiegel et al (1995) treating patients in 
1985/1986, 19 sites monitored for 4 years following GTR procedures. A statistically 
significant clinical attachment lost of all sites of 1.27 mm was seen from 1 to 4 years 
examination. However, between baseline and the 4 year examination there was no 
statistically significant loss of clinical attachment. During the maintenance phase, 
1.42mm of probing attachment were lost at the deepest sites of the teeth, but compared to 
baseline, 1.37mm of new attachment was maintained. Out of the 19 sites, 7 showed a 
continued loss of probing attachment of > 2mm during the maintenance period. Patients
that lost new attachment during the observation period tended to lose attachment in the 
entire dentition. There was an increase in plaque scores from baseline to 4 years 
examination which could contribute to the results which were not as positive as the result 
reported by Gottlow, Nyman & Karring (1992).
The long term stability of attachment gained through GTR procedures was also compared 
to the attachment gained through root planing by Cortellini, Pini Prato & Tonetti, 
(1996a). In this study, 44 patients were involved, full mouth root planing was carried out 
before one infrabony defect in each patient was treated with GTR. After the one year, the 
GTR treated sites were matched to a RP site with matching interproximal CAL, similar 
PD and if possible the same tooth type. These sites were then followed-up for a further 
four years. At the one year examination, GTR sites gained 4.0 + 2.1 mm CAL and root 
planing sites gained 1.1 + 1 mm CAL. On average GTR-treated sites lost 1.2 + 1.4 mm 
and RP sites lost 1.3 + 1-3 mm between 1 and 5 years. The difference in CAL loss 
between GTR and control sites was not statistically significant. This study shows no 
significant differences in terms of CAL loss between GTR and root planing treated sites 
during a 4 year follow-up period, indicating that GTR treated sites were no more 
susceptible to long term periodontal breakdown than root planed sites. In addition, 
stability of CAL was not limited to the experimental and control sites, but in general 
observed in the whole of the dentition.
A recent study by Eickholz, Kim & Holle (1998) evaluated the effects of GTR with non- 
resorbable (ePTFE) and biodegradable barriers (Polyglactin 910) in a split-mouth study,
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24 months after surgery. Similar PD reduction was obtained in both groups at 12 and 24 
months (2.2 + 1.73 mm in ePTFE group vs 2.97 + 1.90 mm in resorbable group). This 
study demonstrated that more favourable vertical attachment gain was obtained after 
therapy with biodegradable barrier membranes (2.02 + 1.83 mm) compared to ePTFE 
membranes (1.18 + 1.50 mm). While the mean vertical attachment gain in the 
biodegradable group remained stable over the complete observation period, there was a 
mean loss of 0.9 mm from 12 to 24 months post-surgically in the ePTFE group. Hence 
attachment level gains after GTR therapy using biodegradable barriers seem to be more 
stable.
1.8.9 Micro flora Associated with the Placement of Physical Barrier
Membranes
A study by Mombelli, Lang & Nyman (1993) reported the microbiological culture results 
from ePTFE membranes retrieved after 6 weeks of placement and indicated a high total 
bacterial counts. 1/3 of all cultivable organisms was Gram-negative anaerobic rods. This 
included considerable proportion of black-pigmented rods and Fusobacterium. The 
presence of bacteria on retrieved ePTFE membranes has also been shown by other 
authors (Selvig et al, 1990; Tempro & Naibandian, 1993; Frandsen et al, 1994; Nowzari 
& Slots 1994).
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The presence of a certain microflora associated with the removed ePTFE membrane at 6 
week may act as a negative or positive predictor in GTR. The presence of 
Porphyromonas gingivalis are associated with loss of attachment; Prevotella intermedia, 
Peptostreptococcus micros, Campylobacter rectus are associated with no gain in 
attachment (Nowzari & Slots, 1994; Nowzari, Matian & Slots, 1995b); Actinobacillus 
actinomycetemcomitans and Bacteroides forsythus are associated with failing GTR 
(Nowzari, London & Slots, 1995a). In contrast, species of viridans streptococci and 
Actinomyces are associated with sites of significant healing (Nowzari, Matian & Slots, 
1995b). Nowzari et al. (1996) has demonstrated that the total microbial counts and the 
percentage of Peptostreptococcus micros and Capnocytophaga species at baseline, and of 
motile rods on the ePTFE membrane surface facing the gingivae at 6 weeks, were 
statistically significant negative predictors of clinical attachment following GTR. In their 
study, the patients were divided into two groups, group AB, patients with no other 
residual pockets except the test site, while group NAB consisted of patients with residual 
pockets. Group AB gained more clinical attachment level and at baseline and 6 weeks no 
putative periodontopathogens were noted in the pockets and on the inner surface of the 
membrane respectively. Group NAB exhibited high levels of tested putative 
periodontopathogens at baseline and at 6 weeks on both sides of the membrane. 
Detection of P. gingivalis by DNA probe technique at 3 minutes of intraoral membrane 
manipulation was a significant negative predictor of attachment gain. Membranes 
showing specific microorganisms at 3 minutes also tended to exhibit the same species 
after 6 weeks of insertion, suggesting long-term survivability of bacteria on barrier 
membranes. This study emphasizes the fact that in patients with high subgingival levels
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of putative periodontopathogens, the barrier membranes are at risk of becoming 
contaminated with motile rods, P. gingivalis, P. intermedia, Spirochetes, P. micros, 
Propionibacterium species, or other pathogens within 3 minutes of intraoral membrane 
manipulation. GTR procedures should only be carried out after other deep pockets are 
eliminated as this would lead to optimum clinical results, as been shown in this particular 
study.
Results from several studies have revealed that distribution of periodontal pathogens on 
the outer and inner surfaces of the barrier membrane (ePTFE) determines the amount of 
clinical attachment gain following GTR (Nowzari et al., 1995b; Yoshinari et al, 1998).
SEM analysis was carried out on the tooth facing surface of polyglycolactic barrier 
membrane which at 5 weeks were clinically exposed and underwent a second surgery for 
membrane removal (De Sanctis, Zucchelli & Clauser, 1996a). The membrane was 
divided into three portions a) the coronal area (clinically exposed portion), b) the mid­
portion (clinically unexposed) and c) the apical portion. 13 of the 20 membrane (65%) 
were exposed supragingivally. Gain in attachment level was statistically greater at sites 
with clinical unexposed membranes. The SEM analysis of the inner surface of the 
membrane revealed that all the randomly selected fields examined in the coronal portion 
were positive for bacterial colonization. In the mid-portion 41% of the fields were 
positive, while no bacteria field was observed in the most apical portion. Colonization of 
the mid-portion of the inner surface of the membrane is a critical factor, as bacteria- 
positive fields had less attachment gain (3.0 + 0.5) compared to bacteria-negative fields
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(3.8 + 0.4) and this difference was statistically significant. The gain in attachment in the 
bacteria negative field of the mid-portion is comparable to the gain in the unexposed 
membrane. The predominant microorganism morphotypes were cocci and short rods. 
Thus this study shows the importance of complete coverage of the membrane material 
during healing. But, caution has to be taken with these results as the removal of the 
membrane could cause trauma to the new tissue and could influence the healing process. 
Bacterial colonization of this membrane material was observed to be of a magnitude 
similar to that previously observed in ePTFE (De Sanctis, Zucchelli & Clauser, 1996b).
In the Nowzari et a l (1995b) study, sites free of pathogens on the membrane surface 
towards the tooth gained the most clinical attachment, even in the presence of various 
pathogens on the gingivae facing membrane surface. Pathogenic bacteria on the tooth- 
facing surface of the barrier membrane seemed to be particularly detrimental for 
periodontal regeneration.
In a very recent study by Yoshinari et al. (1998), using light microscopy the bacterial 
colonization on the ePTFE material was studied by dividing the membrane into vertical 
(coronal, middle and apical portions) and horizontal planes (outer, middle and inner 
portions). The majority of the bacteria were Gram-positive and the number of bacteria 
statistically decreased toward the apical portion in the vertical plane. There was a 
tendency for the bacteria to be observed in almost the same number in the outer and inner 
parts in the direction perpendicular to the long axis of the ePTFE membrane. These data 
indicated that bacteria grow downwards into and onto the unexposed portion of the
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membrane. Mononuclear cell types of T lymphocytes, B lymphocytes and macrophages 
were seen in ePTFE membrane and in tissue adhering to them. The total number of cells 
statistically decreased towards the apical portion vertically and towards the inner part 
horizontally. Moreover, this study showed the negative influence of bacterial 
colonization of ePTFE membranes on the amount of gain in the probing attachment 
following the GTR procedure.
In summary, ePTFE barrier membranes could be colonized as early as three minutes after 
intra-oral manipulation. The microflora on these membranes were shown to be gram- 
negative rods particularly black-pigmenting rods and Fusobacterium. The presence of 
periodontopathogens can act as a negative predictor in the GTR procedure. The 
colonization of the microflora was found to be more detrimental if occurred on the tooth- 
facing side. It is advisable to remove all infective sites in the patients before 
commencing on GTR procedure to obtain the best outcome.
1.8.10 Application of Antibiotics in Relation to the GTR Treatment
It has been demonstrated that new attachment and bone formation were favoured 
considerably in teeth which were crown-resected and completely covered with the 
mucoperiosteal flap during the membrane insertion period in order to eliminate or 
minimize microbial colonization of the wound (Sander & Karring, 1995).
Newman’s review paper (1993) stated that infection and bacterial complications 
associated with regenerative therapy can either occur pre-surgically, intra-operatively, 
immediate postoperatively or during short- and long-term healing. Potential sources of 
contamination must be eliminated by thorough root preparation and instruction in oral 
hygiene procedures pre-surgically. By doing this, the bacterial load could be reduced, 
thereby reducing inflammation and improving the tissue tone.
Intra-operative procedures appear to be important factors in determining whether or not 
the patient will get post-surgical infection (Newman & Fleming 1992; Fleming & 
Newman, 1990). Adequate root preparation, suture technique and material, flap design 
and manipulation and the use of particular regenerative materials are included in this 
variable.
Systemic antibiotic therapy is often prescribed, even though there is no specific antibiotic 
regime recommendations for regenerative procedures (Newman & Fleming, 1990; 
Topazian, 1992). Timing of administration of the drug is of utmost importance if the 
clinician decide to prescribe an antibiotic. A preferred timing would be to have the 
antibiotics consumed before surgical treatment begins (Newman & Fleming, 1992; 
Topazian, 1992; Classen et al., 1992), thus bactericidal concentrations can be achieved at 
the time of surgery.
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It is essentials that clot stability and a clean environment is maintained in the early post- 
surgical management of regenerative surgical wounds (Mombelli, Lang & Nyman, 1993). 
Minimal intervention immediately post-treatment will assist in the maturation of the clot. 
During this critical time, the most common treatment is to rely on topical antimicrobial 
(chlorohexidine) for reducing infection and inflammation. Another post-surgical 
complication is exposure of membranes during the healing phase. The material exposure 
into the oral cavity permits communication between the oral environment and the newly- 
forming tissues thus possibly leading to infection and/or induction of inflammation.
It is recommended that supportive periodontal treatment is increased in its frequency and 
additional adjunctive antimicrobial anti-plaque become standard during the maintenance 
of the regenerative tissues (Zablotsky & Meffert, 1991).
Studies on GTR treatment with additional use of antibiotics is difficult to evaluate due to 
the differences in 1) the AB that has been used, 2) the dosage,3) the time of starting the 
AB therapy, 4) the duration of taking AB, 5) time lapse after membrane placement and 
the sampling.
Systemic antibiotic treatment has been used in conjunction with GTR procedures to 
prevent infection and bacterial colonization of the membrane material. Various antibiotic 
regimes have been used by different investigators including AB given either prior to 
surgery only, prior to surgery and after surgery for a number of days or for a number of
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days after surgery only. Localized application of an antibiotic during placement of the 
membrane has also been tested
The aim of a study by Demolon et al (1993) was to determine whether the presence and 
development of specific target periodontal pathogens differed in subjects treated with a 
systemic antibiotic from subjects not treated with antibiotic following the placement of 
ePTFE membrane. A broad spectrum antibiotic, amoxycillin (given prior and after 
surgery) was only selected after information about microbial and clinical characteristics 
were known in subjects not treated with an antibiotic. In each patient, 2 sites were used 
for microbiological sampling; the test sites with the ePTFE membrane and a control site. 
The target microflora at control sites did not differ over time or between groups of 
patients. Even though there was no difference in total bacterial loads for both group in 
both sites from baseline to week 4, there was a significantly greater level of P. intermedia 
at week one and F. nucleatum at week one and week two in the non-antibiotic group. 
Also at week 4, the total bacterial load was significantly greater at the ePTFE site than at 
control sites and with significantly greater presence of B. forsythus at test site in the non­
antibiotic group. A high level of B. forsythus was also found on all membranes in the 
non-antibiotic group at time of removal, while only low levels were found in two of the 
membranes in the antibiotic group. The use of amoxycillin reduced or prevented most of 
the target pathogens, but did not prevent the total Gram-negative flora from reaching the 
preoperative level. The results also suggested that the bactericidal effect on P. gingivalis 
and B. forsythus during the 10 days extended to the end of week four.
In a study by Nowzari et al. (1995b) a broad spectrum systemic AB, Augmentin was 
prescribed 1 hour pre-op and for 8 days following the procedure. The antibiotic group 
showed significant fewer organisms at the time of membrane removal at 4 to 6 weeks 
(52.2 x 106 vs. 488.6 x 106 log 10 CFU) and also exhibited a significantly higher mean 
CAL gain compared to control patients without antibiotic cover (36.5% of potential gain 
to CEJ vs. 22.4 %). The number of organisms recovered from the most apical part of the 
membrane surface facing the gingivae and the tooth did not differ in the two groups. B. 
forsythus, P gingivalis and P. intermedia were the microorganisms most frequently 
recovered from the control group. It was concluded that Augmentin seemed to augment 
healing when administered in association with the GTR procedure.
In a split-mouth design study (Sander et al., 1994; Frandsen et al., 1994) metronidazole 
gel (250 mg) was applied locally on the outer surface of the ePTFE membrane during 
placement and microbiological and clinical parameters were compared to a control site, 
i.e., membrane without local antibiotic. At the entry of the study no significant 
difference was observed in the subgingival microflora between test and control teeth with 
regard to total anaerobic counts, anaerobic/aerobic ratio, percentage of pockets harboring 
black-pigmented Gram-negative anaerobic rods P. Gingivalis, P. intermedia, A. 
actinomycetemcomitans, or Staphylococci, or proportions of these bacteria in the pockets. 
A statistically significant reduction in the median total anaerobic count between 
presurgical and one week post -surgery was observed in the test group while the control 
pockets showed an increase. However, after one week the values were very similar in
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both groups all throughout the study. This indicated that the local effect of the 
metronidazole gel lasted only for 1 week. At 6 weeks when the membranes were 
retrieved they were found to be heavily colonized with bacteria. There was no significant 
difference in test and control for the anaerobic/aerobic ratio, even though, the control had 
a consistently higher ratio. After membrane removal, the ratio decreased below 
presurgical ratio. At the time of removal, the membranes harboured a microflora which 
was as anaerobic as the pocket flora before surgery. The relative gain in attachment level 
was significantly higher in the test group, even though the antibiotic effect only lasted a 
week, which might indicate that initial healing is one of the important aspects in GTR.
Another study on the use of systemic antibiotic in conjunction with ePTFE placement 
was carried out by De Sanctis et al. (1996b) using Augmentin lg/day for 2 weeks after 
membrane placement. The SEM analysis results for the exposed against the non-exposed 
membranes were as follows: in the exposed membrane, all the fields in the coronally 
exposed portion were positive for bacterial colonization, while only 66% in the 
unexposed. In the mid-portion, 57% for exposed, 17% in the unexposed, in the apical 
portion, 19% in the exposed and negative for the non-exposed. The figures in the mid- 
and apical-portion in the exposed membranes were slightly higher compared to the 
figures in the exposed polyglicolactic membranes indicating that ePTFE material 
harbours more bacteria compared to polyglicolactic membranes even in the presence of 
systemic AB. Gain in probing attachment levels were negatively correlated to microbial 
colonization of the mid part of the membrane. The presence of microorganisms on the 
membrane could either be due to contamination of the barrier membrane during surgery
i l l
or represent true microbial colonization, as even in those cases where the barrier 
membrane had remained unexposed, microorganisms were found in the collar portion of 
the membrane. But in this study, it was ascertained that the microorganisms found were 
due to the microbiological colonization which could either arise from the gingival pocket 
or from residual microbial foci in other areas. The antibiotic regime in this study may 
not be sufficient to eliminate and/or prevent the recolonization of the pathogens.
Systemic use of amoxycillin (lg  per day for 14 days after membrane placement) has also 
been used in relation to application of a bioresorbable membrane. Polyglicolactic barrier 
membranes if clinically exposed at 5 weeks underwent a second surgery to remove the 
barrier membranes (De Sanctis et al., 1996a). The tooth facing surface was analyzed 
using scanning electron microscopy (SEM) which revealed that bacterial colonization 
occurred in the coronal portion of the exposed membrane. This indicated that the 
systemic antibiotic regime and local application of chlorhexidine did not prevent 
bacterial colonization of the exposed membrane material. In the mid-portion 41% of the 
field were positive, while no bacteria were observed in the most apical portion. 
Colonization of the mid-portion of the inner surface of the membrane is a critical factor, 
as bacteria-positive fields had less attachment gain (3.0 + 0.5) compared to the bacteria- 
negative fields (3.8 + 0.4) and this difference was statistically significant. The gain in 
attachment level was statistically greater at sites with clinically unexposed membranes 
and is comparable to the gain in the bacteria negative field of the mid-portion. The 
predominant microorganism morphotypes were cocci and short rods. Thus this study 
showed the importance of complete coverage of the membrane during healing. But,
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caution has to be taken with this results as the removal of the membrane could cause 
trauma to the new tissue and could influence the healing process. Bacterial colonization 
of this membrane was observed to be of a magnitude similar to that previously observed 
in ePTFE (De Sanctis, et al, 1996b).
In summary, none of the antibiotic regimes reported above has been successful in 
complete prevention of the colonization of the membrane, though giving antibiotic prior 
to and after the membrane placement gave better overall results in respect to the clinical 
results and the amount of colonization that occurred (Nowzari et al, 1995b). De Sanctis 
et al. (1996a; b) has demonstrated that ePTFE membrane seem to harbour more bacteria 
than the polyglicolactic membrane even with systemic antibiotic given after the 
placement of membrane.
1.8.11 MMP and the GTR Procedure
The success of GTR depends on the restoration of lost tissue and the maintenance and 
preservation of the new tissue following regeneration. Proteases may play an important 
role in the outcome of the bone regenerative process especially during the initial 
remodeling phase when bone stroma has been regenerated but is not be fully mature and 
mineralized. In this phase of regeneration, proteases may degrade the newly formed 
extracellular matrix and may be a major factor in determining the clinical result.
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Only a few studies have investigated MMPs in relation to GTR procedures. When the 
MMPs produced by cultured cells derived from the ePTFE membrane were compared to 
the MMP produced by cultured periodontal ligament and fibroblasts gingival cells, the 
latter cells expressed MMP-1, MMP-2, MMP-3, and TIMP-1 (Grosso et al, 1997). Cells 
isolates from ePTFE membrane from GTR procedures expressed MMP-1 (Wakabayashi 
et al, 1996), MMP-2, TIMP-1 (in a less amount compared to the periodontal ligament 
cells and fibroblasts cells), and low molecular proteases below 52 kDa. When clinically 
failed GTR cases were compared to successful GTR cases, the former produced multiple 
MMPs including low molecular weight MMPs which were usually not typical of either 
human gingival fibroblasts or periodontal ligament cells, in addition to MMP-2 and 
MMP-1. Successful cases were shown to produced MMP-1 and MMP-2 only. Therefore 
in this study, the best correlation is between the expression of multiple proteinases in 
cells and clinical failure of the subsequent regenerative procedure.
Wakabayashi et al. (1996) compared protease profiles of gingival fibroblast, 
keratinocytes and periodontal ligament cells retrieved from ePTFE membrane with those 
of human gingival fibroblasts, keratinocytes and periodontal ligament cells. All cell 
types except keratinocytes produced 72kD protease (MMP-2). In contrast, only 
keratinocytes produced 92 kD (MMP-9) gelatinase. All cell lines produced TIMP-1. All 
cell lines retrieved from the barrier membrane and periodontal ligament cells produced 
MMP-1.
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1.9 AIMS OF THE STUDY
It has previously been established that healing following the guided tissue regeneration 
procedure is compromised if bacterial contamination of the membrane material occurred 
either during surgery or during the postoperative phase (Gottlow et al, 1986; Demolon et 
al, 1993). Sequentially, some investigators had administered systemic antibiotics to 
patients during the first 2 to 4 weeks after membrane insertion to prevent postoperative 
wound infection (Becker et al, 1988; Demolon et al, 1993; Cortellini et al, 1990; 
Schallhom & McClain, 1988; Proestakis et al, 1992; Kersten et al, 1992). Despite the 
systemic antibiotics administration, occurrence of postoperative wound infection and 
abscess formation related to implanted barrier membranes have been noticed (Cortellini 
et al, 1990; Schallhom & McClain, 1988). The reason may be either the administered 
antibiotic is not directed against the microorganisms responsible for the wound infection 
or that the chug does not reach a concentration sufficiently high enough at the infected 
site. This finding has lead to investigations of the use of a local antibiotic (Elyzol dental 
gel 25%) applied during insertion of ePTFE (Gore Tex®) membranes to obtain a high 
local concentration of an adequate dmg in the healing wound. Clinical results from a 
study carried out by Sander et a l (1994) demonstrated that the gain in probing 
attachment levels as a percentage of the initial defect depth was statistically significantly 
higher in sites treated with ePTFE membrane and locally applied antibiotic than in the 
control sites inserted with ePTFe membrane alone (92% for test defects and 50% for 
control defects). Microbiologically, a reduced median number of cultivable bacteria
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from the presurgical examination was sustained until one week following the insertion, 
whereas an increase was noticed in the same period in the control group.
Microbial contamination of teflon membranes is a common finding due to the lack of 
tissue integration between the gingival flap covering the material and the outer surface of 
the membrane (Nowzari et al, 1995b; Selvig et al, 1992; De Sanctis 1996b). This is 
primarily caused by apical proliferation of the epithelium on the inner aspect of the 
covering tissue flap thus forming a “pocket” thereby exposing the material to the oral 
environment. Many bacteria preferentially colonize the material on both the inner and 
outer surfaces (Grevstad & Leknes 1993; Selvig et al. 1990).
A bioresorable membrane (Guidor®) has been designed so that tissue integration is 
possible between the outer layer of the barrier matrix and the covering gingival 
connective tissue flap. It can thus be anticipated that since there is no epithelial 
downgrowth there is little or no postoperative microbiological colonization of the healing 
wound and the membrane material. It is important to prevent and reduce contamination 
of the barrier membrane at the time of insertion thus providing optimal conditions for 
periodontal regeneration to take place. In preliminary microbiological studies on 
resorbable barrier matrices it has been shown that facultative anaerobic bacteria and 
black pigmented gram-negative anaerobic rods do not seem to develop in number in the 
first 6 weeks postoperatively, thus metronidazole appears to be of limited use (personal 
communication, L.Sander, Aarhus Royal Dental College). An antibiotic selective for an 
aerobe and facultative anaerobic microflora may reduce the possible contamination of the
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material and the wound during membrane insertion. It can be hypothesized that one 
presurgical application of a high dose of penicillin could influence the healing.
Amoxycillin, a broad-spectrum penicillin was used in the present study. It is a derivative 
of ampicillin, and is active against certain Gram-positive and Gram-negative organisms. 
It is better absorbed than ampicillin when given orally and absorption is not affected by 
the presence of food in the stomach. The dosage used is 3g given 1 hour pre-operatively.
MMPs are degradative proteolytic enzymes responsible for remodeling and degradation 
of ECM components. The predominant ECM component of the periodontium is 
collagen. During the inflammatory process of the periodontium, collagenous breakdown 
is taking place. MMP-3 levels had been shown to be higher at gingivitis and 
periodontitis sites than healthy sites (Haerian et al., 1995) and active MMP-8 levels were 
higher in progressive periodontal sites (Lee et al., 1995). In repair processes MMP-3 had 
been demonstrated to be produced in both acute and chronic wounds ( Saarialho-Kere et 
al., 1994; Vaalaamo et al., 1996) and had been associated with scarless healing in fetal 
skin (Bullard et al., 1997). During the healing process the PMN and fibroblast cells 
increased in numbers. These cells are responsible for the production of MMP-3 and -8.
The purpose of the study was to investigate the clinical outcome, the microbiological 
colonization and the levels of matrix metalloproteinases (MMP-3 & -8) of the wound 
healing following insertion of a resorbable membrane (GUIDOR®) either alone or 
combined with one presurgical systemic application of amoxycillin. The clinical and
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microbiological outcomes were also investigated against the levels of the MMPs to see 
whether the fluctuation of the MMPs level could be linked to the clinical outcome and 
the microbiological colonization.
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CHAPTER 2 
MATERIALS AND 
METHODS
2.1 SUBJECTS
Prior to the commencement of the research projects ethical approval was granted from 
the Glasgow Dental Hospital Ethics Committee. Subjects participating in these studies 
were informed of the protocol and consent was obtained. All patients taking part were 
free to withdraw from the study at any time.
Patients with a history of systemic disease, likely to influence periodontal health, and 
patients taking medicines which affect the periodontal tissues, were excluded. Antibiotic 
usage 3 months prior to the baseline visit was a further exclusion criterion. Previous 
allergic reactions towards penicillin also lead to exclusion.
Thirty-eight patients attending the Periodontal Clinic of the Glasgow Dental Hospital 
agreed to participate in this study. The study population consisted of patients who had 
been undergoing hygiene phase therapy (HPT) including OHI and scaling and root 
planing, and possibly periodontal surgery but still had at least one deep infrabony pocket 
of > 6mm in association with a radiographically distinct 2 or 3 wall infrabony defect with 
a depth of at least 4 mm measured on intraoral radiographs as the distance from the 
alveolar crest to the bottom of the defect. Of these subjects, 6 patients dropped-out of the 
study before the six months. Of the 32 left, 19 were female and 13 were male with a 
mean age of 39.2 ranging from 23-66 years old. 20 subjects were categorized as early- 
onset periodontitis patients, and 12 subjects as adult periodontitis patients. The patients 
were divided into treatment group AB (membrane and antibiotic), consisting of 14
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Figure 2.1 Study design
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Microbiological sample was obtained using sterilized size 40 paper points from the 
experimental site and from a contralateral or opposing site (control) with a deep pocket 
of > 6 mm and BOP. These control sites were monitored all throughout the study by 
checking the PD, BOP and the AL every three monthly. Any sites with a loss of > 2mm 
attachment or bleeding on probing would be root planed after sampling.
At baseline visit, the following measurements were taken in the following order:
1) Plaque Index (P1I) (Silness and Loe, 1964) was recorded at the six sites of the 
experimental tooth.
2) GCF samples were taken from the test site, surgical control site from an adjacent 
tooth and a healthy control site and the GCF volumes were recorded with the 
Periotron.
3) Microbiological samples were taken from the test site and a contralateral or opposing 
site with a deep pocket.
4) The first set of pocket depth (PD) measurements was performed with the electronic 
pressure sensitive probe (Florida probe) at six sites of the experimental tooth.
5) Absence or presence of bleeding on probing scores was recorded at the six sites of the 
experimental tooth.
6) The first set of relative attachment levels (RAL) measurements was performed with 
the electronic pressure sensitive probe (Florida probe) at six sites of the experimental 
tooth.
7) The second set of PD and RAX measurements (Florida probe) were carried out.
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8) A set of PD and CAL measurements was carried out manually using the PCP-12 
probe.
The patients were stratified according to age, tooth type, number of infrabony walls, 
depth of infrabony defects and smoking status. Each infrabony defect was randomly 
placed either in treatment group AB: application of the matrix barrier (Guidor®) 
combined with one presurgical systemic application of amoxycillin (3g one hour 
preoperatively) or treatment group NAB: application of the matrix barrier alone. There 
were only 3 smokers in the whole study group.
2.3 CLINICAL MEASUREMENTS
One examiner (SS), carried out all the clinical measurements using the Florida probe 
throughout the study, while another examiner (LS) performed all the manual 
measurements in order to allow non-biased measurements. The computer screen where 
the PD & RAL measurements using the Florida probe was displayed was turned away 
from the operator to allow ‘blind’ measurements. In addition, measurements were 
recorded on paper by another examiner. The plaque index (P1I), PD, BOP and AL 
parameters were recorded for the patients at baseline, 6-month and 1 year post-surgical. 
GCF samples were taken at baseline, week 1, week 4, 3 months and 12 months, while 
microbiology samples were taken at baseline week 1, week 4, 6 months and one year. 
Clinical measurements on the test tooth were again performed at 6 months and one year. 
The order in which the sampling and the measurements were performed has been
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previously explained.
2.3.1 Plaque Index
The plaque index (P1I) of Silness and Loe was used for recording plaque accumulation.
The scorings system is as follows:
0 No plaque in the gingival area.
1 A film of plaque adhering to the free gingival margin and adjacent surface of the 
tooth. The plaque may only be noticed by running a probe across the tooth 
surface.
2 A moderate accumulation of soft deposits within the gingival crevice, on the 
gingival margin and/or adjacent tooth surface.
3 An abundance of soft matter within the gingival crevice and /or the gingival 
margin and adjacent tooth surface.
2.3.2 The Gingival Crevicular Fluid Sampling Method
The GCF samples were taken after the P1I scores but before any other clinical recordings
which could cause tissue irritation and serum contamination of the sample. The site to be
sampled was isolated with cotton wool rolls and supragingival plaque was carefully
removed. The region was dried with a gentle air stream and 30s later GCF was collected
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with a Whatman grade 4 paper strips (Whatman Labsales Ltd., Maidstone, Kent) 
measuring 2 xl3 mm (Griffith, Chatis & Wilton, 1988). The paper strip was inserted 
into the crevice until mild resistance was felt and left there for 30 seconds (Figure 2.2). 
Strips visually contaminated with saliva or blood were discarded. The sampling method 
is reliable and causes no significant disturbance of the gingival blood vessels (Gustafsson 
et al, 1992). The fluid volume on the strip was measured immediately after sampling 
with a Periotron 6000 (Figure 2.3) (Harco Electronic, Winnipeg, Canada), and the strips 
were then placed in individual sterile tubes and stored at -30 degree centigrade (°C) until 
further processing was carried out. The jaws of the periotron were wiped with pure 
methanol and then dried between readings. Subsequently the strips were eluted into 500 
microlitres (pi) of incubation buffer at room temperature using a rotary mixture. The 
strips were then discarded and the elute were aliquoted into sterile tubes and stores at - 
30°C. These aliquots were subsequently analyzed for the quantification of SL (MMP-3) 
and MMP-8.
2.3.3 Microbiological Sampling and Processing
Microbiological sampling was performed at two sites, that is from the test site 
(membrane treated site) and from a control site in a different quadrant with a PD > 6 mm 
and BOP. These samples were taken at baseline, W l, W4, 6 months and 1 year post- 
surgical. The sampling sites were isolated with cotton wool rolls and supragingival 
plaque removed carefully. The region was then dried with a gentle stream of air. Three
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Figure 2.2 Gingival crevicular fluid sampling with a paper strip
Figure 2.3 The Periotron 6000
sterilized size 40 paper points were inserted in the crevice for 30 seconds. The paper 
points were immediately placed in 0.5ml of pre-reduced FAB (Lab M, Bury, England) 
and transported to the lab within 30 minutes of collection. In the laboratory samples 
were vortex mixed for 30 seconds and serial dilution made in FAB from neat to 10"4. 
Appropriate dilutions were inoculated using a spiral plater (Don-Whitely, Shipley, UK) 
onto the following media;
• Columbia agar (Pro-lab diagnostics, Cheshire, UK) containing 7.5 % v/v sterile 
deflbrinated horse blood and 1% v/v vitamin K/haemin (Life Technologies, Paisley, 
UK) dilutions 10*4 and 10'3 and incubated at 37°C in a CO2 incubator (5% CO2 and 
95% air) for 48 hours for total aerobic count and Capnocytophaga species. 
Additional plates were incubated anaerobically in an atmosphere of nitrogen, 
hydrogen and carbon dioxide (80:10; 10 by volume) for 7 days for detection of P. 
gingivalis, P. intermedia, E. corr odens, Fusobacterium species, anaerobic 
streptococci and the total anaerobic count
• Actinobacillus agar (neat and 10'1 dilutions) consisting of Tryptic Soy Bacitracin 
Vancomycin (TSBV) agar (Gibco BRL, Life Technologies, Paisley, Scotland) and 
supplemented with sterile 105 horse serum (v/v) (Gibco BRL, Life Technologies, 
Paisley, Scotland) and incubated in a CO2 incubator for three days for detection of A. 
actinomycetemcomitans; and
0 1• Mitis Salivarius agar (dilutions 10' and 10') (Difco, Surrey, UK) containing 20 
units/ml bacitracin (Sigma) and incubated in CO2 incubator for three days for total 
Streptococcal counts.
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For the detection of amoxycillin resistant colonies a 5pg amoxyl disc was placed on a 
Columbia blood agar plate inoculated with neat sample and resistant colonies were 
picked off and identified.
Identification of predominant colonies
Following incubation each plate was processed by the predominant cultivable flora 
technique. Briefly, this consisted of ten fold dilutions of the specimen prepared in 
reduced transport medium and appropriate dilutions, as well as neat specimen, plated out 
in duplicate on Columbia agar plates containing 7.5% v/v sterile defibrinated horse blood 
and 1% vitamin K/haemin. Duplicates plates were incubated anaerobically and air plus 
10% CO2 at 37°C for 7 days. Following incubation the plates were examined and twenty 
colonies were selected at random from one of the anaerobe plates and identification 
attempted to species level. The isolates were sub-cultured for purity, the Gram stain and 
the atmospheric requirements determined by incubation in air, air plus 10% CO2  and 
anaerobically. Identification was carried out as outlined below.
Identification of microbial isolates
Where possible, a minimum of eight black-pigmented colonies were sub-cultured from 
each positive sample on Columbia agar plates. Subsequently colonies were stained by 
Gram’s method; the atmospheric requirements for growth determined and where
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appropriate, identification was completed with the API 20A strips (API- Biomeriux, 
Basingstoke, UK).
P. gingivalis
Isolates that were strictly anaerobic Gram-negative coccobacilli which produced black- 
pigmented colonies, an acceptable biochemical profile on the API 20A strip and the 
ability to agglutinate sheep erythrocytes (Slots & Genco 1979) were identified as P 
gingivalis.
P. intermedia
Isolates that were strictly anaerobic Gram-negative bacilli which produced black- 
pigmented colonies and an acceptable biochemical profile on the API 20A strip and 
agglutinated sheep were identified as P. intermedia.
E. corrodens
Isolates that were strictly anaerobic Gram-negative bacilli which produced pitting, 
sensitive to metronidazole and urease positive were identified as E. corrodens. 
Fusobacterium species
Isolates that were strictly anaerobic Gram-negative bacilli and an acceptable biochemical 
profile on the API 20A were identified as Fusobacterium species.
Anaerobic streptococci
Isolates that were strictly anaerobic Gram-positive cocci and sensitive to metronidazole 
were identified as anaerobic streptococci.
Capnocytophaga species
Isolates that had a characteristic colony morphology (flat spreading), Gram negative rod 
and growth on CO2 incubated plates were identified as Capnocytophaga species.
A. actinomycetemcomitans
After incubation for three days, the TSBV agar plates were examined and a minimum of 
four colonies exhibiting morphology characteristics of A actinomycetemcomitans were 
subcultured to Columbia agar plates (Gibco, BRL. Life Technologies, Paisley, Scotland) 
supplemented with 7.5% v/v sterile defibrinated horse blood in a CO2  incubator. 
Colonies which consisted of capnophilic, catalase positive, Gram-negative coccobacilli 
that fermented glucose and maltose but not lactose, sucrose, salicin or arabinose, were 
recorded as A. actinomycetemcomitans.
2.3.4 Probing Depth and Attachment Levels Assessments
In this study pocket depth (PD) and relative attachment level (RAL) were recorded to the 
nearest 0.2 mm using the Florida probes (Florida probe Corporation, Florida, USA). The 
PD and AL were also measured manually using the PCP-12 probe. Another examiner 
(LS) did these manual measurements. Gibbs et al. (1988) developed the Florida Probe 
system, which features constant probing force, precise electronic measurement to 0.2 
mm, computerized data capturing, and sterilization of all system parts entering or close to 
the mouth. The system consists of a probe handpiece, a digital read-out, foot switch, 
computer interface and computer (Figure 2.4). The probe tip reciprocates through a 
sleeve and is connected to a movable arm, which transfers the movement to a transducer 
with a digital read-out. The edge of the sleeve, which is 0.6mm in radius, is the reference 
from which measurements are recorded. The probe tip is 0.4mm in diameter and the
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Figure 2.4 The Florida probe system
probing force is usually set at 0.25 N (1.99 N/mm2). The actual measurement of pocket 
depth (or relative attachment level) is made electronically and transferred to the computer 
when the foot switch is pressed.
Besides the pocket depth probe, the disk probe is also available (Fig 2.5). The disc probe 
has a small metal disc attached to the sleeve and uses the occlusal surface or incisal edge 
of a tooth as a reference for relative attachment level measurement. In this study the 
pocket depths measurements were taken using the manual probe as well as the Florida 
probe. Manual probing was also used to obtain attachment levels measurement from the 
CEJ, while a relative attachment level was obtained with the disc Florida probe. 
Duplicate reading of each test sites was taken with the Florida Probe as high levels of 
reproducibility in the measurements could be achieved as shown by Mullally and Linden 
(1994).
The Florida probe records clinical pocket depth as the probe sleeve contacts the gingival 
margin once the probe has passed into the pocket and its downward passage has been 
stopped at the clinical base of the pocket with its probing force of 25g. Care was taken to 
ensure that the probe was held parallel to the long axis of the tooth and the probe should 
be placed as further towards the interproximal point as the sleeve would go.
Option-3 method (Clark et al., 1993) was employed for the PD and AL measurements 
with the Florida probe. This method required two measurements to be taken; the 
difference of which should not be greater than 1mm (the threshold). If the difference was
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Figure 2.5 The Florida pocket probe (top) and the Florida disc probe (bottom)
more than 1 mm, recording of one or more additional measurements were taken until the 
difference between two measurements was less 1mm. After the first measurement of the 
PD, the BOP were assessed and recorded. The manual PD and AL were done last.
2.4 SURGICAL TREATMENT
A single operator (LS), performed all the surgical treatment throughout the study. 
Patients in treatment group AB were given 3 g of amoxycillin orally one-hour pre- 
operatively. Neither the patients nor the observers were blinded to the patients’ 
grouping. After local anaesthesia (Xylocaine 2% with adrenaline 1:80000), 
intracrevicular incisions were made and buccal and lingual/palatal full mucoperiosteal 
flaps were raised and the defect exposed. A vertical releasing incision was placed when 
needed for optimal access to the defect and to facilitate coronal repositioning of the flap. 
Also, it was aimed to preserve the interproximal papillae as it is important to ensure 
future interproximal coverage of the barrier matrix (GUIDOR®).
The defects were carefully debrided and root surfaces scaled and planed using hand 
instruments. Granulation tissue and epithelium on the inner aspect of the flap were 
removed and the surgical area irrigated with sterile saline. The configuration of the 
defects were then measured and recorded. The depth of the defects from bottom of the 
infrabony defects to the bone crest (crest-BD) and to the CEJ (CEJ-BD) and the width of
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the defects (mesio-distally) were measured with a University of North Carolina probe 
with 1 mm graduations.
Before handling the barrier membrane, a resorbable membrane (GUIDOR®), new pairs of 
gloves were put on by the operator and assistant to prevent contamination of the 
membrane. Guidor® matrix barrier is provided in a range of configurations, but only one 
configuration (molar curved) was used for this study (Figure 2.6). This configuration 
were trimmed to the required shape and dimension to cover the defect and the exposed 
root surface. Before placing the membrane on the defect, it was ascertained that the side 
facing the gingiva had the larger rectangular perforations for connective tissue integration 
and the side facing the root had the smaller circular spacers. The membrane was then 
attached to the tooth with the ligature, preplaced in the device. A horizontal releasing 
incision through the periosteum on the inner aspect of the flap was then performed to 
facilitate coronal displacement of the flap in order to cover the barrier material. The 
flaps were coronally repositioned and sutured interdentally with a modified vertical 
mattress suturing technique. The suture used was Gore-tex (ePTFE) suture which is non- 
resorbable and maintains its function for 2-4 weeks. The sutures on the infrabony site 
were left for 4-weeks before removal.
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Figure 2.6 The Guidor® matrix barrier in molar-curved configuration
2.4.1 Post Surgical Period
The patients refrained from mechanical toothbrushing for a period of 6 weeks, 
postoperatively, in the area where surgery had been performed. It is of utmost 
importance for the success of the procedure that the area is kept free from plaque 
accumulation and care should be taken not to disrupt the wound by mechanical means. 
During this period, plaque control was accomplished by rinsing with 0.2 percent 
chlorhexidine solution twice daily, and the patients were seen 1-week and 4-week post- 
surgery. After six weeks of healing, tooth brushing and interproximal cleaning were 
resumed. Plaque control, including supragingival professional tooth-cleaning, was 
continuously monitored on an individual basis until three months after surgery. 
Thereafter the patients were seen every third month until the final examination 12 month 
after surgery.
Some gingival recession and matrix exposure could occur during the initial healing 
process. But since the external layer of GUIDOR® is designed to integrate with the 
surrounding tissues, matrix exposure does not imply a risk of continued epithelium 
downgrowth, pocket formation and infection. Exposed matrix material was not trimmed 
because of the possibility of disrupting tissue that has migrated into the matrix. It 
disappeared 6 to 8 weeks after surgery because of combined resorption and attrition. The 
patients were instructed to keep the exposed matrix clean by using chlorexidine rinse 
until the exposed material has disappeared.
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During the post-surgical visits at one week and four weeks, the occurrence of soft tissue 
inflammation and device exposure were recorded.
2.5 THE GUIDOR® BARRIER MEMBRANE
The Guidor® membrane is a bioresorbable matrix barrier designed to achieve a single- 
step GTR therapy. The Guidor® membrane is made from a bioresorbable polylactic acid 
(a blend of poly-D,L-lactide and poly-L-lactide) blended with a citric acid ester, 
acetylbutyl citrate (ATBC). The Guidor® matrix has to be stored at a temperature 
between 36° and 46° F (2° to 8° C). At low temperature the material is fairly stiff and 
almost brittle, but it softens at room temperature and can be trimmed. When placed in 
the oral cavity, it becomes malleable within seconds and easy to adapt to the tooth and 
bone surfaces. It has a double-layered matrix with two different perforated layers 
(Figure 2.7):
• an external layer facing the gingiva has proportionally large rectangular perforations 
(Figure 2.8a) to enable gingival connective tissue to penetrate quickly into the matrix 
during initial healing thus preventing downgrowth of gingival epithelium. This is 
designed to minimize gingival recession, device exposure, and pocket formation, 
which in turn, reduce the risk of infection and inflammation.
• an internal layer facing the tooth which has many minute circular perforations - as 
many as several thousand per cm (Figure 2.8b). The small size of the perforations is 
designed to retard tissue penetration but still allow for nutrition
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Figure 2 .7  Illustration o f  double-layered matrix o f  GUIDOR®
A = external layer facing the gingival 
tissue
G B = internal layer facing the tooth
C = internal spacers between the two 
layers, into which tissue can 
migrate
D = rectangular perforations on the 
external layer (400-500 per cm 2)
E = outer spacers on the root side of 
the matrix which form part of 
internal layer 
F = smaller circular perforations on the 
inner layer (4000-5000 per cm2)
G = bioresorbable ligature is placed on 
the coronal portion 
H = a bar at the top o f the internal layer 
which function as a seal between 
the matrix and the tooth
Figure 2 .8 (a -b ) . SEM  illustration o f  G uidorRmatrix barrier
a) Large rectangular perforations in the outer layer
__
__
Figure 2.8b Inner layer with small perforations and spacers
Many inner spacers separate the two layers to form an interspace into which the tissue 
can grow. The internal layer has outerspacers projecting on the root side to ensure space 
for natural coronal growth of periodontal ligament in areas where the matrix run close to 
the root. The matrix has a coronal portion in which a ligature is preplaced.
The material is designed to maintain a barrier function for a minimum of 6  weeks. 
During this period, both the design of the matrix and the stability of the polymer are 
maintained. Afterwards, the matrix slowly resorbs and is gradually replaced by 
periodontal tissue. The process of degradation is hydrolysis resulting in lactic acid which 
is absorbed by the surroundings tissue. The polymer fragments are eliminated by 
macrophages and the end degradation products are ultimately metabolized to water and 
carbon dioxide (Figure 2.9).
2.6 EXPERIMENTAL MATERIALS
2.6.1 Whatman Grade 4 Paper Strips
Rubber gloves were worn during the manual preparation of the paper strips in order to 
avoid contamination by substances from the operators hands. Whatman grade 4 
(Whatman Labsales Ltd., Maidstone, Kent) paper were used for the collection of GCF, 
and are described by the manufacturer as a thin pure cellulose paper with an average 
thickness of 0.21 mm. The paper were cut manually to a standard size, 13 mm in length
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Figure 2 .9 \
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and 2  mm wide, using a steel ruler and scalpel as recommended by previous investigators 
(Griffith et al., 1988). A line was drawn on each strip at 8  mm, indicating the length of 
paper strip to be inserted between the Periotron jaws and which was the part of the strip 
to be used for GCF sampling in the crevice. The strips were then placed in glass 
universal bottles for autoclaving and storage.
2.6.2 ELISA Buffers and Reagents
The buffers employed were as followings:
1) Coating buffer (CB)
Carbonate-bicarbonate buffer was prepared by dissolving 1.59g Na2 CO^, 2.93g NaHCC>3 
in 800 ml distilled H2 O. The pH was adjusted to 9.6 at just under 1 litre, with 1M HC1 
before making up to 1 litre in a volumetric flask. It was stored in a sterilised bottle at 
4°C for a maximum of 1 week.
2) Incubation buffer (IB)
8 g NaCl, 0.2g KH2 PO4 , 1.44g Na2 HP04. 2H2 0 , 0.2g Kcl, 0.5g Tween 20 (SIGMA 
chemical company Ltd., Poole, Dorset) was dissolved in 800 ml of distilled H2 O, and 
made up to 1 litre, lg of lyophilised bovine serum albumin was added (BSA) (SIGMA, 
St. Louis, USA). This was layered on the surface without mixing. It was stored at 4°C 
for a maximum of 1 week (pH 7.4).
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3) Wash buffer (PBST)
This was prepared at 10 times the concentration of incubation buffer (nil BSA) and 
stored at room temperature (RT). It was diluted 1/10 immediately before use.
4) Phosphate buffered saline (PBS)
PBS was prepared by dissolving 8 g NaCl, 0.2g NaCl, 0.2g KH2 PO4 , 0.2g KC1, 1.44g 
NaP^PCU 2 H2 O up to 1 litre of distilled water (pH 7.4).
2.6.3 Antibodies and Purified Standards for ELISAs
The antibodies which were used in the ELISA (enzyme-linked immunoabsorbent assay) 
included: Mac 78 anti-stromelysin monoclonal antibody and rabbit anti-stromelysin 
polyclonal antibody, and purified recombinant human stromelysin (SL) were donated by 
Cell Tech. Ltd. Slough, UK. Donkey anti rabbit-HRP conjugated IgG was purchased 
from Jackson Immuno-research Laboratories, Avondale, PA, USA.
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2.7 EXPERIMENTAL METHODS
2.7.1 Calibration of the Periotron 6000 for Use in Clinical Trials
In order to transform the Periotron digital readings for each paper strip into volumes, and 
also to verify the accuracy of the instrument the following procedure was carried out. 
First the blank filter paper strip was placed between the jaws of the machine and the 
reading dial was set to zero. Known volumes of PBS plus serum (in equivalent volume) 
were delivered to Whatman grade 4 paper strip with a Hamilton microsyringe at a range 
of volumes (0.05-1 pi) and Periotron readings taken. The reciprocal jaws were cleaned 
with pure methanol and dried before the filter paper strips was inserted between its jaws. 
Each measurement was performed 3 times. The mean value for each volume was used in 
a linear regression analysis, from which the slope and intercept were used to determine 
the volumes of the GCF collected. Using linear regression analysis, the points plotted 
were resolved into two lines. The first line being determined by fluid volumes from 0 to 
400 nl, and the second line by fluid volumes from 400 to 1000 nl (Figure 2.10). The 
calibration was performed in the periodontal clinic each time the samples were taken, in 
order to reduce variability and thus improve accuracy. Determination of actual GCF 
volume from Periotron indications was performed from a given Periotron calibration 
curve using the following equation, Y = mx + c, where Y = periotron readings, m = 
gradient of the slope, x the unknown volume of GCF in pi and c is the intercept (Figure 
2.11). If a sample yielded a reading beyond the measuring range of the Periotron 6000, it 
was assigned a volume of 1111.77 nl which was the averaged values from 20 Periotron 
readings of 2 0 0  (the maximum reading) in 2 0  different calibration curves.
Figure 2.10 Calibration curves of the Periotron at the volume range of O-lOOOnl. It can 
be seen that there is 2 sets of lines, meeting at 400nl. The first line is for 0-400nl and the 
linear equation in the form of y = mx + c, is y = 3.40x + 6.41 and the second line is y = 
7.93x - 469.18 for 400-1000nl where y = Periotron reading, m = the slope, x = volume 
in nl, and c = the intercept.
periotron reading
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Figure 2.11 ; Linear regression analysis lines used to transform the Periotron digital 
readings for each paper strips into volumes (nl).
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2.7.2 Gingival Crevicular Fluid Elution
GCF samples were eluated in 500 pi of incubation buffer for 1 hour at room temperature 
using a rotary mixer. The strips were then discarded and the eluates were aliquoted and 
stored at -30°C, until further analysis. A previous study (Haerian, 1994) has 
demonstrated that the elution of GCF samples in 500 pi of incubation buffer would yield 
concentrations in the eluate within the precision range of each ELISA.
2.7.3 Sandwich ELISA Methodology for Stromelysin
The sandwich ELISA method was a modification of the technique described previously 
by Cooksley et al. (1990). The modifications used were as follows: a) the sample 
volume in each well was reduced from 200 pi to 50 pi; since we diluted the samples in 
500 pi of incubation buffer and required sufficient volume for two different ELIS As and 
at the same time some back up volume; b) all the paper strips were eluted in the 
incubation buffer; since we had to use the elute from the same paper strip for different 
ELISAs it was impossible to use two different assay buffers to elute each individual 
paper strip; c) the calibration line was altered toward the lower concentration, based on 
the range of absolute amounts of SL detected in preliminary experiments.
SL quantification was performed on the elutes of GCF, and all constituents were assayed 
by means of sandwich enzyme linked immunosorbent assays (ELISA), based on a
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modification of the method of Cooksley et al. (1990). This method assays the amount of 
antigen present in the sample as directly proportional to the amount of the second 
antiserum (rabbit), which was quantified indirectly by the addition of horse radish 
peroxidase (HRP) conjugated anti-rabbit IgG (donkey) (Jackson Immuno-research 
Laboratories, Avondale, USA) resulting in high optical densities (ODs) for high antigen 
concentration.
The results of experiments already carried out in our labratory (Haerian, 1994) 
demonstrated that among five different types of Immulon microplates (Dynatech 
Laboratories), the Immulon IV plates showed the least variability for the sandwich 
ELISAs. In summary, the 96-well polystyrene microplate (Immulon 4 Dynatech 
Laboratories, Billingshurst, Sussex, U.K) was coated with the first antibody, specific to 
the antigen to be quantified. The antibody used was Mac 78 anti-stromelysin 
monoclonal antibody. After overnight incubation at 4°C, these were washed with wash 
buffer and dried, blocked with incubation buffer for 1 hour and then incubated with serial 
dilutions of recombinant human stromelysin of concentration 12.5-0.025 nanogram per 
millilitre (ng/ml) or eluted GCF samples in incubation buffer containing 0.1% protease 
free BSA (Calbiochem), for one hour at 25°C with constant mixing. Any antigen present 
was captured by immobilised antibody. The standard and a total of 20 samples were run 
in duplicate vertically in each plate. The plate was then washed and incubated with a 
rabbit-anti-human (polyclonal) stromelysin antibody in the same buffer for one hour at 
25°C with constant mixing. The plates were then washed and incubated with Horse 
Radish Peroxidase (HRP)-conjugated anti-rabbit IgG (donkey) (Jackson Immuno-
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research Laboratories, Avondale, USA) in the same buffer for one hour at 25 C with 
constant mixing. The anti-SL monoclonal and polyclonal detected both the proenzyme 
and active forms of the SL. Visualization was achieved by incubation with 
tetramethylbenzidine (TMB) substrate for 15 minutes at 25°C with constant mixing, 
giving a blue colour. The plate was read at 630 nm on a Dynatech MR5000 plate reader. 
The method is described in detail in Table 2.1. Serial dilutions of standard antigen were 
run for each plate. The working range of the standard antigen for the stromelysin was 
12.5-0.025 nanogram per millilitre (ng/ml) in incubation buffer (IB) and their optical 
densities (ODs) were used in a linear regression analysis from which the slope and 
intercept were used to determine the level of SL in the samples. The precision range was 
defined as the linear part of the working range. The least squares method was used to 
plot the best fitting line and r2>0.99 were obtained for all assays. Linear functions of the 
type lognOD = a + b x (lognc), where OD=Optical density, c= concentration, a= the 
intercept and b= the lognc coefficient were thus produced, and used for the determination 
of sample antigen quantities. A similar standard curve was generated and a new line 
fitted each time an assay was run.
The central wells were used on each plate for standards or samples in order to avoid the 
edge-effect (Tijssen, 1985). The peripheral wells were used for assaying the controls 
(except for the control 14), and were run in duplicate. Zero antigen wells (Controls 14) 
were run in quadruplicate. Control wells (control 14, Table 2.2 and Table 2.3) in the 
central wells in each plate were included which contained no sample or standard antigen,
T able 2.2
IMMULON 4  ELISA PLATE FOR SL.
1 2 3 4 5 6 7 8 9 10 11 12
1 2 3 4 5
6
A 12.5
ng/ml
6.25 3.13 1.56 0.78 0.39 0.19 0.09 0.05 0.025
B
15 7
C
D
8
E
F
9
G 14 13 12 11 to
CONTROL WELLS
1) 2, 6, 7, 8, 12, 13, 14
2) 3, 6, 9, 10, 12, 13, 15
3) 4, 7, 9, 11, 12, 14, 15
4) 5, 8, 10, 11, 13, 14, 15
! 1) Coat with anti-stromelysin Mac 78 overnight at 4°C 
Block with IB -1 hrRT
I
! 2) Standard or eluted GCF samples - 1 hr on shaker at RT
3) Rabbit anti-SL -1 hr on shaker at RT
4) HRP-anti-rabbit IgG - 1 hr on shaker RT
50pl
lOOpl
50pl
50pl
50pl
in order to calculate background binding. The mean plus two standard deviations of this 
background reading was taken as the cut-off point for detectability (Tijssen, 1985).
Results were expressed as nanogram per 30 second (ng/30s) sample, the absolute amount 
of SL activity in the samples.
2.7.4 MMP-8 Immunofluormetric Assay
MMP- 8  levels in the GCF samples were determined by a time-resolved fluorescence 
immunoassay (FIA) as described by Hanemaaijer et al. (1997). The method involves the 
use of i) fluorescent labels with relatively long half-lives and ii) a pulsed source for 
exciting fluorescence with a time-resolved fluorometer for eliminating unwanted 
background fluorescence, which usually has a short decay period. The monoclonal 
MMP- 8  specific antibodies 8708 and 8706 Medix Biochemica) were used as a catching 
and tracer antibody respectively. The tracer antibody was labeled using europium-chelate 
(Hemmila et al., 1984). The assay buffer contained 20mM Tris-HCl, pH 7.5, 0.5 M 
NaCl, 5mM CaCL, 50 pM ZnCL, 0.5% bovine serum albumin, 0.05% sodium azide, and 
20 mg/litre diethylenetriaminepentaacetic acid (DTPA). Samples were diluted in assay 
buffer and incubated for 1 hour, followed by incubation for 1 hour tracer antibody. 
Enhancement solution was added, and after 5 min fluorescence was measured using 1234 
Delfia Research Fluorometer (Wallac, Turku, Finland). The specificity of the 
monoclonal antibodies against MMP- 8  corresponded to that of polyclonal MMP- 8
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Table 2.3. Control tests for sandwich ELIS As. When the addition of a reagent was 
omitted the equivalent volume of the respective buffer alone was added. Coating refers to 
the first antibody and antiserum refers to the second antibody.
Control_______________________________ Step_______________________________
coating standard antiserum HRP
1 - .
2  + - -
3 + -
4 - +
5 - +
6 +  +  -
7 + - +
8 +  - +
9 .+ + -
1 0  + +
1 1  - + +
1 2  + + +
13 + + +
14 + - + +
15 + + +
2.7.5 Preliminary Experiments
The results of experiments already carried out in our laboratory (Haerian, 1994) 
demonstrated that:
a) Among five different types of immulon (Dynatech Laboratories) microelisa plates, the 
immulon IV plates were selected for the sandwich ELISAs in these studies.
b) There was no significant difference between the levels of GCF components on 
different plates at the same concentration and the intra-plate variability was low for levels 
of SL.
c) Serum components did not interfere in the assaying of GCF SL and TIMP.
d) GCF SL respond in a similar way to the highly purified standard and it was concluded 
that the assays developed could be used for their quantification in GCF.
e) The elution of GCF samples in 500pl of incubation buffer would yield concentrations 
in the eluate within the precision range of each ELISA.
f) The SL sandwich ELISAs described by Cooksley et al. (1990) were suitably 
modified.
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2.8 STATISTICAL ANALYSIS
All statistical analysis was performed using the Minitab and SPSS/PC statistical 
packages on an IBM PC computer. Various Statistical analyses were used as appropriate.
The clinical measurements were treated as two groups, AB and NAB, and the Mann- 
Whitney test was performed for the clinical measurements at each visit for the two 
groups. The null hypothesis was rejected at p<0.05. The Mann-Whitney test were also 
carried out to compare the PD reduction and AL gain between the two groups.
For the GCF volume, the Mann-Whitney test was used to compare the three different 
sites for intra- and inter-sites comparison. The patients were then divided into the two 
groups, AB and NAB, and comparison of these two groups were analyzed using the same 
test.
The SL and MMP- 8  levels for each site and visit were tested using the Mann-Whitney 
test to compare their levels between the different sites at each visit and between different 
visit of different sites. Further analysis using the AB and NAB grouping were carried 
out.
The associations between SL & MMP- 8  in the GCF and the clinical indices (GCF 
volume and PD at baseline) were determined by the non-parametric Spearman rank
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correlation coefficient. This was also used to seek any correlation between the changes 
in pocket depth reduction, attachment level gain and each of the variables (plaque at 6  
and 12 months, SL and MMP- 8  at baseline). Spearman’s rank-order coefficient of 
correlation is symbolized by the Greek letter rho (p) which is similar to that of Pearson’s 
r. The significance (p) of this test was performed to test the null hypothesis of zero rank 
correlation.
For the microbiology results the 95% confidence interval of the median for test and 
control sites was calculated using the binomial distribution (p=0.05). Differences in the 
microbiological parameters between test and control sites at each time of examination 
were tested by the Wilcoxon’s signed rank test for matched pairs. The difference in the 
microbiological parameters for test and control sites over time were tested with the same 
test.
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INICAL RESULTS
iseline findings
was analyzed as two separate groups, antibiotic (AB) and non-antibiotic 
rhese data were derived from 32 patients although 38 were recruited 
the ‘dropped-out’ patients had poor attendance and therefore were not 
c time and one patient emigrated before completing the study. Clinical 
PD, CAL and RAL were obtained at baseline, 6  month and 1 year using 
la probes. Measurements were taken from six sites of the test tooth, i.e. 
iccal, disto-buccal, disto-lingual/palatal, lingual/palatal and mesio- 
he deepest site of each test tooth was chosen for the statistical analysis, 
iurement results are shown in Table 3.1 and 3.2. The mean PDs for 
n-antibiotic groups at baseline were similar at 7.20 and 7.19 mm 
en the Florida probe was used to measured the PD, the measurement 
>5 mm for the AB and NAB groups respectively. These were slightly 
mpared to baseline manual probing measurements. The manual probe 
its for the AB and NAB groups were 8.07 and 8.16 mm respectively 
;urements with the Florida probe were 14.05 and 13.52 mm.
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Table 3.1
a) Mean values (± SD) of test sites PD and APD for the antibiotic and non-antibiotic 
groups using the manual and Florida probe (mm)
antibiotic non-antibiotic
Manual PD FP PD manual PD FP PD
baseline 7.20 ± 1.15 6.98 ±1.32 7.17 ±0.99 6.55 ± 1.10
6  months 4.00 ± 1.04 4.25 ±1.28 4.28 ± 1.32 4.32 ±1.21
1 2  month 4.07 ± 1.19 4.70 ±1.41 3.83 ±0.72 3.90 ± 1.08
b-6 m 3.20 ±0.90 2.80 ± 1.30 3.10 ± 1.10 2.40 ± 1.3
b-1 2 m 3.10 ± 1.00 2.10 ±0.90 3.30 ± 1.00 2.80 ± 1 . 2
b) Medians and interquartile range for PD in the antibiotic group
antibiotic
Manual PD Q1-Q3 FP PD Q1-Q3
baseline 7.00 6 . 0 0  - 8 . 0 0 6.60 6 . 0 0  - 8 . 0 0
6  months 4.00 3.00 - 4.25 4.00 3.35-5.10
1 2  month 4.00 3.00 - 4.00 4.35 3.70 - 5.42
c) Medians and interquartile range for PD in the non-antibiotic group
non-antibiotic
Manual PD Q1-Q3 FP PD Q1-Q3
baseline 7.00 6 . 0 0  - 8 . 0 0 6.30 5.95-7.13
6  months 4.00 3.00 - 5.00 4.00 3.60-4.5
1 2  month 4.00 3.00 -4.00 3.90 2.83 - 5.0
Table 3.2
a) Mean values (± SD) of CAL and RAL for the antibiotic and non-antibiotic groups 
using the manual and Florida probe(mm)
antibiotic non-antibiotic
Manual CAL FP RAL manual CAL FP RAL
baseline 8.07 ± 2.02 14.05 ±2.9 8.16 ± 1.39 13.52 ±3.32
6  months 5.50 ±2.03 13.47 ±2.7 5.44 ±1.82 11.98 ± 3.15
1 2  month 5.53 ±2.07 13.53 ±2.8 5.73 ±2.01 11.87 ±3.42
A b-6 m 2.64 ± 0.93 0.70 ± 2.5 2.61 ±1.09 1.41 ±1.64
A b-12m 2.61 ±0.87 0.42 ± 2.4 2.54 ± 1.04 2 . 2 1  ± 1 . 2 1
b) Median and interquartile values of CAL and RAL for the antibiotic groups using the 
manual and Florida probe (mm)
antibiotic
Manual CAL Q1-Q3 FP RAL Q1-Q3
baseline 8 . 0 0 7.00 - 9.00 12.60 12.20-16.20
6  months 5.00 4.00 - 7.30 13.40 11.10-14.90
1 2  month 5.00 4.0 - 7.00 12.80 11.30-15.90
c) Median values of CAL and RAL for the non-antibiotic group using the manual and 
Florida probe (mm)
non-antibiotic
Manual CAL Q1-Q3 FP RAL Q1-Q3
baseline 8 . 0 0 7.00 - 9.00 13.40 10.20-16.80
6  months 5.00 4.00 - 6.00 12.15 9.95-13.80
1 2  month 5.00 4.00 - 6.00 11.90 9.20 - 14.00
3.1.2 Pocket Depth Reduction following the GTR Procedure for the AB
and NAB Groups
Table 3.1a shows the PD reduction following GTR procedures using the GUIDOR® 
membrane after 6  months and one year. A reduction of 3.2 and 3.1 mm were achieved 
for AB and NAB group respectively at 6  months. There was no significant difference in 
PD reduction in the two groups (Table 3.3). After one year, the reduction in the PD is 
quite similar to the 6  months results, indicating that after 6  months no more pocket depth 
reduction could be achieved. With respect to the PD reduction as measured by Florida 
probe, 2.8 and 2.3 mm reduction was achieved for the AB and NAB respectively. There 
was a discrepancy between the PD reduction obtained by manual measurements and the 
PD reductions obtained by Florida probing measurements.
3.1.3 Clinical Attachment Gain and Relative Attachment Level Gain after
6 Months and One Year Following the GTR Procedure
The CAL and RAL gain at 6  months and one year following GTR using GUIDOR® is 
shown in Table 3.2a. At 6  months, the CAL gain was 2.64 and 2.61 mm for the AB and 
NAB group respectively. The CAL gain at one year was quite similar. The RAL gain in 
the AB group was 0.71 mm at 6  months and 0.42 mm at one year. For the NAB group 
the RAL gain was 1.41 and 2.21 mm respectively for 6  months and one year. When the 
Mann-Whitney tests were performed, there was no significant difference in CAL and 
RAL between AB and NAB group; the p values are shown in Table 3.3. Again,
146
Table 3.3
Significance values (p) of A PD and A AL for the antibiotic and non-antibiotic groups 
using the Mann-Whitney test
Group p values
Antibiotic non-antibiotic
manual PD A b-6 m 3.00 3.00 0.92
A b-12m 3.00 3.00 0.62
FP PD A b-6 m 2.75 2.30 0 . 6 6
A b-12m 2 . 0 0 2.50 0.09
manual CAL A b-6 m 2.50 3.00 0.74
A b-12m 3.00 3.0 0.60
FP RAL A b-6 m 0.65 1.35 0.42
A b-12m 1 . 2 0 1.80 0 . 1 0
For statistical significance a level of p<0.05 is set (*). No significant difference was 
noted.
Table 3.4
Mean of PD reduction and AL gain for sites with membrane exposure and without 
membrane exposure (mm)
without membrane exposure with membrane exposure
PD reduction 3 00 ± 0.93 3.14 ±0.96
AL gain 2.67 + 0.87 2.71+0.96
No significant diiference was noted.
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discrepancies between the attachment level gain obtained by the different measurement 
methods could be seen. Due to this fact only manual measurements were shown in Table 
3.5.
3.1.4 Pocket Depth Reduction and Attachment Level Gain for Sites with
Exposed and Non-Exposed Membranes Following the GTR 
Procedures
Exposure of the bioresorbable barrier membrane occurred in 2 1  out of the 32 test sites. 
More membranes were exposed at week 4 compared to week 1 (15 vs 6 ). When the 
means of PD reduction and the CAL gain were analyzed as an exposed and a non­
exposed group, there was no statistical significant difference between these two groups. 
The PD reduction and the CAL gain is shown in Table 3.4
3.1.5 Plaque Index (P1I) and BOP at Each Visit
Plaque index at the test sites for all the patients were zero at baseline. At 6  months, 12 
patients had a P1I of 1, and 9 patients exhibited the same amount of plaque at 12 months. 
Of these, 4 patients exhibited P1I 1 at both visits. All the test sites at baseline exhibited 
bleeding on probing, but only 7 sites were bleeding on probing both at 6  months and 1 2  
months. The patients clinical data is shown in Table 3.5.
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3.1.6 Correlation between PD Reduction and CAL Gain with Baseline PD
When the correlation test was carried out using the Spearman rank test, the p values was 
0.58 (p<0.001) for pocket depth reduction and only 0.29 (p<0.13) for changes in 
attachment level (Table 3.6).
3.1.7 Correlation between PD Reduction and CAL Gain with the Plaque
Index at 12 Months for the Test Sites
When the PD reduction and the CAL gain were correlated to the plaque index at 
12months, there was a significant negative correlation with the CAL gain. The p values 
is shown in Table 3.6.
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3.2 GCF VOLUME RESULTS
3.2.1 A Cross-Sectional and Longitudinal Analysis of the Association 
between Median GCF Volume and the Type and Clinical Parameters 
of the Three Sampled Sites
A total of 480 GCF samples were taken from 32 periodontitis patients; three sites from 
each patient. The samples were taken from i) the experimental sites where the 
bioresorbable membranes were placed (test site), ii) the adjacent tooth which was 
involved in the flap but without any membrane placement (surgical control), and iii) a 
site without a deep pocket to act as a healthy control. 96 GCF samples were taken at 
each visit i.e. at baseline, week 1, week 4, three months and 1 year. The volumes of the 
GCF were not normally distributed, thus non-parametric tests were performed using the 
Mann-Whitney test.
3.2.2 Inter-Site Comparison at Each Visit
A cross-sectional study of median GCF volumes for the three different sites were carried 
out at different time points in the study to determine whether the GCF volume differed 
between healthy and diseased sites. The results of the median values of the GCF volume 
are shown in Table 3.7. At all time points in the study when samples were taken, the 
greatest GCF volumes were those of the test sites. The second highest volumes were
Table 3.7
Median values of GCF volume (nl) for the three sampled sites
Median Q1-Q3
Test site
baseline 353.50 137.40-705.20
week 1 776.60 409.60-1109.80
week 4 407.60 269.30-873.80
week 1 2 305.90 210.60-637.70
week 52 231.00 128.90-373.90
Surgical control
site
baseline 195.30 84.70-348.40
week 1 350.10 166.30-804.30
week 4 351.40 167.20-576.20
week 1 2 200.40 140.80-319.50
week 52 183.40 94.90-258.20
Healthy control
site
baseline 130.60 93.20-350.90
week 1 135.70 71.10-311.00
week 4 186.80 48.10-267.60
week 1 2 203.80 91.50-311.00
week 52 214.00 84.70-350.10
seen in the surgical control sites at baseline, weekl and week 4 only (Figure 3.1 & 
Figure 3.2).
At baseline, the test sites had the highest GCF volume and were also the sites with the 
deepest pocket depths of the three sites. There was a statistically significant difference 
in volume of the test sites when compared to both the surgical control (p<0 .0 0 1 ) and 
healthy control sites (p< 0.001) (Table 3.8). A week after membrane placement, the 
same trend of volume distribution was seen, with the test sites having the highest volume 
(776.70 nl) and the healthy control the lowest volume (135.70 nl). The differences in 
volume were statistically significant when the test sites were compared to both the 
surgical control and the healthy control. The same trend was seen at week four and three 
months, with the exception that at three months the volume for the healthy control site 
was just slightly higher compared to the surgical control. At one year, there was no 
statistically significant difference seen in the volume distribution.
3.2.3 Intra-Site Comparisons between Visits
The volume distribution and comparisons are best illustrated by the graph in Figure 3.1. 
For the test site, the volume increased to a maximum value at week one, and decreased 
to almost the baseline value at four weeks. Then the value decreased slowly to a lower 
value than the baseline from week four to 1 year. A week after the membrane placement 
at the test sites, the GCF volume at these sites increased two-fold when compared to the
Figure 3.1 Graphs showing the comparison of GCF median levels between the sites
(test = membrane site, surgical = surgical control site, healthy = non-surgical control 
site)
Median values of GCF volume in nl
800 rI
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2 0 0 -
1 0 0 -
0 -------
0
Test sites
Surgical sites
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Significance difference were noted between test and surgical sites and between test and 
normal sites at B, W l, W4, and W12, but only at W1 and W4 between surgical and 
control sites (Table 3.8)
Figure 3.2 Median values of GCF volume (nl) at each visit 
a) for test sites
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c) for healthy control sites
Table 3.8
p values of inter-sites comparisons of volume using the Mann-Whitney test
Test site
surgical control site 
b
W1
W4
W12
W52
b W1 W4 W12 W52 
0.001*
0.001*
0.001*
0.001*
0.07
healthy control site 
b
W1
W4
W12
W52
0.001*
0.001*
0.001*
0.001*
0.55
Surgical control site
Healthy control site 
b
W1
W4
W12
W52
b W1 W4 W12 W52 
0.84
0.001*
0.01*
0.77
0.26
i
* statistically significant (p<0.05)
baseline value. The same picture was reflected by the surgical control sites, but the 
values attained were much lower. For the healthy control sites, the values from baseline 
to one year were lower, with the lowest value found at baseline which then increased 
slowly from week one to one year.
For the test sites there was a statistically significant difference between baseline and 
week 1 (p < 0.001), between week 1 and week 4 (p < 0.05), between week 1 and week 
12 (p < 0.001), between week 1 and week 52 (p < 0.001) and between week 4 and week 
52 (p < 0.001). For the surgical control site the statistical significance differences were 
seen between baseline and week 1, baseline and week 4, week 1 and week 12, week 1 
and week 52 and week 4 and week 52. For the healthy control, there was no statistically 
significant difference between any of the time points. The p values can be seen in Table 
3.9.
3.2.4 GCF Volumes in AB and NAB Group
When the data were analyzed as two separate AB and NAB groups, there were no 
significant differences between the two groups as can be seen from Table 3.10.
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Table 3.9
p values of intra sites comparisons of volume using the Mann-Whitney test
a) for test site
Test site
test site b W1 W4 W12
W1 0.001*
W4 0.24 0.02*
W12 0.88 0.001* 0.09
W52 0.01* 0.001* 0.001* 0.09
b) for surgical control site
Surgical control site
Surgical control
site
W1
W4
W12
W52
b W1 W4 W12 
0.001*
0.04* 0.15
0.56 0.001* 0.10
0.42 0.001* 0.01* 0.16
c) for healthy control site
Healthy control site
Healthy control site b W1 W4 W12
W1 0.50
W4 0.45 0.79
W12 0.75 0.42 0.30
W52 0.69 0.28 0.19 0.74
* statistically significant (p<0.05)
Table 3.10
Median levels of GCF volumes (nl) and the p-values for non-antibiotic and antibiotic 
group.
time site non­
antibiotic
antibiotic p-values
baseline
test 339.90 372.20 0.49
surgical
control
273.50 132.30 0.07
Healthy
control
159.50 123.80 0.18
week one
test 1101.90 641.70 0.15
surgical
control
305.90 416.00 0.43
Healthy
control
254.80 106.80 0.07
week four
test 358.60 748.80 0.09
surgical
control
249.70 268.40 0.62
Healthy
control
220.80 161.20 0.96
week twelve
test 304.20 309.20 0.84
surgical
control
173.10 244.60 0.08
Healthy
control
191.90 227.60 0.89
week fifty- 
two
test 179.90 283.90 0.31
surgical
control
135.70 195.30 0.85
Healthy
control
193.60 273.50 0.64
3.2.5 Correlation between GCF Volume and PD
The PD data for the three sites at baseline were pooled and correlated to the 
corresponding GCF volume. The Spearman rank correlation coefficients (p) was 0.44 
(p<0.001), indicating a significant positive association between these two parameters.
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3.3 MMP LEVELS IN THE GCF SAMPLES - STROMELYSIN (SL)
3.3.1 Stromelysin Baseline Findings
All the available samples taken at B, W l, W4 and 3M were analyzed for MMP-3 and 
MMP-8 regardless of whether the patients completed the study or not. At baseline, when 
individual data was inspected, out of the 105 samples obtained only 13 sites had 
detectable SL, 6 from the test sites, 5 from the surgical control and 2 from the healthy 
control sites.
3.3.2 Findings at W l, W4, and 3M
The only change in the median SL levels between time points was at week one for the 
test sites, where the median levels increased. However, when each of the sites were 
analyzed at week one, 74.2% of the test sites and 45.7% of the surgical sites had 
detectable increased levels of stromelysin. The percentage of sites with detectable 
amounts of SL at each visit is presented in Table 3.11 and Figure 3.3.
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PERCENTAGE OF SITES WITH DETECTABLE LEVELS OF 
STROMELYSIN
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Figure 3.3 Percentage o f sites with detectable levels o f stromelysin. The cut-off point for 
detectability was taken as the means OD plus 2 SD o f the control wells which contain no 
sample or antigen (control 14).
Table 3.11
Percentage of sites with detectable levels of stromelysin
% of sites
Test site
baseline 15.2
week 1 74.2
week 4 16.1
week 12 25.9
Surgical control
site
baseline 12.1
week 1 45.7
week 4 9.6
week 12 7.4
Healthy control
site
baseline 6.1
weekl 11.4
week4 10.0
week12 14.8
3.3.3 Intra-Site Comparison of Stromelysin Levels in the GCF
When non-parametric Mann-Whitney tests were carried out for the intra-sites 
comparison, there was a statistically significant difference for the test and surgical sites 
at baseline and week 1 (p< 0.001 for test sites and p<0.01 for surgical control sites), 
week 1 and week 4 (p< 0.001) and at week 1 and week 12 (p<0.001) (Table 3.12).
3.3.4 Inter-Site Comparison of Stromelysin Level in the GCF
At week 1 statistically significant differences could be observed between test and healthy 
control sites (p< 0.001) and also between surgical control and healthy control sites (p< 
0.001). There was also a statistically significant difference in stromelysin level between 
test and surgical control sites at week 4 (p<0.01). The p values can be seen in Table
3.13.
3.3.5 Correlation between SL and GCF Volume
When stromelysin levels from test, surgical control and healthy control sites at baseline 
were pooled and correlated to the GCF volume at baseline, the p value was equal to 0.21 
(p<0.19). These findings do not support a correlation between SL and GCF volume.
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Table 3.12
p values of intra sites comparisons of stromelysin levels using the Mann-Whitney test
a) for test site
Test site
test site b Wl W4
Wl 0.001*
W4 0.95 0.001*
W12 0.46 0.001* 0.51
b) for surgical control site
Surgical control site
Surgical control 
site
b Wl W4
Wl 0.01’k
W4 0.84 0.001*
W12 0.72 0.001* 0.87
c) for healthy control site
Healthy control site
Healthy control site b Wl W4
Wl 0.70
W4 0.52 0.77
W12 0.34 0.54 0.73
Table 3.13
p values of inter-site comparisons of stromelysin levels using the Mann-Whitney test
Test site
surgical control site 
b
Wl
W4
W12
b Wl W4 W12 
0.87
0.07
0.01*
0.21
healthy control site 
b
Wl
W4
W12
0.30
0.001*
0.66
0.47
Surgical control site
Healthy control site 
b
Wl
W4
W12
b Wl W4 W12 
0.40
0.001*
1.00
0.60
3.3.6 Antibiotic and Non-Antibiotic Group
When the data were analyzed as two separate antibiotic and non-antibiotic groups, there 
was no significant difference between the two groups.
3.4 MMP-8 LEVELS IN THE GCF SAMPLES
3.4.1 MMP-8 Baseline Findings
The median levels of MMP-8 at baseline for the three different sites is shown in Table
3.14. The test sites have the highest amount of MMP-8, followed by the surgical control 
sites and then the healthy control sites. While there is no statistically significant 
difference between the test and surgical control sites and between the surgical control 
and healthy control sites, there was a statistically significant difference between the test 
and healthy control sites (p< 0.02).
3.4.2 Findings at W l, W4,3M and Inter-Sites Comparisons
The pattern of change of median values of MMP-8 is best illustrated by a graph as
shown in Figure 3.4 and Figure 3.5. At week 1, a dramatic increase in the MMP-8 level
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Table 3.14
Median values (ng/30s) of MMP-8 levels in GCF for the three sampled sites
Median Q1-Q3
Test site
baseline 67.60 36.20-165.20
week 1 178.30 66.60-299.90
week 4 120.00 49.70-199.40
week 12 121.30 63.70-206.4
Surgical control
site
baseline 48.30 13.90-113.00
week 1 63.50 25.60-137.00
week 4 50.90 24.70-114.80
week 12 36.90 18.70-133.70
Healthy control
site
baseline 39.1 12.60-76.50
weekl 27.90 11.90-93.90
week4 48.80 7.40-92.30
week12 39.20 14.90-138.60
Figure 3.4 Graphs showing the comparison of MMP-8 median levels between the sites
(test = membrane site, surgical = surgical control site, healthy = non-surgical control 
site)
Median values of MMP-8 in ng/30s
180
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Significance differences were noted between test and surgical sites at W l, W4 and W12, 
and at all visit between test and normal sites but only at Wl between surgical and control 
sites.
Figure 3.5 Median values of MMP-8 in ng/30s
a) for test sites
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p<0.01 *
was shown by the test sites. There was a slight increase for the surgical control sites but 
for the healthy control sites the slight change was in a negative direction. When the 
Mann-Whitney test was used to compare the data, there was a statistically significant 
difference between the test and surgical control sites (pO.OOl), the test and the healthy 
control sites (pO.OOl) and between the surgical control and healthy control sites (p< 
0.03), as shown in Table 3.15.
At week 4 there was a drop in the MMP-8 levels for both the test and surgical control 
sites, but the drop for the test site was above the baseline values. Interestingly, there was 
a slight increase above the baseline value in the MMP-8 values for the healthy control 
sites. There is a statistically significant difference for the test and surgical control sites 
(p<0.001) and also for the test and healthy control sites (p<0.001), but there was no 
significant difference for surgical control and healthy control sites.
At three months, the values for the test sites seemed to plateau from the 4W values, 
while there was a drop for the surgical control sites below the baseline values, the 
healthy control sites seemed to drop to its baseline values. There is a statistically 
significant difference between the test and surgical control sites (p<0.001) and also 
between the test and the healthy control sites (p<0.01).
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Table 3.15
Significance values (p) of inter-sites comparisons of MMP-8 levels using the Mann- 
Whitney test
Test site
surgical control site b Wl W4 W12
b 0.09
Wl 0.001*
W4 0.001*
W12 0.001*
healthy control site
b 0.02*
Wl 0.001*
W4 0.001*
W12 0.01*
Surgical control site
Healthy control site b Wl W4 W12
b 0.42
Wl 0.03*
W4 0.24
W12 0.89
* statistically significant (p<0.05)
3.4.3 Intra-Site Comparisons
When the MMP-8 levels were compared at different time points of the study, for the test 
sites only between baseline and week 1 was there a significant difference (p<0.01). 
There was no statistically significant difference for both the surgical control and the 
healthy control sites at any two time difference (Table 3.16).
3.4.4 Comparisons of MMP-8 Levels at Each Visit for the AB and NAB 
Group
When the MMP-8 data were analyzed as two separate antibiotic and non-antibiotic 
groups, there was no significant difference between the two groups as in the SL case. 
The median and significance values are tabulated in Table 3.17.
3.4.5 Correlation between MMP-8 and PD at Baseline
When the MMP-8 levels for all the three sites at baseline were pooled and correlated to 
the corresponding PD, the p value was 0.36 (p<0.01), showing a significant positive 
association between these two parameters.
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Table 3.16
p values of intra sites comparisons of MMP-8 levels using the Mann-Whitney test
a) for test site
Test site
test site b Wl W4
Wl 0.01*
W4 0.15 0.13
W12 0.26 0.17 0.94
* Significant difference was noted for test site between baseline and week 1.
b) for surgical control site
Surgical control site
Surgical control 
site
b Wl W4
Wl 0.24
W4 0.40 0.54
W12 0.92 0.24 0.42
c) for healthy control site
Healthy control site
Healthy control site b Wl W4
Wl 0.83
W4 0.78 0.72
W12 0.71 0.47 0.69
Table 3.17
Median levels of MMP-8 in the GCF and the p-values for the comparison between the 
non-antibiotic and the antibiotic group.
time site non­
antibiotic
antibiotic p-values
baseline
test 100.2 59.30 0.44
surgical
control
57.27 48.15 0.654
Healthy
control
38.10 39.10 1.00
week one
test 166.90 189.80 0.3992
surgical
control
69.60 50.00 0.29
Healthy
control
32.87 24.05 0.64
week four
test 138.30 76.60 0.08
surgical
control
61.08 50.38 0.71
Healthy
control
31.70 57.40 0.43
week twelve
test 121.30 124.20 1.00
surgical
control
53.50 29.00 0.12
healthy
control
91.40 32.60 0.24
No significant difference was noted.
3.4.6 Correlation between MMP-8 and GCF Volume
When both the MMP-8 levels and the GCF volume were pooled and correlation 
Spearman rank test were performed, the p value obtained was 0.22 (p<0.18).
3.4.7 Correlation between MMP-8 and Stromelysin Levels
When both the stromelysin and MMP-8 levels were pooled and Spearman rank 
correlation test was carried out, the p value was 0.47 with p<0.001, indicating a positive 
significant correlation.
3.4.8 Correlation between PD Reduction and CAL Gain with Stromelysin
and MMP-8 Level at Baseline
The coefficient values for the Spearman correlation test can be seen in Table 3.18. Both 
the pocket depth reduction and the attachment gain were poorly correlated to the levels 
of stromelysin at baseline. There were significant positive associations between MMP-8 
levels and the PD reduction and also the CAL gain.
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Table 3.18
Spearman rank correlation coefficients (p) between pocket depth reduction and 
attachment level gain (A b-6m) with other variables for test sites. Probability levels (p) 
are shown.
Parameters Pocket depth reduction Attachment level gain
SLb
MMP-8 b
0.33 (p O .ll)  
0.39 (p<0.05)*
0.20 (p<0.33) 
0.71 (p<0.01)*
* significant positive association noted
3.5 MICROBIOLOGICAL RESULTS
Two microbiological samples were taken from each patient at baseline, week 1, week 4, 
6 months and 12 months. The two sites chosen had deep pockets > 6mm with BOP. 
One site acted as a test site where the membrane was placed and the other site acted as a 
control without any membrane placement. Three sterilized paper points of size 40 were 
placed at each predetermined site for 30 seconds. Samples were taken from 30 patients, 
14 from the antibiotic and 16 from the non-antibiotic group. Two patients from each 
group dropped out before the 6 months results were obtained. None of the control sites 
need any treatment during the study.
3.5.1 Microbiological Results at Each Visit
At baseline, no significant difference was observed between the test and control sites 
with regard to total aerobic, total anaerobic, anaerobic/aerobic ratio, total streptococcal 
and A. actinomycetemcomitans count for both AB and NAB groups.
The median log10 total anaerobic counts of test and control sites for AB and NAB group 
are presented as Figure 3.6. The values were very similar throughout the study. The 
median values of anaerobic/aerobe ratios of test and control sites for AB and NAB 
during the investigation period are presented in Table 3.19. No statistically significant 
difference between test and control for both AB and NAB groups in total aerobic, total
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Table 3.6
Spearman rank correlation coefficients (p) between pocket depth reduction and clinical 
attachment level gain (A b-12m) with other variables for test sites. Probability (p) levels 
are shown
APD A CAL
PD b 
APD
plaque 12M
0.58 (p<0.001)* 
-0.16 (p<0.43)
0.29 (p<0.13) 
0.61 (pO.OOl)* 
-0.41 (p<0.03)*
* significant association are noted
Microbiology results
Table 3.19 Bacteriological counts expressed as the mean log10 CFU 
a)
Antibiotic
group Test sites Control sites
b W1 W4 26W 52W b W1 W4 26W 52W
n 13 14 14 13 12 13 14 14 13 12
Aerobic (Oj) 6.62 6.57 6.68 6.70 6.15 6.31 6.65 6.75 6.41 6.32
95% 6.59 6.51 6.4 6.73 6.00 6.36 6.81 6.86 6.28 6.19
Anaerobic 7.44 7.62 7.21 7.07 7.09 6.94 7.09 6.78 6.95 7.13
(A n 0 2)
95% 7.50 7.77 7.01 6.94 6.90 7.03 7.18 6.70 6.68 7.12
A n 0 2:0 2 1.13 1.15 10.8 1.05 1.15 1.10 1.07 1.00 1.08 1.13
Strep 5.88 6.13 6.27 5.97 5.69 5.42 5.81 6.03 5.70 5.78
95% 5.78 6.05 6.18 5.95 5.22 5.90 5.97 5.61 5.92
Aa 6.06 4.64 4.35 5.31 3.61 5.26 4.87 4.85 4.95 3.19
95% 6.21 4.67 4.26 5.04 3.182 5.47 5.03 4.54 4.76 3.21
b)
Non-antibiotic
group Test sites Control sites
b W1 W4 26W 52W b W1 W4 26W 52W
number 14 16 16 11 11 14 16 16 11 11
Aerobic 5.99 6.25 6.85 6.65 5.99 6.25 6.00 6.69 6.75 6.09
95% 5.90 6.05 6.80 6.51 5.78 5.91 5.82 6.77 6.76 5.91
Anaerobic
(A n 0 2)
6.95 6.84 7.49 7.00 7.00 7.40 7.33 7.49 6.49 7.20
95% 6.93 6.54 7.62 6.87 7.04 7.53 7.32 7.6 6.34 7.08
An02:02 1.16 1.09 1.09 1.05 1.19 1.18 1.22 1.12 0.96 1.18
Strep 5.57 5.61 6.31 6.25 5.76 5.78 5.57 5.87 5.71 5.61
95% 5.4 5.5 6.4 6.5 6.0 6.04 5.55 5.83 5.83 5.76
Aa 4.4 4.66 5.17 4.65 4.9 4.73 4.56 4.92 4.75 5.50
95% 3.1 3.9 5.3 6.5 6.1 4.722 4.43 4.71 4.46 5.39
anaerobic, ratio of anaerobic and aerobic, streptococcal and A. actinomycetemcomitans 
counts was observed at any time throughout the study.
When the proportion of samples in which P. intermedia could be isolated was analyzed, 
at baseline a higher proportion of the control sites in NAB group was found to harbour 
P. intermedia compared to the rest. At week one no samples was found to harbour P. 
intermedia. At week 4, P. intermedia was found in 7% of the test site in the AB group 
and at 6 months only the control sites (8%) in AB group harbour this microorganism. At 
one year, only the control sites in the AB did not harbour P. intermedia, while the rest 
had a similar percentage of sites affected (Figure3.7).
When the presence of E. corrodens were analyzed at baseline, 31% of the test AB sites 
were affected, 23% in control AB, 29% in test NAB and 0% in control NAB sites. At 
week one, 13% of the NAB group (both test and control sites) were found to harbour this 
bacterial species. All the results for the different periodontal pathogens present in the 
sites at each visit are shown in Table 3.20 and in Figure 3.7 & 3.8.
There is no obvious pattern of distribution that can be seen with the proportion of 
samples affected by the periopathogens. At week one, there was no statistical significant 
difference between the AB and NAB group for the test site for all the periopathogens, 
indicating that placement of a bioresorbable membrane did not affect or influence the 
microbiological counts. In fact, there is no statistical significant difference in the
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Table 3.20 Proportion of samples in which periodontal pathogens were detected
a)
Antibiotic
group Test sites Control sites
number
b W1 W4 26W 52W b W1 W4 26W 52W
13 16 16 11 11 13 16 16 11 11
P. intermedia 8% 0% 7% 0% 8% 8 0 0 8 0
B. corrodens 31 0 7 15 8 23 0 14 8 8
Fusobacterium 8 0 0 8 0 0 0 8 0 8
Ana. Strep 23 50 0 8 42 23 43 8 15 25
Aa 0 0 0 15 0 8 0 8 15 8
P. gingivalis 0 0 0 0 0 0 0 0 0 0
Capno 0 7 0 23 0 16 14 29 8 0
AB R 8 21 14 0 0 16 29 21 8 0
b)
Non-antibiotic
group Test sites Control sites
number
b W1 W4 26W 52W b W1 W4 26W 52W
13 16 16 11 11 13 16 16 11 11
P. intermedia 7 0 0 0 9 14 0 0 0 9
B. corrodens 29 13 0 9 18 0 13 6 0 9
Fusobacterium 7 0 0 0 9 7 0 6 0 9
Ana. Strep 21 38 38 18 18 14 31 0 0 9
Aa 7 0 0 9 9 0 13 0 18 9
P. gingivalis 0 0 0 0 0 0 0 6 0 0
Capno 0 13 6 18 0 7 13 6 9 9
AB R 14 0 6 9 0 21 6 9 9 0
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proportion of samples in which periopathogens were detected from either groups and test 
and control sites at all the time interval.
Although there was a trend of increased recovery of amoxycillin resistant isolates in the 
antibiotic group particularly one week after the surgery for both the test and control sites, 
there was no statistically significant difference observed for AB and NAB group.
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CHAPTER 4 
DISCUSSION
1,1 METHODOLOGICAL CONSIDERATION
1.1.1 Study design
]CF samples were taken from 3 sites from each patient to evaluate the effect o f  placing 
ibioresorbable membrane and to compare this effect with an adjacent tooth which was 
wolved in the surgical flap design and with a healthy control site not involved during 
lie surgery. The adjacent tooth acting as a surgical control was not chosen for their 
locket depths measurements but because that tooth was going to be involved in the flap 
iesign, so unavoidably the PD varies in these subjects.
M e the GCF volume and microbiological samples were analyzed up to a year, the 
tfMPs levels were only analyzed up to 3 months from membrane placement. The 
tionale for this was that i) there was little activity change in SL after 1 week o f 
aembrane placement, and ii) we were mainly interested in the MMP activity during the 
arly healing phase following the GTR procedure.
1.1.2 Clinical Measurements
'o evaluate the effect o f the GTR procedures using the bioresorbable barrier membranes 
Guidor®), measurements o f PD, CAL and RAL were obtained at baseline, 6 months and 
2 months using a manual probe and an electronic probe (Florida probe). PD
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There is no consensus in the literature whether manual or electronic probing 
measurement is more reliable, sensitive or accurate, therefore in this study both 
methodologies were used.
4.1.3 Antibiotic of choice
Amoxycillin, 3g given 1 hour pre-operatively was given so that a high concentration 
could be achieved during placement of the membrane so as to reduce the risk of 
biomaterial contamination of the healing area. Studies have shown that the regenerative 
process is compromised if bacterial contamination on the membrane material during 
insertion occurs. With the ePTFE barrier membrane tissue integration is not possible 
and formation of a pocket between the gingival flap and the matrix occurs due to the 
apical proliferation of the epithelium leading to bacterial colonization. As the barrier 
membrane used in this study was bioresorbable, tissue integration between the material 
and the gingivae will take place, thus limiting the bacterial contamination from the oral 
cavity during the healing period. As the concern is only for bacterial contamination and 
colonization during insertion, a pre-operative dosage of antibiotic was most appropriate 
in this study. Preliminary microbiological studies performed in Aarhus Dental School 
laboratory have shown that the microflora associated with Guidor® predominantly 
consist of facultative anaerobic bacteria and that black pigmented Gram-negative 
anaerobic rods did not seem to develop in number during the first 6 postoperative weeks
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(personal communication). Application of a high systemic dose of penicillin selective 
for aerobe and facultative anaerobic microflora would be most suitable, thus one pre- 
surgical systemic application of amoxycillin was the antibiotic regime of choice.
4.1.4 Quantification of Gingival Crevicular Fluid Matrix
Metalloproteinases
The enzyme linked immunosorbent assay (ELISA) is being used increasingly in clinical 
laboratories for the assessment of constituents of biological fluids. The ELISAs 
methodology provides precision and low detectability limits, although visual assessment 
is possible, results can be automatically obtained using spectrophotometry. It is also a 
simple method and a large numbers of samples can be run at a time. ELISA used in 
these studies were validated and proven suitable for the quantification of MMPs 
(Haerian, 1994).
The ELISAs methodology has the following inherent problems which may introduce 
erroneous results or making their interpretation difficult:
a) High background
The background of an assay can be determined by evaluating the ODs readings in the 
control wells that contain no sample or standard (control 14). High background can 
easily obscure the results of positive samples, making the interpretation difficult.
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Increasing the number and efficiency of the wash steps as well as using a non-specific 
protein i.e. bovine serum albumin (BSA) to bind unreacted sites on the solid phase may 
solve the problem (Carpenter, 1992).
b) Edge effect
It has been noticed that perimeter wells of a plate may absorb more protein than the inner 
wells thus, resulting in an assay bias (Tijssen, 1985; Carpenter, 1992). In order to avoid 
this phenomena only the inside wells were used for running samples (Tijssen, 1985)
c) Hook effect
The hook effect is an unexpected fall in the amount of a substance at the high end of the 
dose-response curve, resulting in a gross underestimation of the substance (Carpenter, 
1992). This is particularly a problem with patients samples that contain an extremely 
high level of an analyte. When the standard assay dilution is used a low to moderately 
high result will occur. On further dilution, nonetheless, the result will be out-of range 
high or, if it is diluted will give extremely elevated value. However, in these 
experiments the possibility of hook effect was not demonstrated as assaying serial 
dilutions of GCF eluates did not demonstrate such an effect.
4.1.5 Reporting of GCF Constituents
GCF is an osmotically mediated transudate and the amount of fluid in any crevicular 
location tends to increase with inflammation and capillary permeability (Brill & Krasse,
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1959; Brill and Bjom, 1958; Egelberg, 1966a, b). The volume of GCF in individual 
crevicular locations is both very small (generally < 1 pi) and extremely variable 
depending on the clinical situation, however, it has a very high constituent concentration 
in small volumes. Unlike serum, a standard amount of GCF cannot be collected and 
analyzed. Considering that the amount of fluid present at individual crevicular sites is 
extremely variable, and variations in fluid volume depend on the state of the tissues from 
which they are derived, reporting the constituent concentration is not acceptable and is 
inadequate.
In the present study GCF data was reported as absolute amount of GCF constituents per 
30s sample, and does not include the volume of GCF in its calculation. The rationale for 
expressing results of GCF constituents as absolute amount has been discussed 
extensively (Lamster et al., 1986; Lamster et al., 1988). Standardization in sampling is 
required and this is achieved by sampling all sites for the same length of time (30s) with 
a reproducible collection procedure.
4.2 The Choice of GCF Components to be examined
These studies were carried out to investigate 1) the effect of antibiotics on GTR 
outcome, 2) the MMP levels in GCF during the healing period following the placement 
of bioresorbable membrane in the treatment of infrabony defects. The levels of MMP-3 
and -8 in the membrane treated sites were also compared to surgical and non-surgical
healthy sites during the first 3 months of the healing period. By looking at the MMP 
levels during the wound healing the role of the degradative phase of the regenerative 
process can be ascertained. The reasons for choosing MMP-3 and MMP-8 for the 
analysis of the early wound healing following the GTR procedure are:
a) MMP-3 has been shown to be overexpressed and overactivated during wound repair 
process (Buisson et al., 1996) and is correlated to deposition of repair tissue (Fini et 
al., 1996). Increased MMP-3 levels have also been shown to contribute to scarless 
healing (Bullard et al., 1997).
b) MMP-3 is secreted by fibroblasts, endothelial, and macrophages cells (resident cells) 
while MMP-8 is produced by PMN cells, gingival and periodontal ligament 
fibroblasts (Salo et al., 1995, Sorsa et al, 1996) and also chondrocytes (Chubinskaya 
et al., 1996; Cole et al., 1996). Fibroblast and macrophages are the principal cellular 
source of matrix components constitutive of the healing granulation tissue. MMP-3 
also degrades the core protein of proteoglycan in addition to its role in MMP-1, 
MMP-8 and MMP-9 proteolytic activation. In this study, only the fibroblast-derived 
SL was quantified.
c) The major fibrous constituents of the periodontal connective tissues are collagen type 
I and III and MMP-8 degrades both these collagen types. MMP-3 can degrades type 
IV collagen which is present in healthy and inflamed gingiva, and also it degrade 
type V collagen in inflamed gingiva.
d) To test the view that collagenase biosynthesis is essential for collagen turnover 
during the early repair process (Cionni et al., 1986; Davidson & Galbavy, 1985; 
1986) in periodontal tissue. Girard et al. (1993) has earlier proved this in cornea.
168
43 Clinical Findings
When the manual and the electronic PD measurements were compared to each other at 
baseline, 6 month and 12 months, the measurements were comparable, even though the 
Florida probe measurements were generally lower than the manual measurements. It has 
to be emphasized that the manual probe is recorded to the nearest mm, while the Florida 
probe measurements are displayed to the nearest 0.2mm. In addition, the two different 
methods of measurement could be measuring probing depths at different locations. The 
manual probe obtains measurements at a more interproximal location compared to the 
Florida probe as the sleeve of the automated probe restricts the placement of the probe 
relative to the interproximal area where the deeper probing depths are usually 
encountered.
For the CAL and the RAL only the changes between baseline and 6 months and between 
baseline and 12 months can be compared for the two different measurement methods. 
These two measurements are not comparable as the CAL value is measuring from the 
CEJ to the bottom of the pocket, while the RAL value is recording measurement from 
the incisal/cuspal tip to the bottom of the pocket. There was a big difference between 
the changes calculated using the manual probe compared to the changes calculated using 
the Florida disc probe. Between baseline and 6 months the changes were 2.75mm 
manually and 1.00mm using Florida disc probe, and 3.00mm manually and 1.5mm 
electronically between baseline and 12 months. Due to this fact, only the manual 
measurements for both PD and CAL were used for the statistical analysis. Eight anterior
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teeth, 13 premolars and 11 molars were the teeth used in this study. The large variability 
of the differences could be explained by the fact that the Florida disc probe has quite a 
long dimension and this creates difficulty when inserting the probe in the molar region 
especially if the patient has a limited opening. Due to this difficulty the probe could be 
inserted not along the long axis of the tooth but slightly slanting, thus causing the 
variability. When the probe is placed not parallel to the long axis of the tooth the value 
measured would be higher than the actual value. Due to the high resolution of the 
automated probe, even slight alteration in the probe placement between passes would 
result in some variability. Also owing to the slender dimension of the probe, it is quite 
flexible and thus can bend easily while taking measurement of the molar region. The 
difficulty in measuring the molar region leading to measurement variability has been 
shown by Ahmed et al. (1996) who also noted that the distal site of either buccal or 
lingual aspects showed significantly more variability in repeated measurements 
reflecting the degree of ‘awkwardness’ in measuring this site.
4.3.1 CAL Gain following the GTR Procedures
CAL gain in this study was found to be 2.61 + 0.87 for the AB group and 2.54 + 1.04 
mm for the NAB group. Higher CAL gain has been reported by several investigators 
using the Guidor ® membrane, Falk et al. (1993) achieved 4.5 + 1.6, Laurell et al.
(1994) achieved 4.9 + 2.2 and Falk et al. (1997) achieved 4.8 + 1.5 mm gains. The 
initial PD of the present study was 7.18 + 1.04 mm which were slightly lower compared
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to the above-mentioned studies which was between 8.1 to 9.0 mm. Several investigators 
have also showed that there was a positive correlation between the mm gain of clinical 
attachment and the initial PD (Tonetti et al., 1993; 1996; Garrett et al., 1988; Falk et al, 
1997).
When the PD reduction and AL gain were compared between AB and NAB groups at 6 
and 12 months, there was no statistically significant difference between the two groups. 
This indicates that the antibiotic regime using amoxycillin 1 hour pre-operatively did not 
influence the pocket depth reduction and the attachment level gain in the GTR procedure 
using Guidor®.
In the present study membrane exposure occurred in 21 out of the 32 test sites. 6 of 
these sites were exposed at week 1 and 15 exposed at week 4. In all cases the extent of 
the exposure was minor, and in most instances limited to a small portion of the 
interdental tissue. The exposed part of the membranes disintegrated within several 
weeks. Membrane exposures do not influence the PD reduction and the AL gain in the 
present study. This finding is in agreement with other studies (Selvig et al., 1992; 
Schallhom & McClain 1994; Trombelli et al., 1997) which emphasized the fact that only 
the probing bone level and not PD reduction and AL gain were influenced by membrane 
exposure. However, contrasting observations have also been reported where membrane 
exposure was found to be a negative predictor of AL gain (De Sanctis et al., 1996a; Falk 
etaL, 1997).
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4.3.2 Correlation between the PD Reduction and CAL Gain with other
Clinical Parameters
The baseline pocket depth seems to moderately influence the pocket depth reduction, and 
the pocket depth reduction was moderately correlated to the attachment level gain. 
When the gain in AL was analyzed with the Spearman rank correlation test, there was 
only a weak correlation with the baseline PD (refer Table 3.6). This finding is in 
contradiction to the established fact that generally the deeper the baseline defect, the 
greater the amount of attachment gain. This can be explained by the fact that, even 
though our pocket depths were considerably deep when we started, a number of patients 
had residual deep pockets which were root planed every 3-monthly. The presence of 
residual periodontal infection in the oral cavity has been shown to be strongly associated 
with the clinical outcomes of both regenerative and conventional surgical procedures 
(Tonetti et al., 1996). The criteria of patient selection in our protocol were that the 
patients had completed initial therapy (oral hygiene instruction and root-planing) or in 
maintenance and had at least 2 deep pockets > 6mm with BOP, one of them had to have 
an infrabony defect.
The AL gain was significantly negatively associated with the plaque index at 12 month. 
This is in agreement with other studies which emphasized that oral hygiene influenced 
the outcome of the GTR procedure (Tonetti et al., 1995; 1996; Cortellini et al., 1994; 
Falk et al., 1997).
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The effect of smoking on the clinical outcome was not analyzed as we had a limited 
number of smokers in this study group.
4.4 CHANGES IN GCF VOLUME
The median levels of GCF volumes were investigated at baseline, week 1, week 4, 3 
months and 1 year following the placement of the bioresorbable membrane barrier. The 
values obtained at baseline for the 3 different sites are explicable by the clinical and 
pathological differences of the three sites. The lowest value was seen at the healthy 
control sites while the highest was seen at the test site with PD > 6mm. This was 
expected as it has been shown that the degree of gingival inflammation is positively 
correlated to the GCF volume obtained (Brill, 1960; Egelberg, 1964; Loe & Holm- 
Pederson, 1965b). A week after the surgical procedure, both the test and the surgical 
control sites showed an increase in volume, though the test sites have statistically higher 
volume than the surgical control sites. This implies that placement of a membrane 
barrier creates more inflammation as the surgical control sites which were also involved 
in the surgery did not have this large increase in volume. This is further illustrated at 
week 4 when the same pattern occurred though in lower volumes. At one year, there was 
a slight increase in volume compared to the baseline visit for the healthy control sites. 
This can be explained by the fact that the plaque control at one year was not as good as 
when the study was initiated.
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There was no statistically significant difference between the two groups for the GCF 
volume, thus demonstrating that AB given 1 hour pre-operatively did not influence the 
GCF level at any visit.
4.5 MMP-3 LEVELS
MMP-3 has been shown to be at a significantly higher level in diseased sites (gingivitis 
and periodontitis) compared to healthy sites (Haerian et al., 1995) and the level was 
reduced after periodontal therapy (Haerian et al., 1996). Haerian et a l (1994) has also 
shown that MMP-3 level was higher in newly referred periodontitis patients (at healthy, 
gingivitis and periodontitis sites) compared to maintenance patients. It was shown that 
during the wound healing which would invariably include inflammation and remodeling, 
SL level increased, thus we expect increases in MMP-3 level at the test and surgical 
control sites. The levels of MMP-3 would be expected to be more at the membrane site 
than at the surgical control site as the inflammation would be more at the membrane site, 
i.e. from the remodeling and from the host reaction to a foreign implant.
When the MMP-3 levels at baseline were analyzed, it was not surprising to find low 
levels at all the sites, even though the test sites had PD > 5mm, these sites had received 
scaling and root planing treatment. Only 13 out of the 105 sites analyzed at baseline had 
detectable MMP-3. When the overall results were analyzed, at week 1 there was an
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increase in the MMP-3 levels for the test sites only. When the individual MMP-3 data 
was analyzed at that same visit, 78% of the test sites and 45% of the surgical control 
sites exhibited detectable MMP-3 levels. Whenever SL was detected, it was at least 1.5 
fold higher than the control wells which contains no samples. The surgical control sites 
exhibited lower levels when compared to the test sites. This implies that the increased 
SL level was due to both the inflammatory healing process and the presence of the 
resorbable membrane barrier. The membrane placement caused more increase in the 
fibroblast-derived SL than the surgical procedure alone. Thus both the inflammatory 
process and the membrane placement provided a stimulus for the fibroblasts to produce 
more MMP-3. Even though these cells were increased in number for both the test and 
surgical control sites during the healing period, only the cells at the test sites were 
producing more overall detectable MMP-3 levels, implying that the presence of the 
membrane was responsible for the increased MMP-3 levels. The SL detected by the 
ELISA method was in the proenzyme and the active enzyme state only, but it has to be 
bom in mind that it is highly likely that active MMP-3 reaching the crevice would 
readily bind to inhibitors and causes MMP-3 in GCF not to be detected by this method.
Though an increase in the inflammatory process is expected when the bioresorption 
process began at week 6, unfortunately no samples were taken at this time to study 
MMP-3 levels.
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4.5.1 Correlation between GCF Volume and MMP-3
There is a very weak correlation between these two variables. This demonstrated that an 
increase in the GCF volume does not necessarily increase the amount of stromelysin 
levels in that GCF. This makes sense as MMP-3 is locally derived from resident cells 
and not part of the serum transudate.
4.6 MMP-8 LEVELS
MMP-8 has been demonstrated as the main collagenase in GCF, saliva and inflamed 
gingivae in adult periodontitis patients (Sorsa et al., 1988; Ingman, 1996), but the 
mRNA levels of this protease has been shown to be the same in inflamed and normal 
gingivae in periodontitis patients (Aiba et al., 1996). mRNA of MMP-8 was also shown 
to be detectable in healthy patients (in 17%) as well as in periodontitis patients (46%) by 
Tonetti et a l (1993).
The levels of MMP-8 active form were predominantly quantified by the ELISA used in 
this study. At baseline, the highest activity was seen for the test sites which was 
statistically significantly different to the healthy control sites but not to the surgical 
control sites. Even though the test sites were active sites (BOP positive) they were not 
classified as progressive sites, thus the amount of active MMP-8 was not very much 
different to the adjacent site. Active sites are expected to have higher amount of active
MMP-8 than stable periodontitis and gingivitis sites based on observations by Lee et al.
(1995).
Previously MMP-8 was thought to be exclusively produced by PMN, but based on recent 
evidence MMP-8 has also been shown to be expressed by gingivae, periodontal ligament 
and mucosal fibroblasts (Chubinskaya et al, 1996; Cole et al., 1996; Cole & Kuettner, 
1995). PMN derived MMP-8 is influenced by PMN degranulation and pro-MMP-8 
activation while non-MMP-8 is most likely to be regulated by inflammatory mediators. 
The release of the latent PMN enzymes to the surrounding tissues can be stimulated by 
cytokines synthesized and secreted by host cells during the inflammatory process or by 
the interaction of PMN cells with whole microbial cells or microbial products (Page 
1991; Birkedal-Hansen, 1993b; Ding et al., 1995).
One week post-surgery, the activity of MMP-8 was increased for both the test and 
surgical control sites. Based on a review paper by Wikesjo et al., (1992) on early 
healing events, at week 1, the wound healing process would have gone through the early 
and late phase of inflammation while the granulation tissue formation process was still 
going on. During the early phase PMN predominates in the infiltrates and thus most 
probably contributes most of the MMP-8, while during the granulation tissue formation 
phase, fibroblasts are predominant. Based on this fact, it was postulated that the increase 
in the MMP-8 levels at week 1 was due to the fibroblasts. The presence of the 
bioresorbable membrane also seemed to be a factor determining the MMP-8 level, as the 
test sites with the membrane had higher levels compared to the sites without membrane.
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By the fourth week, the granulation tissue formation phase is almost over (Wikesjo et 
al., (1992), thus the levels of active MMP-8 decreased for both the test and surgical 
control sites. For the test sites, the MMP-8 levels did not decrease to the baseline levels, 
but halfway between the baseline and the week 1 values. However, the MMP-8 levels 
for the surgical control sites dropped to the baseline values. The difference seen could 
be related to the presence of the membranes at the test sites as stated earlier. The 
membranes in some way triggered more MMP-8 activation at these sites as evidently 
shown by the MMP-8 level at three months.
4.6.1 Correlation between MMP-8 Levels and Other Clinical Parameters
The baseline pocket depths for the three sites significantly influence the amount of 
MMP-8 present at baseline (p = 0.35, p<0.01). The deeper the initial pocket depth the 
higher the levels of MMP-8 found at that site. The levels of MMP-8 have been 
associated with disease activity as previously demonstrated by Lee et al, (1995). The 
GCF volume did not influence the MMP-8 levels. There was a significant positive 
correlation between the stromelysin level and the MMP-8 level (p = 0.49). This can be 
explained by the fact that MMP-3 has the ability to activate pro MMP-8. Active MMP-8 
levels has been shown to be high at actively diseased sites and in the present study was 
associated with early wound healing after surgery. The amount of active MMP-8 pre- 
operatively for the test sites was significantly and positively associated with the pocket
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depth reduction. This implies that the higher the diseased activity of the sites as 
measured by MMP-8 level the more the pocket depth reduction to be expected.
4.7 MICROBIOLOGICAL ASPECTS OF THE STUDY
The use of the Guidor® barrier membrane did not result in an increase in adverse 
bacteriological parameters, such as an increased proportion of anaerobic Gram negative 
black pigmented bacilli at wound sites. This is shown by the similar log CFU count of 
the total anaerobic flora at the pre-operative period and one week after membrane 
placement for the test and control sites in both groups. If the barrier membrane provided 
a colonization niche the level of microflora for the test sites would be much higher 
compared to the control sites which did not have the barrier membrane.
There was no significant difference in periodontal pathogens recovered from patients 
receiving antibiotics compared to no antibiotics. In view of the trend to increasing 
proportion of amoxycillin resistant isolates from the antibiotic group we would suggest 
that good oral hygiene measures and wound toilet are probably of more importance for 
successful surgery. From the microbiological point of view, the use of systemic 
antibiotics is not necessary to enhance the success rate of the GTR with resorbable 
membranes.
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4.8 GENERAL FINDINGS & ASPECTS OF FUTURE RESEARCH
The healing event in this study was uneventful, with no obvious gingival pathology 
caused by insertion of the barrier membranes. It is established in the present study that 
the use of 3g amoxycillin 1 hour-pre-operatively for the GTR procedures using Guidor® 
did not affect the clinical outcome, microbiological and protease level. The use of 
Guidor® membrane in infrabony defects resulted in PD reduction and a general gain in 
attachment levels as reported by other investigators (Gottlow et al., 1992a; 1992b; 
Laurell et al., 1992; 1994). It has been shown that the rate of periodontal destruction is 
higher in sites with infrabony defects compared to sites with horizontal destruction 
(Papapanou & Wennstrom; 1991). Recent evidence (Ehnevid & Jansson, 1998) suggests 
that healing in proximal sites with horizontal destruction after non-surgical treatment 
was impaired by the presence of a vertical destruction in the adjacent proximal site. 
Earlier the same investigators (Ehnevid et al, 1997) demonstrated that healing after non- 
surgical treatment was impaired in vertical defects compared to horizontal defects. So, 
not only is the vertical defect area at risk of further destruction, but the healing of the 
adjacent horizontal defects are also impaired. GTR procedure is one of the treatments of 
choice in treating infrabony defects the success of which has been demonstrated over the 
years.
The present study also demonstrated that to achieve the best possible clinical outcome 
following the GTR procedure, strict patient selection should be implemented. Patients 
should not have any deep infective pockets, as the presence of these pockets can harbour
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periodontopathogens which may affect the clinical results (Tonetti et al, 1993; Machtei 
et al., 1994).
This study has provided the evidence that MMP-3 and -8 are involved in the early 
remodeling phase following guided tissue regeneration and surgical procedures in the 
periodontium. This is not surprising as the periodontium is made up primarily of type I 
and El collagen which can be degraded by MMP-8 while MMP-3 degrades the core of 
the proteoglycan and is also involved in the activation of MMP-8.
For future studies, it would be most interesting if the different forms of MMP-3 and -8 
could be analyzed using Western Blotting. Western Blotting can characterize the 
different molecular sizes of the different state of the MMPs. This method has been used 
for MMP-8 and -9 (Sorsa et al., 1995; Ding et al., 1995; 1996; 1997) molecular forms 
and sizes characterization. By knowing the levels of each state at different points in the 
study, it may give a clearer picture of the role of MMPs in surgical wound healing and 
disease.
In conclusion, the present study provides evidence that collagen biosynthesis is taking 
place during the early phase of wound repair in the periodontium following conventional 
surgical treatment and the GTR procedure.
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